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Abstract 
Nanoparticles are structures of different dimensions (1-100 nm) and composition (metal 
oxides, organic acid polymers, silica polymers) present in the environment as a 
consequence of natural processes (such as volcanic eruptions or dusts erosion) or 
anthropogenic activities (industrialization or pollution). In the last decades they have been 
intensely studied and engineered for industrial applications (as additive of food, cosmetics 
and building materials) and medical purposes, where they can be employed as drug 
carriers or imaging agents. Thanks to its abundance, cheapness and resistance to a variety 
of environmental perturbations, silicon dioxide (SiO2) is one of the most widely used 
materials in both industrial and biomedical fields in its amorphous form (contrary to 
crystalline silica that causes silicosis, a chronic pulmonary disease common in 
occupational categories largely exposed to silica crystals, such a miners and ceramic 
workers). Despite amorphous silica is considered much less dangerous than crystalline 
silica, recent evidences have shown cytotoxic and pro-inflammatory potential in in vitro  
and animal models. To shed more light on this topic, in the first part of my PhD work I 
have characterized amorphous silica toxicity and inflammatory effects in primary human 
monocytes and macrophages (myeloid professional phagocytic cells) and on primary 
human lymphocytes and HeLa cells (lymphoid and epithelial non-phagocytic cells), using 
as nanoparticles model the commercial non labeled Ludox TM40 (29 nm Ø) and the 
fluorescein labeled Stöber (35 nm Ø). In particular, the influence of serum and the 
possible mechanisms determining silica nanoparticles (SiO2-NPs) effects have been 
investigated. I have found that SiO2-NPs toxicity (evaluated as mitochondrial dysfunction 
and plasma membrane permeabilization) was stronger in phagocytes (LD50 after 18 h 
exposure  40 µg/ml) and, in these cells, associated to the production of the three main 
inflammatory cytokines (IL-1 , TNF-  and IL-6). On the contrary, non phagocytic cells 
were much more resistant (LD50 after 18 h exposure  300-500 µg/ml) and, curiously, 
HeLa cells were subjected apoptosis after SiO2-NPs treatment (while monocytes, 
macrophages and lymphocytes became necrotic). Cytofluorimetric and confocal 
microscopy analysis have shown that SiO2-NPs were engulfed in acidic compartments 
(phagolysosomes) in monocytes and macrophages, while they mostly localized onto 
plasma membrane in HeLa cells. This suggested that the higher sensitivity of the two 
phagocytic models could be due to the more efficient internalization of the particles, 
followed by lysosomal rupture (as indicated by experiments showing the decrease of the 
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fluorescence associated to the lysosomotropic agent Lysotracker upon cellular exposure 
to high NPs doses) and the consequent liberation of lysosomal proteases (as reported in 
literature for crystalline silica). To investigate if acidic lysosomal pH could influence 
SiO2-NPs cytotoxicity in phagocytes, cells were treated with silica in the absence or in the 
presence of two pH neutralizing agents (NH4Cl and Bafilomycin AI), resulting in a 
significant protective effect in monocytes and in a negligible protection in macrophages.                                                             
As mentioned above, we found that in myeloid cells SiO2-NPs induced an inflammatory 
response (more pronounced in monocytes), starting in the correspondence of the 
beginning of cytotoxicity, reaching a peak and decreasing at high NPs doses because of 
the strong and anticipated cellular death. In particular, IL- was the cytokine most 
represented in both cellular types, while TNF-  and IL-6 levels were lowers. Moreover, 
in monocytes (and, in less degree in macrophages) IL-1  production was synergized by 
the co-stimulation with silica and lypopolisaccharide (LPS). Since crystalline silica is 
known to activate the NLRP3 inflammasome (a cytosolic multiprotein complex 
responsible of the production of some inflammatory cytokines, primarily IL-1 ) we 
investigated NLRP3 activation by amorphous SiO2-NPs in our myeloid cellular models. 
We found that monocytes and macrophages treatment with SiO2-NPs increased pro-IL1  
levels, and that its conversion into mature IL-1  involved caspase 1 activation, 
intracellular ATP release and subsequent binding to ATP receptor P2X7. Interestingly, 
P2X7 blockage did not affect SiO2-NPs induced cellular death in both cells, and caspase 1 
inhibition did not reduce SiO2-NPs toxicity in macrophages but showed a protective 
effect in monocytes, suggesting that amorphous silica might induce pyroptosis (a caspase 
1 dependent cellular death) in these cells.  
Afterwards, I have studied how serum could modulate SiO2-NPs toxicity and pro 
inflammatory effects. In the presence of increasing FCS amount both SiO2-NPs 
cytotoxicity threshold and LD50 were shifted to higher NPs doses, indicating a serum 
protective action (more pronounced in non-phagocytic cells in comparison to 
phagocytes). In parallel, also inflammatory cytokines production in myeloid cells 
occurred at higher NPs concentrations with the increment of FCS percentage. To 
investigate if the protective serum effect reflected a modification in NPs cellular 
association I have performed experiments with the fluorescent Stöber NPs, finding that 
the presence of serum strongly decreased NPs cellular binding in lymphocytes and HeLa, 
with a moderate reduction in monocytes and macrophages. This result was in accord with 
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the stronger serum protection in non phagocytic cells, and consolidated the hypothesis 
that SiO2-NPs toxicity depends on their interaction level with cells. Also SiO2-NPs 
cellular localization was affected by different serum concentrations. In particular, I have 
found that in the absence of serum SiO2-NPs mostly localized onto the plasma membrane 
in monocytes and HeLa, while in macrophages they were still internalized into 
phagolysosomes, even if with a lower efficiency. Considering this different NPs sub-
cellular localization, I have investigated if the protective effect of NH4Cl, Bafilomycin AI 
and caspase 1 inhibitor observed in monocytes in standard culture conditions (10% FCS) 
was maintained also in the absence of serum. Interestingly, neither acidic compartments 
neutralization nor caspase 1 blockage were able to reduce SiO2-NPs toxicity in serum free 
conditions, suggesting that monocytes cellular death mechanism was different with or 
without serum.  
In the second part of my PhD work I have studied several aspects of nanoparticles 
interaction with plasma and serum proteins, since this is a very important point in 
nanomaterials biomedical applications. Indeed, when nanoparticles (functioning as drug-
gene vectors or imaging agents) are introduced in the human body (primary, into the 
bloodstream), they are rapidly coated by a series of specific proteins, forming the so 
called “ nanoparticles corona” and mediating cellular response to nanomaterial. This 
problematic was approached by using Ludox TM40 as nanoparticles model (to maintain 
the continuity with the previous characterization work), and performing a comparative 
analysis between fetal calf serum and human plasma. I have found that the main proteins 
adsorbed to NPs surface were plasminogen, albumin, apolipoprotein AI (ApoAI), 
hemoglobin and apolipoprotein AII (ApoAII) from FCS, and immunoglobulins (IgG), 
histidine rich glycoprotein (HRG), albumin, apolipoprotein AI, apolipoprotein AII and 
apolipoprotein CIII (ApoCIII) from human plasma. In both situations, albumin (the most 
abundant plasma/serum protein) was the principal polypeptide bound to NPs at very low 
serum/plasma concentrations, while at greater serum/plasma doses it was displaced by 
less plentiful proteins (over all, apolipoproteins), indicating an higher affinity of these 
latter for SiO2-NPs surface. Congruent with this, NPs firstly absorbed plasminogen, 
apolipoproteins and hemoglobin, while once these proteins were depleted from serum 
albumin started to bind NPs surface proportionally to NPs dose. I have also found that the 
serum proteins pattern associated to NPs surface was not rearranged from a neutral 
environment (representative of cytosol) to an acidic environment (representative of endo-
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lysosomes). Finally, I have investigated how single plasma opsonines could influence 
SiO2-NPs biological activity, finding that IgG and HRG did not protect cells against NPs 
toxicity, while albumin and, over all, high density lipoproteins (the complexes containing 
ApoAI, ApoAII and ApoCIII) strongly reduced NPs adverse effects by inhibiting NPs 
cellular association.  
Part of this PhD work has been published on Nanomedicine (London) [186]. 
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Riassunto 
Le nanoparticelle sono strutture di diverse dimensioni (1-100 nm) e varia composizione 
(ossidi metallici, polimeri di silice, polimeri di acidi organici), presenti nell’ambiente 
come conseguenza di processi naturali (eruzioni vulcaniche, erosione di rocce) o 
antropogenici (inquinamento, attività industriale). Negli ultimi decenni esse sono state 
intensamente studiate e ingegnerizzate a scopo industriale (come additivi di cibi, 
cosmetici e materiali utilizzati nell’edilizia) e nell’ambito biomedico, in cui possono 
essere impiegate come vettori per farmaci o agenti di imaging. Grazie alla sua 
abbondanza, economicità e resistenza, il biossido di silicio (SiO2) è, nella sua forma 
amorfa, uno dei materiali maggiormente usati sia in ambito industriale che biomedico 
(contrariamente alla forma cristallina che provoca l’insorgenza della silicosi, una malattia 
polmonare cronica molto diffusa nei minatori, lavoratori di ceramica e altre categorie 
occupazionali quotidianamente esposte a cristalli/fibre di silicio). Nonostante la silice 
amorfa sia considerata molto meno pericolosa di quella cristallina, studi recenti condotti 
in vitro e su modelli animali hanno messo in luce un potenziale citotossico e pro 
infiammatorio. Per chiarificare questo aspetto, nella prima parte del mio dottorato ho 
caratterizzato la citotossicità e l’induzione di una risposta pro infiammatoria di 
nanoparticelle di silice amorfa (la variante commerciale non fluorescente Ludox TM40 e 
la variante fluorescente Stöber) su due modelli di cellula fagocitica (monociti e macrofagi 
primari umani) e in due modelli di cellula non fagocitica (linfociti primari umani e la 
linea stabile epiteliale HeLa). In particolare, mi sono concentrata sui possibili meccanismi 
coinvolti nell’azione delle nanoparticelle e su come il siero possa influenzarli. Un primo 
risultato ha indicato una maggior tossicità delle nanoparticelle di silice (valutata in 
termini di disfunzione mitocondriale e permeabilizzazione della membrana) nelle cellule 
fagocitiche, associata anche alla produzione delle tre principali citochine pro 
infiammatorie (IL-1 , TNF-  and IL-6). Più in dettaglio, la dose di nanoparticelle in 
grado di uccidere il 50% delle cellule (LD50) dopo un trattamento di 18 h è risultata 
essere di  40 µg/ml, mentre le cellule non fagocitiche hanno mostrato una maggior 
resistenza alle nanoparticelle (LD50  300-500 µg/ml). Analizzando il tipo di morte 
indotta dalle nanoparticelle di silice, le cellule HeLa hanno mostrato un fenotipo 
apoptotico, mentre i monociti, macrofagi e linfociti sono risultati andare incontro a 
necrosi. Da una valutazione al citofluorimetro e al microscopio confocale 
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dell’associazione e della localizzazione cellulare delle nanoparticelle è emerso che queste 
venivano internalizzate in compartimenti acidi nelle due cellule fagocitiche, mentre nelle 
cellule HeLa rimanevano legate alla membrana plasmatica. Questo risultato ha suggerito 
che la maggior sensibilità dei fagociti fosse dovuta a una maggior captazione delle 
nanoparticelle che, una volta accumulate all’interno di endo-lisosomi, potessero 
provocarne la rottura con la conseguente liberazione di enzimi litici (proteasi, idrolasi, 
lipasi) in grado di danneggiare la cellula. A questo proposito, è stato valutato il contributo 
dell’ambiente acido degli endo-lisosomi alla tossicità delle nanoparticelle di silice nei 
fagociti trattando le cellule in presenza o in assenza di due agenti neutralizzanti (NH4Cl o 
Bafilomicina AI), ottenendo una diminuzione della citotossicità della silice nei monociti e 
solo un lieve effetto nei macrofagi.  
Come anticipato precedentemente, le nanoparticelle di silice si sono mostrate in grado di 
indurre una risposta infiammatoria (più evidente nei monociti) caratterizzata da 
un’iniziale fase di latenza fino al raggiungimento della soglia di tossicità, un picco 
centrale e una fase finale decrescente (in corrispondenza delle dosi più alte di 
nanoparticelle) a causa della forte e anticipata morte cellulare. In particolare, l’ IL-1 è 
risultata essere la citochina prodotta più abbondantemente, seguita dal TNF-  e dall’IL-6; 
inoltre, in copresenza di nanoparticelle e LPS essa veniva secreta in modo sinergico. Dal 
momento che la silice cristallina è in grado di attivare l’inflammasoma NLRP3 (un 
complesso multi proteico citosolico responsabile della produzione di alcune citochine pro 
infiammatorie, prima fra tutte l’ IL-1 una parte del lavoro di tesi è stata dedicata allo 
studio dell’attivazione di NLRP3 da parte di nanoparticelle di silice amorfa nei nostri due 
modelli di cellula fagocitica. Inizialmente è stata evidenziata sia in monociti che in 
macrofagi la capacità delle nanoparticelle di silice amorfa di aumentare i livelli di pro 
IL1- e stimolarne la conversione nella forma matura IL-1 tramite un processo 
dipendente dall’attivazione della caspasi 1, della secrezione di ATP ed dal successivo 
legame di ATP al suo recettore P2X7. Inoltre, a seguito del blocco di P2X7 con uno 
specifico inibitore la mortalità indotta dalle nanoparticelle di silice non ha subito 
variazioni sia nei monociti che nei macrofagi, mentre i monociti hanno mostrato una 
maggior resistenza alle nanoparticelle in presenza di un inibitore della caspasi 1, segno di 
una possibile morte per piroptosi causata dalle nanoparticelle in queste cellule.                    
Un altro aspetto importante presentato in questa tesi di dottorato riguarda l’influenza del 
siero (FCS) sugli effetti citotossici e pro infiammatori indotti dalle nanoparticelle di silice 
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amorfa. Innanzitutto, all’aumentare della concentrazione del siero sia la soglia di tossicità 
sia l’LD50 delle nanoparticelle di silice sono risultate spostate verso valori più alti, 
indicando un effetto protettivo dell’ FCS (più evidente nei non fagociti rispetto ai 
fagociti), cosi come la produzione di citochine pro infiammatorie nei monociti e nei 
macrofagi. Per capire se questo spostamento fosse dovuto a una diversa associazione 
delle nanoparticelle alle cellule sono stati fatti esperimenti con le nanoparticelle 
fluorescenti Stöber, che hanno evidenziato come la presenza di siero fosse in grado di 
diminuire il legame fra la nanoparticelle e le cellule, in particolare nel caso dei linfociti e 
delle HeLa. Questo risultato è in accordo con la precedente osservazione di un maggior 
effetto protettivo del siero nei non fagociti, e rafforza l’ipotesi che la tossicità delle 
nanoparticelle sia in qualche modo legata al loro livello di interazione con le cellule. 
Inoltre, anche la localizzazione intracellulare delle nanoparticelle è risultata essere 
influenzata dalla concentrazione di siero. In particolare, in assenza di siero le 
nanoparticelle erano prevalentemente distribuite sulla membrana cellulare nei monociti e 
nelle HeLa, mentre nei macrofagi venivano internalizzate in fago-lisosomi, anche se 
meno efficientemente che con 10% FCS. Vista la diversa localizzazione subcellulare nelle 
due diverse condizioni di siero, ci si è chiesti se l’effetto protettivo dell’ NH4CL, 
Bafilomicina AI e dell’inibitore della caspasi 1 osservato nei monociti nelle condizioni di 
coltura standard (10% FCS) venisse mantenuto anche in assenza di siero. Né la 
neutralizzazione dei compartimenti acidi né l’inibizione della caspasi 1 si sono dimostrati 
efficaci nel prevenire la tossicità, indicando che nei monociti il meccanismo di morte 
cellulare fosse diverso in assenza o in presenza di siero.  
Nella seconda parte della mia tesi di dottorato ho analizzato diversi aspetti 
dell’interazione delle nanoparticelle con le proteine del plasma e del siero, essendo questo 
un aspetto cruciale nell’applicazione dei nanomateriali in campo biomedico. Infatti, 
nanoparticelle introdotte nell’organismo (in particolare del circolo sanguigno come 
vettori per farmaci o agenti d’immagine) vengono rapidamente rivestite da una serie di 
proteine (costituenti la cosiddetta “corona di proteine”) in grado di mediare l’interazione 
cellula-nanoparticella. Questa problematica è stata affrontata utilizzando come 
nanoparticelle modello le Ludox TM40 (per mantenere la continuità con la 
caratterizzazione fatta in precedenza) ed eseguendo esperimenti in parallelo con il siero 
fetale bovino ed il plasma umano. Le principali proteine del siero bovino legate alle 
nanoparticelle di silice sono risultate essere il plasminogeno, l’albumina, le 
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apolipoproteine AI e AII e l’emoglobina, mentre quelle del plasma umano le 
immunoglobuline, l’histidine rich glycoprotein, l’albumina e le apolipoproteine AI, AII e 
CIII. Il pattern di proteine adsorbite alle nanoparticelle di silice ha evidenziato che a basse 
concentrazioni di siero/plasma la principale proteina legata era l’albumina (la proteina più 
abbondante del siero/plasma), mentre all’aumentare della concentrazione di siero/plasma 
essa veniva “spiazzata” da proteine meno abbondanti (in primis dalle apolipoproteine), 
suggerendo una maggiore affinità di queste ultime per la superficie di nanoparticelle di 
silice amorfa. In accordo con questa ipotesi, le nanoparticelle inizialmente legavano il 
plasminogeno, l’emoglobina e le apolipoproteine, mentre solo quando queste proteine 
venivano esaurite dal siero (in presenza di alte dosi di nanoparticelle) iniziava a legarsi 
l’albumina, proporzionalmente alla quantità di nanoparticelle presenti. Dall’analisi del 
pattern di proteine legate alla silice in presenza di differenti pH è emerso che esso non 
subiva variazioni rilevanti in presenza di un ambiente neutro (rappresentativo del 
citoplasma) o di un ambiente acido (rappresentativo degli endo-lisosomi). Infine, 
esperimenti preliminari su come le singole proteine della corona potessero influenzare 
l’attività biologica delle nanoparticelle hanno indicato né le immunoglobuline né l’HRG 
erano in grado di diminuire gli effetti citotossici delle nanoparticelle, mentre l’albumina e, 
in particolare, le HDL erano fortemente protettive, riducendo l’associazione delle 
nanoparticelle alle cellule.  
Una parte di questo lavoro di dottorato è stata pubblicata sulla rivista Nanomedicine 
(London) [186].  
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Aim of the thesis 
The first objective of this PhD thesis is to characterize the cytotoxic and pro inflammatory 
potential of amorphous silica nanoparticles, since they are widely used in the industrial 
field for the manufacture of several products and they are very similar to the well known 
crystalline silica (responsible of the development of silicosis and other pulmonary 
pathologies). In particular, we focused on the differential mechanism of action of SiO2-
NPs on our cellular models (primary human monocytes and macrophages, representative 
of myeloid professional phagocytes population, and primary human lymphocytes and 
HeLa cells, representative of non phagocytic cells), considering also its modulation by 
serum. The evaluation of serum influence of SiO2-NPs biological effects acquires big 
importance in view of the fact that nanoparticles used for biomedical purposes (as 
imaging agents or drug carriers) are mainly administered by intravenous injection so that, 
once in the bloodstream, they are coated by specific plasma proteins modulating 
nanomaterials biological effects. In the light of this, the second aim of my thesis is to 
identify the principal bovine serum and plasma proteins (representative of an in vitro and 
in vivo condition, respectively) absorbed on SiO2-NPs surface, to characterize some 
important aspects of this interaction (such as the evolving of protein “corona”, the affinity 
and the dependence on pH) and, finally, to investigate how the single absorbed proteins 
can modulate SiO2-NPs biological activity (e.g. promoting NPs cytotoxicity or exerting 
protective effects on cells.).  
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1. Introduction 
1.1 Nanoparticles  
Nanomaterials are defined as particles or systems that have at least one dimension less 
than 100 nanometers (nm) in length. In particular they can be classified in nanoplates 
(nanoscale only in one dimension), nanofibers (nanoscale in two dimensions) and 
nanoparticles (nanoscale in all three dimensions) [1]. They can have different shapes 
(tubes, spheres, crystals, wires), composition (inorganic or organic compounds) and 
dimensions, depending on their origin [2]. Natural processes such as desert storms, 
volcanic eruptions, and ocean evaporations are the primary source of nanoparticles 
present in the environment [2]. In addition, the advent of the industrial revolution and 
technological progress has introduced new typologies of nanoparticles, called 
“anthropogenic” because they derive from human activities. A first category of these 
particles includes nanoparticles unintentionally generated by anthropogenic processes 
(unintentional nanoparticles) [3], like ultrafine particles released in diesel and other 
engines exhausts, fumes of industry and incinerators and indoor pollution derived from 
common activities (cooking, cleaning and smoking) [4]. A second large category is 
related to nanoparticles intentionally produced by humans and used in industrial and 
biomedical fields. 
1.1.1 Nanoparticles for industrial applications 
The main characteristic that has determined a wide use of nanoparticles in industry is the 
large ratio of surface area to volume (that increases exponentially with decreasing particle 
size) [3]. This means that an increasingly high percent of atoms are located on the surface 
in smaller and smaller nanoparticles, while in a bulk material they are virtually all in the 
inner part of the structure, and that the same mass unit is composed by a higher particles 
number with their large surface area, in comparison to macro or micro material (Figure 
1). As a consequence, nanomaterials have much more point of interaction with 
environment (e.g., a solvent) or surrounding nanostructures, with a strong influence of 
physical – chemical properties (increased reactivity, solubility and stability). For 
example, gold is an inert element at a macroscale dimension, while gold nanoparticles 
(nanoscale) become reactive and can be used to catalyze reactions [5]. 
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Figure 1: (a) Surface molecules as function of particle size [3]. (b) Exemplification of surface area 
increment in the presence of smaller objects keeping the same total volume. 
An emerging field for nanoparticles applications is the food industry, where they are 
employed as coloring or clarifying agents for beverages, additives to enhance flavors, 
preservants and packaging materials [6]. Other common applications are cosmetic (e.g. 
titanium dioxide nanoparticles are used as sunscreen and silver nanoparticles are present 
in different products as antibacterial/antifungal agents), building trade (e.g., for thermal 
insulation) and others, as summarized in [2]. 
1.1.2 Nanoparticles for biomedical applications 
The peculiar characteristics of nanomaterials have determined, in the past decades, an 
increasing interest around the use of nanotechnology in biological and medical fields. The 
new discipline concerning these purposes is nanomedicine, defined as an “application of 
nanotechnology for treatment, diagnosis, monitoring and control of biological systems” 
[7]. Traditional medicine presents many limits for the diagnosis and treatment of 
pathologies, for example, it acts at a “macro” level (losing sensitivity and specificity), and 
it is non-site-specific targeting (so high doses of therapeutic agent must be administrated 
to obtain the desired effect at the designated area, but several aspecific side effects may 
develop) [8,9]. Moreover, drugs have often poor solubility and short half life in the blood 
circulation, sometimes they cause undesired immune reactions and other adverse effects, 
so their administration can be problematic [7-10]. Nanomedical studies have developed a 
series of nanostructures of different dimensions and chemical composition that are 
expected to solve many problems related to canonical medicine (Figure 2). First of all, 
nanosystems have a size (1-100 nm) comparable to biological structures (DNA, proteins, 
macromolecular assemblies) and can easily interact with them. They can act as “carriers” 
for insoluble drugs, that are entrapped in the inner cavity or exposed on the surface of 
nanosystems and can reach the target area without losing their concentration and 
effectiveness (so, they can be administered at a lower dose). Moreover, nanocarriers can 
19 
 
be largely modified in their chemical composition, in order to acquire several advantages 
for drug delivery and imaging. For instance, to improve the specificity of target they are 
often conjugated with a specific molecule (e.g. a peptide or an antibody) that recognize, 
for example, a receptor present or over-expressed in a particular tissue (e.g., in neoplastic 
formations). Once reached the interested area, therapeutic and diagnostic agents can be 
selectively activated and released by changes in the environmental conditions (by 
modifying pH or applying a magnetic field or an external heat source) [7,11,12]. Another 
common modification is the attachment of units of polyethylene glycol (PEG), a non 
toxic and non-immunogenic polymer with an high hydrophilicity, that reduces the 
adsorption to nanoparticles surface of plasma proteins (the so called “opsonines”), usually 
promoters of the NPs clearance by macrophages of the reticuloendothelial system (RES) 
[9]. 
 
Figure 2: schematic illustration of  nanoparticles used in medicine. (a) liposome: concentric bilayered 
vesicle in which an aqueous volume is entirely enclosed by one or more lipid bilayers mainly composed of 
natural or synthetic phospholipids. Drug molecules can be either entrapped in the aqueous space or 
intercalated into the layer. (b) polymeric micelle: spheroidal structure with an hydrophobic core shielded 
from the water by a mantle of hydrophobic groups. They are used for the delivery of water insoluble drugs 
that, once trapped within the hydrophobic core, can be dispersed in aqueous media such as bloodstream. (c) 
polymeric nanoparticle: spherical polymers of biodegradable materials, such as polylactic acid (PLA) or 
polylactic-glycolic acid (PLGA). Drugs are entrapped into the matrix, and functional groups can be 
conjugated to the surface. (d) dendrimer: highly branched macromolecule with a three dimensional 
architecture growing from a central core through a series of convergent or divergent polymerizations 
reactions. Drug molecules can be loaded inside the central core or attached to the surface groups. (e): 
ceramic nanoparticle: nanoparticle made up of inorganic (ceramic) compounds either metals (iron, gold, 
alumina, titanium) or non metals (silica). (f): carbon nanotube: sheets made of > 60 carbon atoms 
(fullerenes) rolled up into a tubular form (one sheet: single-walled nanotube; several concentric sheets: 
multi-walled nanotubes). Modified from [9]. 
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1.2 Nanotoxicology 
The present day increasing exposition of humans to nanoparticles has pointed the 
attention on the possible side effects of these systems (considering their high reactivity 
and “foreign nature” for human body). A new branch of toxicology, “nanotoxicology”, 
has been proposed to address the gap in knowledge and specifically address the 
understanding of possible adverse health effects caused by nanomaterials [13]. 
Nanotoxicology purpose is to study physicochemical determinants, routes of exposure, 
biodistribution, molecular determinants and genotoxicity of nanomaterials, and to 
deliberate protocols for nanoparticles-associated risk assessment in humans and 
environment [14]. 
1.2.1 Route of exposure to nanomaterials and possible consequences 
Because of their small-scale dimension, nanomaterials can easily cross biological barriers 
and enter into the body through several routes. The major portal for nanomaterials in 
body is the respiratory system, through inhalation. Once inside the respiratory tract, 
nanoparticles can be subjected to chemical or physical clearance processes [15]. The first 
case occurs when nanoparticles are biosoluble and involves their rapid dissolution in 
extracellular or intracellular fluids. On the contrary, if nanoparticles are insoluble, they 
are subjected to slow physical translocation in different ways, depending on their size and 
on the region they are located in. Bigger particles (> 2.5 µm) are usually cleared by the 
mucociliary escalator system [16] and enter the gastrointestinal tract, where they are 
usually excreted. Smaller particles can enter the blood or lymph and be distributed in 
other districts of the body, reaching the central nervous system via sensory neurons [17] 
or being phagocytized by resident alveolar macrophages, that are attracted in the site of 
particles deposition by specific chemotactic signals [18,19]. 
The way of exposure to nanoparticles present in the environment or in cosmetics is skin, a 
1.5-2 m
2
 organ composed of three main layers: epidermidis (external), dermis 
(intermediate) and subcutaneous (inner) [1,3,14]. The principal sites of dermal 
penetration are hair follicles [20] and broken skin [3], but it has been shown that very 
small nanoparticles (< 10 nm) are able to cross spontaneously epidermidis and dermis. 
Once inside the deepest layers of skin, nanoparticles can be recognized by the resident 
macrophages and dendritic cells (Langherans cells) with a possible consequent 
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inflammatory response [21], or reach other districts of the body through the lymphatic 
and blood vessels network [3]. In addition, they can exert toxic effects on epidermal cells 
(keratinocytes and fibroblasts) [22]. 
Another possibility is nanoparticles contact with the gastrointestinal tract after ingestion 
(if they are present in food or water) or after the mucociliary clearance from the 
respiratory tract [3,14]. Few data are currently available on this topic and it is generally 
assumed that the large majority of ingested NPs are rapidly eliminated via feces or urine 
[23]. However a limited, but biologically relevant, translocation at the level of the 
gastrointestinal mucosa, cannot be excluded, especially for nanostructured food-additives, 
like amorphous silica based ones [24]. 
Nanoparticles used in biomedical applications (as carriers of drugs or imaging agents) are 
mostly designed to be injected in the blood circulation and get distributed to several 
organs, where they can accumulate or be cleared more or less efficiently. An important 
aspect to consider is that, once in blood, NPs come in contact with several soluble 
molecules naturally present in circulation (e.g. coagulation factors or complements 
proteins), determining possible adverse effects (complement activation, thrombosis). 
Furthermore, the huge amount of proteins present in plasma can absorb to NPs surface 
(forming the so called “nanoparticles corona”) and mediate many cellular processes in 
response to a foreign material introduced in the bloodstream [25-27, 180-181]. This 
central aspect, will be better considered in the next paragraph.  
1.2.2 Nanoparticles interaction with plasma proteins 
Plasma, the acellular portion of blood, is a very concentrated solution containing small 
and macromolecular solutes. Among these latter, we can find more than 3,700 different 
protein types [26] present in variable concentrations, ranging from < pg/ml to > mg/ml. 
Plasma proteins are involved in several essential physiological processes, such as 
coagulation, immune response and inflammation, lipid metabolism, proliferation, 
signaling, proteolysis and transport [28]. Since the majority of nanosystems for 
biomedical applications is developed for intravenous injection, many studies have 
concentrated on NPs interaction with plasma proteins and its possible influence of 
cellular/organism response. Indeed, it is universally accepted that the biological fate and 
biodistribution of NPs do not depend on nanoparticle per se but on the particle “dressed” 
with its protein corona, as this is the real system that cells see and respond to [26,29,181]. 
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Physicochemical aspects 
Plasma proteins adsorption to nanoparticles surface is driven by several interactions that 
are established at the nano-bio interface (hydrophobic, electrostatic, steric, Van der Walls 
forces and hydrogen bonds). Each nanoparticle type presents peculiar surface properties 
(determined by chemical composition, surface functionalization, shape and angle of 
curvature, porosity and crystallinity, hydrophobicity and hydrophilicity) that influence the 
nature of proteins that bind the surface, determining a specific protein pattern adsorbed to 
different NPs typologies [181]. However, it has been reported that the vast majority of 
nanoparticles studied so far binds apolipoproteins, which are proteins belonging to 
lipoprotein complexes (VLDL-LDL-HDL) responsible of lipid transport. In addition, 
Hellstrand et al. recently documented the presence of complete HDL in the biomolecular 
corona surrounding polymeric NPs [30], indicating that not only the proteic component 
but also the lipidic/saccharidic ones can compose NPs corona. This preferential binding 
of apolipoproteins/lipoproteins to different classes of nanoparticles can be explained 
considering that, similarly to nanostructures, lipoprotein complexes have dimension in the 
nanoscale (Figure 3) and so their reciprocal binding can be driven by size or curvature 
dependent interactions [30,180]. Other plasma polypeptides often found in the corona of 
several NPs are albumin, immunoglobulins and coagulation factors (e.g., fibrinogen) 
(Table 1), but their ubiquity is probably due to their high plasma concentration (> 10 
mg/ml).  
 
Figure 3: Size comparison of a 70 nm generic nanoparticle with lipoprotein complexes - chylomicrons, 
very low, low, and high density lipoproteins [180].  
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Table 1: Summary outlining various nanoparticles and the proteins they bind. Modified from [25]. 
Protein adsorption on NPs surface is a very rapid process occurring within seconds-
minutes, and, most importantly, is highly dynamic, with continuous association and 
dissociation events over time. In particular, it has been found, as a general trend, that the 
more plentiful plasma proteins (like albumin) first absorb to NPs, independently on their 
affinity for NPs surface. However, subsequently these proteins are displaced by less 
abundant proteins endowed with a higher affinity for a certain nanoparticle type [31,32]. 
The whole process of competitive adsorption of proteins onto a limited surface based on 
abundance, affinities and incubation time is collectively known as “Vroman Effect” [25], 
from the name of the author that firstly documented these changes of NPs corona 
composition [33]. A consequence of the Vroman effect is that the pattern of protein 
bound to a given NP at low serum concentrations, corresponding to a situation in which 
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high affinity but scarce proteins are limiting and negligible, reflects the pattern present at 
early time, while the pattern in high serum concentrations reflects that occurring in the 
second, slower phase, in which there is a displacement of abundant low affinity binding 
components by less concentrated high affinity ones. The “Vroman Effect” can be 
explained considering the balance between association rate (kon) and dissociation rate 
(koff) of a protein to a nanomaterial, defined as the dissociation constant Kd (normally 
varying from 10
-4
 M to 10
-9
 M). The value of kon, which depends on the frequency of 
contact between the protein and the nanomaterial, is high in abundant plasma proteins 
that, thanks to their huge amount, have large probability to interact with NPs surface. 
Once binding is established, if proteins have a low koff (which depends on the binding 
energy of the protein-nanomaterial complex) they remain attached to NPs while, in the 
opposite case (low binding energy), they dissociate within minutes leaving space for the 
binding of less plentiful proteins (low association rate) with higher affinity [29]. To 
distinguish these two series of proteins differently adsorbing onto NPs surface the terms 
“soft” and “hard” corona have been introduced, indicating respectively polypeptides that 
rapidly dissociate from NPs and high affinity proteins stable on NPs surface determining 
the final molecular signature of a particle in a certain environment [29,34,35]. As a 
confirmation that apolipoproteins present a large propensity for NPs binding, several 
studies have documented their ability to displace much more plentiful plasma proteins 
(albumin, fibrinogen, immunoglobulins) from the surface of different NPs types, finally 
constituting the “hard” NPs protein corona [31,32,36,37,181]. The process of protein 
exchange may also be important when particles redistribute from one compartment or 
organ to another. For example upon NPs i) diffusion from the bloodstream to the 
interstitial space; ii) cell uptake with possible transport to endocytic acidic compartments; 
iii) cytosol translocation possibly followed by organelle targeting (mitochondria, nucleus) 
[180]. 
Another important aspect concerning macromolecules interaction with NPs is that 
proteins can undergo conformational changes, leading to either a loss or a gain of the -
helix content at the expense of random coil structures without affecting their catalytic 
activity [38], while TiO2-NPs induce a transition of -helix into -sheets resulting in a 
substantial inactivation of lysozyme [39]. In other cases, the interaction of a protein with 
NPs can determine the exposure of amino-acid residues normally buried in its core. For 
example, fibrinogen binding to poly(acrylic acid) polymer-coated gold nanoparticles 
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determines the exposition of a cryptic peptide that specifically interacts with macrophages 
Mac-1 receptors resulting in the activation of nuclear factor B (NF- B) signaling 
pathway and the release of inflammatory cytokines [40].  
Functional aspects 
One of the main problems concerning NPs injection into the bloodstream is their rapid 
clearance from the circulation by the cells of the mononuclear phagocytic system (MPS), 
also known as the reticuloendothelial system (RES), represented by monocytes and 
macrophages located in the liver (Kupffer cells) or in the spleen and specialized in the 
engulfment of foreign particles (viruses, bacteria, cellular debris or “non-biological” 
entities). Once internalized by phagocytes, NPs became ineffective as site-specific 
delivery devices (they cannot reach the target tissue/organ). Moreover, if they are non-
biodegradable (resistant to enzymes and other oxidative reactive chemical factor normally 
produced to break down the phagocytized material) or with a molecular weight higher 
than renal threshold (only molecules of around 5,000 Da can be removed by renal 
system), they accumulate in the MPS organs leading to possible cytotoxic and 
inflammatory events [25,41]. In the majority of cases, phagocytes of the MPS cannot 
identify the nanoparticles themselves, but rather recognize specific proteins (the so called 
“opsonins”) bound to the surface of the particles that promote phagocytic event (for 
example, recognizing a particular receptor expressed on cellular membrane). The most 
common opsonins are complement proteins such as C3, C4, C5, and immunoglobulins, 
which respectively bind complement receptors or Fc receptors present on macrophages 
[42]. Recently, several methods of camouflaging or masking nanoparticles from possible 
opsonins have been developed, in order to increase NPs blood circulation half life. As a 
general rule, NPs surface has been modified by adding chemical groups (such as long 
hydrophilic polymer chains or non-ionic surfactants) which can block the electrostatic 
and hydrophobic interactions at the nano bio-interface (indeed, a charged or hydrophobic 
surface is more prone to adsorb serum proteins) [41]. The most common modification is 
“PEGylation”, which consists in the covalent linkage of poly ethylene glycol (PEG) 
chains on NPs surface [25]. PEG is an hydrophilic and neutral polymer of ethylene oxide 
(C2H4O) with different weight and length, depending on the number of the repeated units. 
Several studies have demonstrated that PEG addition not only reduces the amount of 
proteins adsorbed to NPs [43,44] but also particles uptake and its possible connected 
adverse effects, such as toxicity and inflammatory response [43-46]. Protein binding to 
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NPs is, however, a still debated question, because in addition to opsonins there are also 
molecules promoting prolonged circulation times in the blood (“dysopsonins”, e.g. 
albumin [32,47]) or useful for distribution of the particles in organs otherwise 
inaccessible. For example, it has been found that NPs coated with ApoE or ApoB 
(apolipoproteins belonging to low density lipoproteins (LDL) complexes) can cross the 
blood brain barrier (BBB) through the binding to LDL receptors, that are specifically up-
regulated on the surface of the endothelium forming BBB, and consequently can act as 
“Trojan Horses” for drugs destinated to the Central nervous System [48,49]. In 
conclusion, a systematic biochemical and functional study of plasma proteins adsorbing 
to NPs surface is required, with the final aim to target nanomaterials at a determined site 
by attaching a particular plasma protein ex vivo or, alternatively, by engineering 
nanoparticles preferentially binding specific molecules that direct them at the desired 
district.  
 
Figure 4: Effects of NPs on proteins, and the forces of interactions [181]. 
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1.3 Silica Nanoparticles 
1.3.1 Silicon dioxide 
Silicon dioxide (SiO2) is, after oxygen, the second most abundant compound present on 
Earth’s crust, as a major component of rocks, sands and environmental dusts. SiO2 
derives from the condensation of silicic acid -Si(OH)4- monomers through formation of 
siloxane bonds and water (Figure 5a). Usually, silicic acid polymerization occurs when its 
concentration exceeds 2*10
-3
 M [50]. This simple reaction can be repeated hundreds of 
times, forming a regular structure in the space where silicon is tetrahedrically 
coordinatinated with 4 oxygen atoms (Figure 5b). 
 
Figure 5: (a) Polymerization of silicic acid molecules through formation of siloxane bond and water [50]. 
(b) three-dimensional structure of silicon dioxide. (c) structure of amorphous silica, (d) structure of 
crystalline silica, (e) glass, an example of amorphous silica (f) quartz, an example of crystalline silica. 
Silica can be present in amorphous form (glass, opal) or in crystalline form (quartz, 
cristobalite), depending on the disposition of atoms in the lattice. In amorphous silica, 
tetrahedral are randomly connected while in crystalline silica the arrangement of all the 
atoms is ordered in all dimensions [50]. This difference can be appreciate at microscopic 
level by X-ray diffraction experiments (Figure 5 c, d) and also at macroscopic level 
(Figure 5 e, f).  
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1.3.2 Silica nanoparticles applications 
Thanks to its abundance and cheapness, silicon has been largely employed in several 
fields in the form of silica nanoparticles (SiO2-NPs). A first application is at the industrial 
level, where SiO2-NPs (e.g. the commercial available Ludox®) are used as additives in 
the production of toners, varnishes, anticorrosive coatings, cosmetics and food (for 
example, as clarifying agents for beverages or anticaking agents in powdered products) 
[24,50]. Another common employment is in the biomedical sector, where SiO2-NPs have 
been proposed for drug delivery, DNA transfection, imaging and enzyme immobilization. 
In particular, SiO2-NPs (and, in general, all ceramic nanoparticles) appear to be preferable 
than other types of NPs (organic polymers, liposomes and dendrimers) because of their 
rigidity and chemical stability, conferring a higher resistance to the denaturing effects of 
pH, solvent or temperature [8,45] and their transparency (that allows the conjugation with 
photoactivable compounds). Moreover, the presence of superficial silanol groups (Si-OH) 
confers an high hydrophilicity (by forming hydrogen bonds with the surrounding water 
molecules), that decreases to some extent the adsorption of plasma proteins (opsonins) on 
SiO2-NPs surface, compared with other materials, and their consequent clearance by 
macrophages of RES, incrementing their circulation time in the blood [182]. 
SiO2-NPs are generally synthesized following three principal methods (I, II, III, Figure 6). 
Stöber synthesis is based on the hydrolysis and condensation of tetraethylortosilicate 
(TEOS) in ethanol, in the presence of ammonia as catalyst [183]. NPs dimension depend 
on the amount of water and ammonia in the reaction. In the microemulsion protocol, 
SiO2-NPs are produced by the hydrolysis of TEOS in the presence of ammonia (catalyst), 
a non-ionic surfactant and a microemulsion of water in octane [51]. In Prasad synthesis, 
vinyltriethoxysilane (VTES) units polymerize in the hydrophobic core of detergent 
micelles (e.g. Brij 35). This method has been employed to synthesize ORMOSIL-NPs 
(organically modified silica nanoparticles) that, thanks to the possibility of entrapping 
hydrophobic molecules in the lipophylic core of micellar aggregates, can be modified by 
the addition of several biomolecules (such as PEG, targeting agents or drugs) [45] 
improving the biocompatibility, selectivity and therapeutic efficacy or SiO2-NPs for 
biomedical applications. Owing to these advantages provided by ORMOSIL-NPs (first of 
all, the much less adverse effects on health in comparison to amorphous and crystalline 
silica), they have become the primary SiO2-NPs studied in the field of nanomedicine.  
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Figure 6: Synthesis methods of silica nanoparticles. 
1.3.3 The toxicity of silica 
Prolonged or chronic exposure to silica crystals induces silicosis, one of the oldest 
occupational diseases documented in particular in miners and ceramic workers [52-54]. 
Once inhaled, because of their micro-nanoscale dimension and fiber shape, silica crystals 
easily accumulate in small airways of the lungs, where mucocilial clearance is not 
functional and where they are ingested by resident macrophages (alveolar macrophages) 
[54]. As non-biodegradable material, phagocytized crystals stimulate the secretion of 
inflammatory cytokines and chemokines from alveolar macrophages and also alveolar 
epithelial cells [55] with an auto-sustained mechanism, indeed uptake of silica crystals 
can initiate apoptotic cell death with concomitant release of ingested material, which is 
re-engulfed by other macrophages inducing a new cycle of inflammation [56]. Some 
cytokines released by macrophages, such as interleukin-1 (IL-1), tumor necrosis factor  
(TNF- , platelet derived growth factor (PDGF), fibronectin and type-1 insulin like 
growth factor promote fibroblasts proliferation and collagen synthesis, leading the 
formation of fibrotic scars that replace pulmonary tissue damaged by excessive/prolonged 
inflammation and reactive oxygen species production [55,57]. As final result, lungs 
undergo a progressive failure and, in some cases, also pulmonary cancer can be 
developed. Due to this evidence, in 1997 the International Agency of Research on Cancer 
(IARC) has classified some crystalline silica polymorphs (quartz and cristobalite) in 
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group 1 (sufficient evidences for the carcinogenicity to experimental animals and to 
humans) [50]. 
Amorphous silica (probably because of its less fibrogenic nature) is not considered as 
toxic as crystalline (it was classified by IARC in group 3 – inadequate evidence for 
carcinogenicity), but several in vitro and in vivo studies have documented possible 
adverse effects occurring after amorphous silica exposure. Chang et al. [58] reported that 
amorphous silica causes a reduction of mitochondrial activity and plasma membrane 
permeabilization in human normal and tumor cells belonging to district most exposed to 
NPs (lungs, gastrointestinal system and skin), with a more pronounced toxicity on non-
tumoral cells. Similar metabolic and membrane damages have been described in mouse 
keratinocytes [184], human endothelial cells [50,59], murine macrophages [60] and 
fibroblasts [61], and rat myocardial cells [62]. Interestingly, in comparative studies with 
nanoparticles of different sizes cellular toxicity was stronger upon treatment with small 
NPs. For instance in rat cardiomyocites LD50 of 21 nm NPs (0.32 mg/ml) was 
significantly lower than LD50 of 48 nm NPs (1.29 mg/ml) [62], in human endothelial 
cells LD50 of 15 nm NPs was 5 times lower than that of 60 nm NPs (50 µg/cm
-2 
vs 250 
µg/cm
-2
) [50] and 30-48 nm NPs killed more effectively mouse keratinocytes than 118-
535 nm NPs [184]. Confirming that increased cytotoxicity of smallest NPs depends on 
their higher surface area, Waters et al. have shown that the expression of cellular viability 
as a function of surface concentration (cm
2
/ml) instead of mass concentration (µg/ml) 
results in the convergence of different size particles dose-response curves [63].  
In addition to mitochondrial and membrane damage, also the ability of SiO2-NPs to 
induce reactive oxygen species (ROS), reduced glutathione (GSH) decrease (index of 
anti-oxidant activity) and lipid peroxidation have been documented in human HepG2 
cells [64,65], HUVEC cells [59], A549 cells [66] and L-02 cells [67], highlighting that 
amorphous silica can lead to oxidative stress (more pronounced in the presence of smaller 
particles). Since ROS cause DNA damage and this triggers apoptosis, several studies have 
investigated the pro-apoptotic potential of amorphous silica evaluating various markers of 
programmed cell death. In effect, phosphatidylserine exposure [64,65,67], caspase-3 
activation [60,64], induction of pro-apoptotic proteins such as p53, pro-caspase 9 and Bax 
reduction of the anti apoptotic factor Bcl-2 [65] and DNA laddering [67] have been 
observed after cellular exposure to SiO2-NPs.  
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Other studies investigating the different sensitivity of phagocytic and non-phagocytic 
cells to SiO2-NPs found that, in general, the first ones are more affected by NPs. For 
example, Rabolli et al. documented that Ludox SM NPs killed murine macrophages J774 
~ 2.5 folds more effectively than murine fibroblasts 373 [68]; Mohamed et al. showed 
that different size SiO2-NPs induced cytocidal effects in monocytic THP1 cells but not in 
alveolar epithelial A549 [69] and Herd et al. reported that silica nanomaterials of different 
geometries (worms, cylinders and spheres) caused functional damage in murine 
macrophages RAW 267.4 at lower doses (~ 80 µg/ml) than in A549 cells (> 200 µg/ml) 
[70]. A possible explanation of the major sensitivity to SiO2-NPs of 
monocytes/macrophages compared to epithelial cells could be that phagocytes have an 
inherent capability in engulfing nanoconstructs, as reported by [69,70]. Also amorphous 
silica microparticles were shown to affect macrophages more than non-macrophages cell 
lines, although in this case both cellular types showed similar ability to internalize the 
particles [60]. 
The higher sensibility of macrophages to amorphous silica and the fact that, in lungs, 
alveolar macrophages engulf inhaled silica nanoparticles/nanofibers leading to the 
inflammatory disease silicosis (in the case of crystalline silica) have determined an 
increasing interest around the mechanism of SiO2 induced inflammatory response. 
Crystalline silica is known to activate the NLRP3 inflammasome, a cytosolic multiprotein 
complex responsible of the production of IL-1 from its immature form through the 
caspase-1 mediated cleavage of pro-IL1 see paragraph 1.5). Indeed, it has been 
demonstrated that both LPS primed murine and human monocytic-macrophagic cells 
secrete IL-1 after stimulation with silica crystals, and that the blockage or the deletion of 
NLRP3 proteins (such as caspase 1, ASC and Nalp3) reduce/abolish this process 
[53,54,71,72]. Further, Hornung et al. highlighted the role of crystals phagocytosis, 
lysosomal damage and lysosomal cathepsins activation in silica induced NALP3 
activation, while the production of ROS was not found to be essential [54]. On the 
contrary, Cassel  et al. showed that the inhibition of NADPH oxidase (source of cellular 
ROS) markedly abrogated silica induced IL-1  and caspase-1 activation [53].  
Recently, evidences concerning the pro-inflammatory potential of amorphous SiO2-NPs 
have been described in both in vivo and in vitro models. Park et al. reported an increase of 
inflammation related genes (IL-1 , TNF- , IL-6 and iNOS) and pro-inflammatory 
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cytokines (IL-1 , TNF- ) in mice treated with SiO2-NPs [52]. In other studies, SiO2-NPs 
of different diameters were found to activate the NALP3 inflammasome in murine and 
human macrophages (respectively, RAW264.7 and THP-1) via mechanisms similar to 
crystals, such as endosomal rupture, lysosomal proteases activation and ROS production 
[73,74]. Moreover, amorphous silica was found to induce a pro-inflammatory activity (in 
particular, NF-kB activation and upregulation of IL-6/IL-8 gene) also in non-immune 
cells HUVECs [75]. All these results clearly indicate that, despite amorphous silica 
nanoparticles are widely used in cosmetics, food and medicinal products, they can have 
cytocidal and inflammatory effects potentially dangerous for health [74]. However, 
additional studies are necessary to better clarify death and inflammation mechanisms, and 
how they affect each other.  
 
1.4 Immune system and inflammation 
In addition to the mechanical barrier of skin, mammals present a complex and extremely 
effective immune system, in which two arms cooperate to assure a successful defense 
against pathogens: the innate and the adaptive immune systems. The first (whose major 
players are phagocytic cells and natural killer cells) provides a very rapid response (e.g. 
phagocytizing and killing a microorganism), but lacks in specificity and memory. The 
second (represented by B and T lymphocytes) is able to produce a response specific (and 
so more effective) for each pathogen and, after the first contact, can “remember” the 
undesired host and quickly react at the subsequent exposures. Innate and adaptive systems 
collaboration derives from their complementary functions (a rapid non-specific action vs 
a slower selective one), and from their ability to communicate and potentiate one each 
other, by a complex signaling of cytokines, chemokines, receptors and co-stimulatory 
molecules. Since crystalline and amorphous silica activate mechanisms characteristic of 
the innate immunity (uptake by phagocytes, ROS and pro-inflammatory cytokines 
production), the next section will be focused on this topic. 
Generally, innate immune system can be activated by two types of signals, the so called 
PAMPs (pathogen associated molecular patterns) and DAMPs (damage associated 
molecular patterns). PAMPs are highly conserved microbial structures (essential for 
microbial survival) such as the cell wall components peptidoglycans and 
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lipopolysaccharide; DAMPs are molecules, normally present in the cell, released by 
injured or danger tissues as danger signal (e.g., ATP) [76]. Both PAMPs and DAMPs are 
recognized by germline-encoded pattern recognition receptors (PRRs), expressed by 
classical immune cells (e.g., myeloid cells as monocytes, macrophages, dendritic cells 
and neutrophils) and also by non immune cells (epithelial) [77,78]. PRRs can be 
classified into phagocytic PRRs (which directly bind the microorganisms and mediate 
their internalization), and sensor PRRs, responsible of the initiation of pro-inflammatory 
signaling pathways [79]. Four main categories of sensor PRRs, characterized by a specific 
ligand and cellular localization, have been identified: 
1) Toll-like receptors (TLRs), located on the cell surface and lumen of 
endosomes and lysosomes and able to recognize a plethora of PAMPs and 
DAMPs 
2) RIG-I-like receptors (RLRs), cytosolic and able to sense viral RNA 
3) C-type lectin receptors (CLRs), associated to cellular membrane and 
specific for glycopeptides and polysaccharides 
4) Nod-like receptors (NLRs), localized in the cytosol and activated by many 
DAMPs and PAMPs.  
The most important PRRs for this work are TLRs (implicated in 
monocytes/macrophages LPS stimulation) and NLRs (involved in myeloid cells 
activation by silica). They will be described in the next sections.  
1.4.1 TLR 4 activation by LPS  
Bacterial endotoxin (lipopolysaccharide, LPS) constitutes the outer layer of the outer 
membrane of Gram-negative bacteria, and represents one of the most potent microbial 
initiators of inflammation, by activating myeloid cells to produce pro-inflammatory 
cytokines (such as IL-1 , TNF- , IL-6 and IL-8) [80,81] It consists of three covalently 
linked regions (as represented in Figure 7): 
- Lipid A: this is an hydrophobic domain (formed by six fatty acyl chains 
linked to two glucosamine residues) situated in the inner part of the membrane 
and responsible for toxicity 
- Oligosaccharide core, situated in the centre of the molecule and consisting 
of 10 saccharidic residues 
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- O antigen: this hydrophilic domain (made up of many repeated units of a 
branched tetrasaccharide) is exposed in the outer side of the membrane and is 
variable between different bacteria, determining LPS antigenic specificity [81].  
 
 
 
 
 
 
 
 
 
Figure 7: Structure of lypopolisaccharide 
 
Host response to LPS begins with LBP (lipid binding protein) mediated transfer of 
endotoxin to CD14. LBP is a soluble serum glycoprotein, while CD14 is a glycoprotein 
either expressed on the surface of myelomonocytic cells as glycosylphosphatydilinositol 
anchored molecule (mCD14) or is present in the bloodstream as a soluble molecule 
(sCD14). A first pathway consists in LPS clearance, through its localization in high 
density lipoproteins particles (HDL) and subsequent excretion by the liver (Figure 8a). 
The second important pathway leads to inflammatory response, involving the ternary 
complex CD14-TLR4-MD2 (Figure 8b). mCD14 (in case of cells lacking this receptor, 
sCD14) concentrates LPS in proximity of the transmembrane protein TLR4 (Toll like 
receptor 4), made up of an extracellular leucine-rich-domain for ligand interaction, a 
transmembrane portion and an intracellular domain TIR (Toll IL-1 receptor), responsible 
of subsequent signal transduction. MD-2 (myeloid differentiation protein-2) is a small 
molecule associated to the external domain of TLR4, important for LPS recognition and 
regulation of TLR4 cellular distribution [80]. As demonstrated by Akashi et al., CD14-
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TLR4-MD2 cooperate to form a very stable complex with LPS before signal transduction 
step [82]. After LPS binding, the complex TLR4-MD2 dimerizes and activates two 
possible pathways: MyD88 dependent and MyD88 independent. MyD88 (myeloid 
differentiation factor 88) is an adaptor cytosolic protein that with its TIR domain interacts 
with TLR4 and with its death domain recruits members of IL-1 receptor associated 
kinases (IRAK), that activates mitogen activated protein kinases (MAPK) such as p38, 
ERK and JNK, leading the activation of the transcription factor AP-1 (activator protein 
1). In parallel, IRAK can recruit IkB  kinase complex (IKK), that induces the 
phosphorylation, polyubiquitination and proteasome-mediated degradation of IkB an 
inhibitor of nuclear factor- b (NF- B)). Once NF- B is liberated, it can migrate into the 
nucleus and, together with AP-1, activate the transcription of many genes for 
inflammatory cytokines. In MyD88 independent pathway, TLR4 recruits through TIR-
TIR domains interactions two molecules (TRIF and TRAM) that activate IRF3 (INF 
regulatory factor 3), leading to the induction of INF / . Interferons can act in a 
autocrine/paracrine way, binding their receptor and activating STAT1, a transcriptional 
activator of genes for iNOS and MCP-5 (monocytes chemoattractant protein 5). As the 
previous pathway, also MyD88 independent one activates NF- B [81] 
 
 
 
 
 
 
 
Figure 8: (a) LPS processing, signaling and clearance [81]. (b) LPS activation of MyD88 –
dependent/independent pathway (modified from [80]).  
 
 
 
A B 
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1.4.2 NLRs and inflammasomes 
Inflammasomes (whose name derives from the fusion of the word inflammation with the 
suffix “some”, form Greek meaning body) are cytosolic molecular platforms involved in 
the production of pro-inflammatory cytokines (IL-1 , IL-18), through the recruitment and 
subsequent activation of inflammatory caspases (over all, caspase 1) [76]. They result 
from PAMP/DAMP induced assembly of NLRs to other inflammasome associated 
molecules (such as adaptors and effector molecules) [83].                                                                                                 
NLRs, as mentioned before, are cytosolic receptors able to sense danger or pathogen 
associated signals. They present a tripartite architecture, consisting of: 
- an N-terminal effector domain (different for each receptor), which 
mediates signal transduction to downstream targets.  
- a central NACHT domain, conserved in all NLR members , able to bind 
nucleotides (ATP) and responsible of oligomerization. NATCH is commonly 
associated to an additional domain NAD (NATCH associated domain), and 
together they are called NBD (nucleotide-binding domains) 
- a C-terminal domain LRR (leucine rich repeat), consisting of a 20-30 
residues repeated motif enriched in the hydrophobic amino acid leucine, and 
responsible of ligand sensing (probably through amino acid hydrophobic 
interactions) [77,78]  
On the basis of N-terminal domain, NLRs can be classified in 5 big families designed as 
NLRA (A as AD, acidic activation domain), NLRB (B as BIR, baculoviral inhibitory 
repeated domain), NLRC (C as CARD, caspase activation and recruitment domain), 
NLRP (P as PYD, pyrin domain) and NLRX (X because lacks omology to any known 
domain) [76,78,83] (Figure 9a). Interestingly, mammalian NLRs structure strongly 
resembles plant R-proteins, implicated in immune defense against bacteria, virus, fungi 
and other pathogens [76]. The main adaptor molecule involved during inflammasomes 
formation is ASC ( apoptosis-associated speck-like protein containing a CARD), that 
mediates pro-caspase 1 recruitment through its PYD and CARD domains (Figure 9a). On 
the base of the molecular assembly of NLRs – Caspase 1 complex and on the different 
stimuli activating inflammasome pathway, at least 10 inflammasomes have been 
identified. The four more studied are NLRP1, NLRC4, AIM2 and NLRP3 (Figure 9b).  
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Figure 9: (a) members of human NLR family. (b) structure of  the four main inflammasomes . Modified 
from [78] . (c) structural organization of the NALP3 inflammasome (modified from [76]). 
NLRP1 was the first inflammasome described in 2002 by Martinon et al. [84]. In addition 
to the common LRR, NATCH and PYD domains, it presents a C-terminal extension 
consisting of a FIIND motif and a CARD. It can directly recruit pro-caspase 1 and pro-
caspase 5 by CARD-CARD interaction, or even include ASC with an augmented 
activation [77,85].  NLRP1 is activated by Bacillus Antracis lethal toxin and cell wall 
component muramyl dipeptide (MDP) [78]. 
NLRC4 (also known as IPAF) is activated by gram negative bacteria possessing type III 
or IV secretion systems, such as Salmonella typhimurium, Shigella flexneri, Pseudomonas 
Aeruginosa [77]. With its N-terminal CARD, NRLC4 can directly recruit pro-caspase 1 
without the need of an adaptor protein (even if ASC may stabilize or facilitate this 
process) [78]. 
AIM2 inflammasome is composed by AIM2, ASC and Caspase-1. It contains a PYD 
domain that interacts with ASC via PYD-PYD interactions, allowing the ASC CARD 
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domain to recruit pro-caspase 1 to the complex. AIM2 is activated by cytosolic double 
strand DNA from virus, bacteria or the host itself [77,78]. 
The NLRP3 (also known as NALP3 or cryopirin) is currently the most studied and 
characterized inflammasome, as sensor of many sterile/microbial and 
exogenous/endogenous stimuli. It was for the first time described in 2004 by Agostini et 
al., as involved in the Muckle-Wells autoinflammatory disorder [86]. NALP3 
inflammasome “monomer” consists of the NLRP3 scaffold, the adaptor protein ASC and 
the functional unit caspase 1. In the presence of activators signals (they will be presented 
in section 1.5), NLRP3 PYD domain interacts with ASC PYD domain, and ASC CARD 
domain recruit pro-caspase 1. Usually, seven monomers are assembled in a big complex 
of 2 µM diameter [85], (Figure 9c). Once pro-caspase 1 is recruited, in all the four 
inflammasomes listed above it is subjected to autoproteolitic activation, leading to a 
mature form able to cleave pro IL-1 into IL-1 and the consequent start of inflammatory 
response against a particular DAMP or PAMP.  
1.4.3 IL-1
IL-1 represents one of the most important mediators of inflammation following host 
stimulation with a PAMP or a DAMP, and is mainly produced by cells of the monocytic 
lineage (monocytes, macrophages, dendritic cells and polymorphonucleates) as inactive 
precursor of 31 kDa, subsequently cleaved by caspase 1 into the bioactive form of 17 kDa 
[87,88]. IL-1  is released extracellularly through a non-classical secretory pathway (in 
fact, it  lacks the conventional hydrophobic signal sequence for the secretion via 
endoplasmic reticulum and Golgi apparatus), and then binds to its membrane receptors 
(IL-1R1, IL-1R2, IL-1R3) promoting pro-inflammatory activities (such as increasing the 
expression of  adhesion molecules, vasodilatation and induction of chemokines for the 
recruitment of inflammatory cells at the injured site, or inducing other inflammatory 
cytokines as TNF-  and IL-6), and executing also regulatory functions of blood heat and 
appetite [89]. As mentioned before, IL-1 is not released via the traditional secretory 
pathway. To date, five different mechanisms have been suggested [88]. The first, 
proposed in 1990 by Rubartelli et al. [90], suggests that both pro IL-1 and caspase 1 are 
transported from the cytosol into secretory lysosomes, where pro IL-1  is processed to 
the mature form during their trafficking to the plasma membrane. After docking to the 
membrane, lysosomal content is released into the extracellular space in a Ca
2+
- dependent 
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manner, while lysosomal membrane fuses with the plasma membrane. In a second model, 
IL-1 is released through the shedding of membrane derived microvesicles of dimension 
varying from 0.1 to 1 µM and characterized by phosphatidylserine exposure on the outer 
side of lipid bilayer. Also in this case, IL-1  processing occurs inside microvesicles, and 
shedding seems to be calcium dependent [91]. A third model proposes that IL-1  is 
released in a protected form by being packaged and secreted via small exosomes (30-100 
nm diameter), accumulated into bigger multivesicular bodies (MVB) [92]. In a fourth 
model, pro IL-1 is cleaved to the mature form in the cytosol, and IL-1 is released by 
direct passage through the plasma membrane via a plasma membrane transporter ( 
possible candidates for this role are ABC transporters) [93]. Alternatively (fifth model), 
IL-1 can be passively released as a consequence of cellular lysis or can reach 
extracellular space by passing through membrane pores (e.g. the ones formed during 
pyroptosis) [88,94]. 
1.4.4 Caspase-1 
Caspases are cysteine proteases that hydrolyze peptide bonds on the carboxyl side of an 
aspartate residue. At present, 11 human caspases have been identified [95] and classified 
in apoptotic caspases (initiator caspases 2, 8, 9, 10 and effector caspases 3, 6, 7) and 
inflammatory caspases (pro-inflammatory caspase 1, 4, 5 and anti-inflammatory caspase 
12) [76]. Briefly, catalytic mechanism (schematized in Figure 10a)  involves the 
deprotonation of the sulfydhryl Cys 285 (caspase 1 numbering) by the imidazole ring of 
His 237, producing a thiolate nucleophile that attack the carbonyl carbon of the scissile 
bond forming a tetrahedral intermediate, which is stabilized by hydrogen bonding to the 
amide nitrogen of Gly 238. After the detachment of the C-terminal portion of peptidic 
bond, an oxidrylic group (derived from an H2O molecule deprotonated by H 237) attacks 
the carbonylic carbon of peptide (bound to S of Cys 285), allowing the release of N-
terminal portion of peptide and the free enzyme. Due to their catalytic function, C 285, H 
237 and G 238 are conserved in all human caspases [95]. Another characteristic in 
common between all caspases is that they are synthesized as inactive precursors 
(zymogens) and, only when it is strictly necessary, they become active through an 
autoproteolitic process. In this way, a widespread and uncontrolled activation/ proteolitic 
action (dangerous for the cell) is avoided. 
40 
 
The first identified caspase was caspase 1, described in 1989 by Kostura et al. as a 
“processing activity” present only in cytosolic extracts of human monocytes and THP.1 
cells, “capable of cleaving precursor IL-1  to authentic mature IL-1 ” [96]. For this 
characteristic, it was also called ICE (interleukin 1 converting enzyme). In the subsequent 
years, the enzyme was purified, cloned and its structure determined by X-ray diffraction 
[97,98]. In immune cells, caspase 1 is constitutively expressed as an inactive 
homodimeric precursor of 90 kDa (each subunit has a molecular weight of 45 kDa (p45)). 
In the presence of an activation stimulus, an autoproteolitic process occurs, resulting in 
two 20 kDa fragments (p20) and two 10 kDa fragments (p10) that intimately associate 
and form mature caspase 1 [97] (Figure 10b). 
 
Figure 10: (a) Caspase 1 catalytic mechanism [97]. (b) Caspase 1 structure.  
In addition to its original function (the processing of proIL-1  to IL-1 ), caspase 1 is 
implicated also in the maturation of other members of the IL1 family, such as IL-18 (a 
pro-inflammatory cytokine constitutively expressed in human PBMCs and implicated in 
the activation of NK cells and induction of interferon INF ), IL1F7 (an anti-
inflammatory cytokine that negatively regulates the expression of inflammatory 
molecules), and IL-33 (promoter of Th2 response, regulator at nuclear level of the gene 
transcription of IL-4, IL-5, IL-13 and, on the contrary of IL-18 and IL1F7, inactivated by 
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caspase 1 proteolytic process) [78,89]. Moreover, caspase 1 appears to be the key 
determinant of pyroptosis, a particular cell death type that affects macrophages infected 
by pathogens (see paragraph 1.4.5). 
1.4.5 Pyroptosis 
Pyroptosis is defined as “Caspase-1 dependent programmed cell death” [99], and was first 
described in macrophages infected by Shigella flexneri as a cell suicide induced by an 
invasive bacterial pathogen [100]. Subsequent studies (in most cases performed in 
macrophages subjected to a microbial infection) have revealed that this is a new type of 
cell death, although it has characteristics in common with necrosis and apoptosis (the two 
classic cell deaths). During apoptosis (an high regulated cellular suicide aimed at 
removing damaged individual components to preserve the safety of an organism or a 
cellular population), the so called apoptotic caspases are activated, resulting in 
chromosomal DNA cleavage in fragments of approximately 180 bp [101], nuclear and 
cytoplasmic condensation, cell shrinking (pyknosis) and formation of “apoptotic bodies” 
(membrane-bound cellular compartments containing cellular residues and destined to be 
engulfed by resident phagocytes) [102-104]. In addition, apoptotic cells retain an intact 
plasma membrane and no inflammatory events occur. Necrosis, a passive accidental cell 
death resulting from environmental perturbations (e.g. chemical or thermal damage), is 
characterized by dilatation and dismantling of cellular organelles, membrane damage with 
consequent water entrance, cytoplasmic swelling and final cellular lysis. Contrary to 
apoptosis, chromatin condensation and degradation is not observed, while a strong 
inflammatory process is initiated. At a microscopic level, the major features of pyroptotic 
cells are chromatin condensation, DNA cleavage (but, differently from apoptosis, the 
classical oligonucleosomal DNA fragmentation pattern is not observed) and cytoplasmic 
swelling with large spherical protrusions of the membrane [99,104] (Figure 11). A 
peculiar characteristic is represented by 1.1-2.4 nm diameter membrane pores throughout 
cellular ionic gradient is dissipated, producing an increased osmotic pressure, water influx 
and consequent swelling and lysis (with the release of inflammatory intracellular 
contents) [104] (Figure 11). Pathogens-infected or toxin treated cells in the presence of 
osmoprotectants with molecular diameter > 2.4 nm (glycine or PEG) are protected from 
cellular lysis, as demonstrated in [101,105]. At a molecular level, pyroptotic cell death is 
not characterized by the activation of apoptotic caspases (over all, caspase 3) [99,106], 
but it strongly depends on caspase 1, as largely reported in literature. Indeed, it has been 
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demonstrated that caspase 1 inhibitor YVAD significantly reduced macrophages death 
induced by Salmonella typhimurium [101,106] or Shigella [107], and the same result was 
obtained in caspase 1 deficient mice after macrophages infection with Francisella 
tularensis [108]. Moreover, inhibition or deletion of caspase 1 abolished pyroptosis-
associated IL-1  and IL-18 production and DNA fragmentation [105], suggesting a 
possible role of ICE even in nucleic acid degradation (that, as said before, in pyroptosis 
are not dependent on caspase 3 classical pathway). Recently, several studies have 
documented caspase-1 importance in regulating cell death in systems different from 
pathogens-infected cells, such as macrophages treated with carbon black nanoparticles 
[109] and in models of cardiovascular-cerebral diseases [102]. 
 
Figure 11: the typical pathway of pyroptosis [105]. 
 
1.5 NLRP3 inflammasome 
1.5.1 Stimuli and models for NLRP3 inflammasome activation 
NLRP3 activates in the presence of several infection/danger signals. At present, the better 
characterized are: 
- monosodium urate (MSU) crystals, derived from precipitation of uric acid 
in the joints of the hyperuricemic patients and responsible of gout 
- silica and asbestos particles, that cause pneumonitis and the progressive 
pulmonary fibrotic diseases asbestosis and silicosis [53,56,71] 
- alum and chitosan (used as adiuvants for vaccines) [110] 
- extracellular  amyloid aggregates, accumulated in senile plaques during 
the development of Alzheimer disease [111] 
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- a large variety of bacteria and their toxins, that form membrane pore in the 
infected cells 
- high concentration of extracellular ATP (sensed as danger signal) [112]. 
Given the structural dissimilarity of the NLRP3-activating stimuli, it is unlikely that 
NLRP3 directly interacts with all of them. However, it is plausible that different stimuli 
can promote the release, modification or recognition of a common ligand, which can 
interact with the inflammasome [113]. Several mechanisms leading to NLRP3 have been 
proposed. The three widely supported in the literature concern (1) K
+
 efflux through the 
P2X7 ATP gated ion channel, (2) lysosomal damage, (3) generation of reactive oxygen 
species (ROS).  
K
+
 efflux and the role of P2X7 receptor   
Under basal conditions, the normal intracellular K
+
 concentration is about 150 mM, while 
the extracellular concentration is typically 5 mM. This ionic gradient is maintained by the 
sodium-potassium pump (also known as Na
+
/K
+
-ATPase). It has been demonstrated that 
K
+
/H
+
 ionophore nigericin (a bacterial pore forming toxin from Streptomyces 
hygroscopicus) activates caspase 1 processing and formation of mature IL-1  in LPS-
primed macrophages [114,115]. Moreover, classical NLRP3 activators (ATP, nigericin, 
MSU, silica crystals) lose their functionality in the presence of extracellular medium 
containing an high potassium concentration (130 mM) [71,114,116]. Both these 
evidences indicate that for NLRP3 (and also for NLRP1-NLRC4 and AIM2) [78] 
activation a potassium efflux is required. At least two potential mechanisms may explain 
how cytosolic K
+
 levels might regulate inflammasome activation. The first is that the 
basal concentration of cytoplasmic K
+
 could block the recruitment of caspase-1 to ASC 
(by inhibiting the interaction between their CARD domains) and consequently avoid 
inflammasome oligomerization [114,116]. This is also supported by other studies 
showing that caspase-1 activation in THP-1 extracts is repressed by high ionic strength 
[117]. A second mechanism purposes that K
+
 efflux activates phospholipases C (PLC) 
and Ca
2+
 -independent phospholipase A2 (iPLA2). Activated PLC promote an increment 
of Ca
2+
 intracellular concentration, and the consequent activation of Ca
2+
 -dependent 
phospholipase A2 (cPLA2) that might generate a lipidic messenger recognized by LRR 
domain and inducer of inflammasome oligomerization. On the other hand, activation of 
iPLA2 could generate lipid second messengers inducing the assembly of scaffolding 
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molecules and promoting pro-IL1  recruitment by caspase-1 [114,118].                            
In addition to ionophore nigericin (that directly exchanges K
+
 for H
+
 across membrane), 
K
+ 
intracellular loss can be indirectly determined by the binding of ATP to the receptor 
P2X7. Under basal conditions, intracellular ATP derived from glicolysis and oxidative 
phosphorylation is present at concentrations of 3-5 mM [119], while outside the cell its 
concentration is negligible. Following cellular lysis or signaling mechanisms, ATP is 
released respectively in a passive and active manner and can bind purinergic receptors in 
an autocrine or paracrine way determining a specific cellular response (depending on 
cellular type and class of bound receptor). In the case of NLRP3 activation, secreted ATP 
binds to P2X7 receptor, a cation selective channel constituted by two transmembrane 
hydrophobic domains separated by a bulky extracellular region and with N- and C- 
terminal residue on the cytoplasmic side of the membrane [120,121]. ATP binding 
determines on one hand K
+
 efflux (and consequently NALP3 activation, as described 
above) and Ca
2+
 influx (activating cPLA2 involved in IL-1 maturation); on the other the 
formation of a pannexin-1 hemichannel allowing the entrance of microbial molecules 
(such as MDP) into the cytosol and the direct interaction with NLRP3 components 
[122,123]. 
Lysosomal damage 
The model of NLRP3 activation through lysosomal rupture has been proposed for large 
particulate activators, such as alum, silica and amyloid- . Once phagocytized by 
monocytes/macrophages, these particulates are inefficiently cleared and accumulate into 
lysosomes, leading to a phagosomal destabilization and subsequent leakage 
[78,85,113,124]. The mechanisms throughout lysosomal rupture can occur are still 
unknown, however, it can be assumed that particles directly damage lysosomal membrane 
[125] or that induced ROS trigger membrane destabilization through lipid oxidation [74]. 
After lysosomal disruption, a plethora of proteolitic enzymes normally confined in these 
compartments are reversed into the cytoplasm, where on the one hand they can degrade 
cellular structures, on the other hand they may induce the cleavage of a yet-unidentified 
substrate, which in turn leads to NLRP3 activation [78]. Particularly, the protease 
cathepsin B has been found to be important in particulates mediated inflammasome 
activation. Indeed, several studies have demonstrated that the inhibition as well as 
deficiency of cathepsin B leads to greatly reduced caspase 1 processing and IL-
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1 secretion, while stimuli acting  from the cell surface (e.g. ATP) are not affected 
[56,73,74,111]. However, it seems likely that also other lysosomal proteases are involved 
in this process, since cathepsin B deficient macrophages still display NLRP3 activation 
when stimulated by phagosomal activators at very high concentrations [78]. 
Generation of reactive oxygen species 
It has been reported that almost all NLRP3 activators trigger the generation of ROS [124], 
that derive from the activity of NADPH oxidases family (NOX) (e.g., the membrane 
bound NOX2 present in phagocytes), or from other cellular sources such as mitochondria 
or xanthine oxidase [78]. In addition, ROS inhibition by N-acetyl-L-cysteine (NAC) and 
(2R,4R)-4-aminopyrrolidine-2,4,-dicarboxylate (APDC) can reduce IL-1 secretion 
induced by crystals [71] and MSU [116], and blockage or knock down of NADPH 
oxidase results in a diminished IL-1 production [53,71], suggesting that reactive oxygen 
species play a role in NLRP3 inflammasome activation. A possible mechanism explaining 
cryopirin triggering by ROS has been proposed by Thsopp and colleagues in 2010 [126]. 
Briefly, they found that, under basal conditions, thioredoxin-interacting protein (TXNIP) 
is constitutively bound and inhibits the oxidoreductase thioredoxin (TRX), while after 
cellular ROS concentration increases the complex TRX-TXNIP dissociates and TXNIP 
binds to LRRs of NLRP, inducing inflammasome activation.  
However, it has to be kept in mind that in some cases the deletion or inhibition of ROS 
producing machinery did not affect macrophages response to NLRP3 activators [56,124], 
or that cathepsin B blockage and lysosomal acidic pH neutralization did not impair ATP 
induced inflammation [56]. This suggests that the best model for NLRP3 activation is an 
integration of the three proposed mechanisms, in some circumstances substituting and in 
others potentiating each other (Figure 12). 
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Figure 12: the three major models for NLRP3 
inflammasome activation:  
(1) ATP-mediated K+ efflux 
(2) Lysosomal rupture 
(3) Reactive oxygen species generation 
[77]. 
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2. Methods 
2.1 Nanoparticles 
LUDOX
®
 TM40 colloidal silica nanoparticles (SiO2-NPs) (40% wt. suspension in H2O) 
were purchased from Sigma Aldrich. Dynamic light scattering (DLS) measurements 
(Malvern Zetasizer Nano S instrument) provided an average diameter of 25±2 nm 
(number weighted) in phosphate-buffered saline [PBS], pH 7.4, while transmission 
electron microscopy (TEM) analysis (FeiTecnai 12, 100 kV) yielded a 24±2 nm diameter 
in good agreement with the DLS size. The zeta-potential value (same conditions as DLS 
analysis) was -15.6 mV. 
FITC-labeled Stöber nanoparticles were prepared in the laboratory of Professor Fabrizio 
Mancin (Dipartimento di Scienze Chimiche, Università di Padova) following Stöber 
method [183]. DLS measurements provided an average diameter of 32±3 nm (number 
weighted) in phosphate-buffered saline pH 7.4, while TEM analysis yielded a 30±3 nm 
diameter in good agreement with the DLS size. The zeta-potential value (same conditions 
as DLS analysis) was -18.3 mV. All NPs suspensions were endotoxin free (<0.05 
Endotoxin units/ml [1 EU = 100 pg] as measured with Limulus test (Sigma Aldrich)).  
All physicochemical characterizations of nanoparticles were performed in the laboratory 
of Prof. Fabrizio Mancin, at a temperature value of 37°C to reproduce the conditions of 
biological assays.  
2.2 Cells 
2.2.1 Monocytes isolation from Buffy Coat 
Human monocytes were obtained from Buffy Coat (the fraction of non coagulated blood 
enriched in leukocytes and platelets), gently provided by Centro Trasfusionale of the 
Hospital of Padua (ULSS16). Whole blood (generally 40 ml) was divided in 2 Falcon, 
washed with phosphate saline buffer (PBS) without Ca
2+
 and Mg
2+
 to a final volume of 50 
ml and centrifuged at 1100 rpm for 10 minutes at room temperature (RT), without 
accelerator and brake. Supernatant (containing residual serum) was removed, and cellular 
pellet was resuspended in 25 ml of PBS and stratified on 15 ml of Ficoll-Paque PLUS 
(Amersham Biosciences). After 30 minutes centrifugation at RT, 2000 rpm without 
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accelerator and brake, lympho-monocytes were recovered and washed with 50 ml of PBS 
by centrifuging at 1000 rpm for 10 minutes at RT (with accelerator and brake). Then, 
cellular pellet was resuspended in 30 ml of “A solution” (containing RPMI-1640 (Gibco) 
supplemented with 10% (v/v) fetal calf serum (FCS) (Euroclone) plus 100 U/ml penicillin 
- 100 µg/ml streptomycin (Gibco) and Hepes 4 mM (Sigma Aldrich), 285 mOs), and 
stratified on “C solution”, containing 50.3% of “A solution” and 49,7% of “B solution” 
(92.5% Percoll (Amersham Biosciences) diluted in PBS 10X, 285 mOs). After 30 
minutes centrifugation at RT at 1500 rpm without acceleration and brake, monocytes 
were recovered, washed with 50 ml PBS, resuspended in RPMI 2% FCS, seeded in 24 
wells plates (Falcon) at 2 x 10
6
 cells/well (500 µl) or in 96-wells plates (Falcon) at 2 x 10
5
 
cells/well (200 µl) (depending on the experiment), and incubated for 1 h at 37°C for 
adhesion step. Adherent monocytes were extensively washed with medium to remove 
non-adherent contaminating lymphocytes and subsequently treated with stimuli.  
2.2.2 Macrophages differentiation 
Monocytes adherent to 24 wells plates were incubated with 500 µl of RPMI 
supplemented with 20% FCS and macrophage colony-stimulating factor (M-CSF) 100 
ng/ml (Immunological Sciences), and differentiated to macrophages for 7 days at 37°C. 
At day 4 or 5, half medium was removed and replaced with new.  
2.2.3 Lymphocytes isolation from Buffy Coat 
Whole blood was incubated for 20 minutes at RT with 50 µl/ml of RosetteSep
® 
Human T 
Cell Enrichment Cocktail (StemCell Technologies). Then, it was diluted with an equal 
volume of PBS + 2% FCS, stratified on Ficoll-Paque PLUS and centrifuged for 30 
minutes at 2000 rpm at RT (no accelerator and brake). After centrifugation, lymphocytes 
were recovered, washed with 25 ml PBS + 2% FCS, resuspended in complete medium 
(RPMI supplemented with 10% FCS and antibiotics) and seeded onto 96 wells plates at 2 
x 10
5
 cells/well in 75 µl.  
2.2.4 HeLa cells 
Human stable epithelial cell line HeLa was maintained in DMEM (Gibco) supplemented 
with 10% FCS and antibiotics (complete medium). At the moment of splitting (every 2-3 
days), cells adhered to flask were washed with PBS and detached with trypsin-EDTA 
(Gibco) for 3-5 minutes at 37°C. Then, complete medium was added to neutralize trypsin 
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and about 2/3 of cellular suspension were removed and replaced with new complete 
medium. The day before experiments, HeLa were detached and seeded onto 24 well 
plates at 1 x 10
5  
cells/well in 500 µl or onto 96 wells plates at 5 x 10
3
 cells/well in 200 µl.  
2.3 Cellular viability assays 
2.3.1 Propidium iodide – Annexin V viability assay 
Monocytes, macrophages, lymphocytes and HeLa cells seeded onto 24 wells plates were 
incubated for different times in the presence of different stimuli, depending on the 
experiment. At the end of incubation, cells were recovered (monocytes and macrophages 
by gentle scraping; HeLa by trypsinization) and, after centrifuging for 7 minutes at 1600 
rpm at RT, culture medium was collected for ELISA assays while cellular pellets were 
washed with 1 ml of PBS. Then, cells were resuspended in 300 µl of cold FACS buffer 
(PBS containing 1% FCS and 0.1% sodium azide) and, just before cytofluorimetric 
analysis, stained with 15 µg/ml propidium iodide (PI) (Sigma Aldrich). 
In apoptosis experiments, cells were treated for 16-18 h with Ludox TM40-NPs at 
different concentrations in complete medium or with Actinomycin D 1 µg/ml (positive 
control for apoptosis) [127]. Then, cells were recovered by centrifugation for 5’ at 200 x 
g, washed, resuspended in 50 µl of Incubation Buffer and stained with 1 µl of Annexin V 
for 15’ at RT in the dark. Incubation Buffer and Annexin V were provided by Annexin-V-
FLUOS Staining Kit (Roche). Finally 250 µl of Incubation Buffer were added, cells were 
stained with PI as above and acquired for 30 seconds at flow cytometer (BD FACSCanto 
II). Data analysis of the gated cellular populations was performed with FACSDiva 
software (Becton Dickinson).  
2.3.2 MTS cytotoxicity assay 
Monocytes, lymphocytes, HeLa (seeded on 96 wells plates) and macrophages (seeded on 
24 wells plate) were incubated with different stimuli for different times, depending on the 
experiment. Treatment with H2O was used as positive control. At the end of incubation, 
cellular culture medium was collected and stored for other assays, while cells were 
incubated in the dark at 37°C for 0.5-18 h (depending on cell type) with 110 µl 
(monocytes, lymphocytes and HeLa) or 200 µl (macrophages) of CellTiter 96® AQueous 
One Solution Reagent (Promega), diluted 1:11 in serum free medium. After colour 
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development, plates were centrifuged for 5 minutes at 1500 rpm at RT (to precipitate any 
component responsible of aspecific scattering phenomena, such as NPs at high 
concentrations), and 80 µl of supernatant were collected and immediately red at 492 nm, 
using a Biotrak II Reader spectrophotometer. Cellular viability was expressed as % of 
absorbance value compared to untreated cells (assumed as 100% viable).  
2.3.3 LDH cytotoxicity assay 
LDH assay was performed on the same samples prepared for MTS assay, using CytoTox 
96® Non-Radioactive Cytotoxicity Assay (Promega). Cells incubated for 45 minutes at 
37°C with Lysis Solution diluted 1:10 in serum free medium were used as positive 
control (assumed lysed at 100%). 50 µl of cellular supernatants (collected just before 
MTS assay) were incubated with 50 µl of reconstituted Substrate Mix for 30-60 minutes 
at RT in the dark. After colour development, reaction was stopped adding 50 µl of Stop 
Solution and samples absorbance was red at 492 nm with Biotrak II Reader 
spectrophotometer. Cellular lysis was expressed as % of absorbance value compared to 
100% lysed cells (positive control).  
2.3.4 Caspase 3 assay 
Monocytes (3 x 10
6 
/well), lymphocytes (3 x 10
6 
/well), macrophages (2 x 10
6 
/well) and 
HeLa (250 x 10
3
 /well) 
 
seeded onto 24 wells plates were incubated for 18 h with Ludox 
TM40 NPs diluted in medium + 10% FCS at different concentrations (0-50-100-300-500 
µg/ml). Actinomycin D 1 µg/ml was used as positive control for apoptosis. At the end of 
incubation, cells were washed with PBS and resuspended in lysis buffer (10 mM Tris-HCl 
pH 7.5, 0.2 M NaCl, 0.5% Triton X-100, 1 mM dithiothreitol (DTT) at 170 x 10
6 
cells/ml 
for monocytes and lymphocytes, 40 x 10
6 
cells/ml for macrophages and 2.5 x 10
6 
cells/ml 
for HeLa. Cells were vortexed for 50”, then NaCl was added at a final concentration of 
200 mM to induce osmotic shock and cells were re-vortexed for 15” to complete lysis. 
After centrifugation at 13000 rpm, 4°C for 10’ to separate the particulate fraction 
(membrane, organelles) from soluble fraction (proteins), supernatants were collected and 
protein concentration was determined by DC Protein Assay (Biorad), according to 
manufacturer’s instruction. Caspase 3 activity was evaluated using a colorimetric assay 
system (CaspACE
TM
, Promega), based on the cleavage of Ac-DEVD-pNA by caspase 3 
and the consequent release of the chromophore p-nitroaniline (pNA), detectable by a 
spectrophotometer at 405 nm. Briefly, 100 µg of protein were incubated in a 96 wells 
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plate at 37°C over night in the dark with Caspase Assay Buffer, DMSO 2%, DTT 10 mM 
and DEVD-pNA 200 µM. After colour development, absorbance was red at 405 nm.  
2.4 Hemolysis assay 
Fresh buffy coat was washed 3 times with PBS to remove residual serum and resuspended 
in the initial volume of phosphate buffer. Then blood was mixed at 1:1 (v/v) ratio with 
Ludox TM40 NPs at increasing concentrations (0-12.5-25-50-100-300-500 µg/ml) diluted 
in 150 mM NaCl (saline solution) with or without FCS 10% at two different pH (5.2-7). 
In other experiments, blood was incubated with 150 mM NaCl alone or supplemented 
with 35 g/ml HDL or 5 mg/ml human serum albumin (HSA). Saline solution and 
distilled water were used respectively as negative and positive control. Samples were 
incubated for 1, 4, or 18 h at 37°C and then centrifuged at 1500 rpm for 5’. Supernatants 
were collected and absorbance values of released hemoglobin (indicative of red blood 
cells lysis) were determinated at 450 nm with a microplate reader spectrophotometer. The 
percentage hemolysis was calculated as ((sample absorbance-negative control 
absorbance)/(positive control absorbance-negative control absorbance)) x100.  
2.5 Cytofluorimetric analysis 
Monocytes, macrophages and HeLa cells seeded onto 24 wells plates were rapidly 
washed with PBS and incubated for 1, 5 and 18 h with increasing doses of FITC labeled 
Stöber-NPs, in the presence of different serum concentrations (0-2-10% v/v). At the end 
of incubation, monocytes and macrophages were detached from plate by gentle scraping, 
HeLa cells by trypsinization. Then, cells were centrifuged for 7’ at 1600 rpm, washed 
with 1 ml of PBS and finally resuspended in 300 µl of cold FACS Buffer supplemented 
with 10 mM NH4Cl  to neutralize acidic compartments. Samples were acquired for 30 
seconds at flow cytometer (BD FACSCanto II). Data analysis of the gated cellular 
populations was performed with FACSDiva software (Becton Dickinson).  
In fluorescence quenching experiments, the relative contributions to total cell MFI by 
fluorescein labeled Stöber SiO2-NPs on the cell surface (MFI
out
) and inside cells (MFI
in
) 
were estimated by Trypan Blue (TB, Sigma Aldrich) quenching effect obtained by flow-
cytometry in the presence of 10 mM NH4Cl. TB concentration of 3 mg/ml was used since 
it quenched the fluorescence of FITC-labeled anti EGF-R on A431 cells after binding at 
0°C to 7% of the value with no TB (not shown). Assuming that MFI
out
 + MFI
in 
= MFI and 
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that MFITB
out
 + MFITB
in 
= MFITB intracellular percentage of NPs (%NPs
in
) can be 
calculated with the derived equation: %NPs
in
= [(MFITB/MFI) – fe]x[100/(fi-fe)] (a); were 
fe and fi corresponded to the correction factor in the presence of TB to be multiplied with 
MFI
out
 and MFI
in
 in case of fully surface bound and fully internalizes NPs, respectively. 
SiO2-NPs were bound to cells at 0°C, a condition which does not allow cell endocytosis, 
for two hours at different doses (25-100 µg/ml) and quenching by TB was then analyzed 
producing a fe value of 0.4 ± 0.04 (n=8 ± SE), corresponding to a ~ 60% decrease of cell 
fluorescence. Alternatively, monocytes and macrophages were incubated for two hours 
with NPs at 37°C and chased for 24 hours in complete medium, allowing the estimation 
of a fi value of 0.84 ± 0.06 (n=4  ± SE), corresponding to ~ 16% decrease of cell 
fluorescence. Equation (a) assumed then the following form in our experiments: %NPs
in
= 
(MFITB/MFI – 0.4)x(100/0.44). 
2.6 Confocal microscopy analysis 
Monocytes, macrophages and HeLa cells seeded on cover glasses in 24 wells plates were 
incubated for 18 h at 37°C in the dark with FITC labeled Stöber-NPs at different 
concentrations (0-25-50-100-300-500 µg/ml), diluted in medium + 10% FCS. 30 minutes 
before pictures acquisition, cellular lysosomes were stained adding the lysosomotropic 
agent LysoTracker® Red (Invitrogen) at a final concentration of 75 nM.                          
In other experiments, cells were washed with PBS to remove serum excess and then 
incubated for 1 h at 37°C with Stöber-NPs, in the presence of different amounts of serum 
(0-0.5-2-10% v/v). Unfixed cells were rinsed with PBS and directly analyzed under a 
confocal microscopy (SP2 Leica). Representative pictures were collected as Tiff files and 
processed with standard imaging programs.  
2.7 Inhibition experiments 
In some experiments, monocytes and macrophages were pre-incubated for 1 h with 
ammonium chloride (NH4Cl) 10 mM (Sigma Aldrich), Bafilomycin AI (BafAI) 12.5 nM 
(Sigma Aldrich) or Ac-YVAD-CMK 100-200 µM (Cayman Chemical), and subsequently 
incubated for 4 or 18 h with increasing doses of Ludox TM40 NPs, in the absence or in 
the presence of 10% FCS. In other experiments, cells were treated with TM40 NPs for 4 
or 18 h at 37°C in RPMI 10% FCS in the presence of oATP 100 µM (Sigma Aldrich).   
At the end of incubation, samples were analyzed for cellular mortality by PI, MTS, LDH 
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assays (see paragraph 2.3), and IL-1  and TNF-  production was evaluated by ELISA 
assays (see paragraph 2.8). 
2.8 ELISA assays 
In this work ELISA assays were performed to quantify the three main pro-inflammatory 
cytokines (IL-1 , TNF-  and IL-6) released by monocytes and macrophages in culture 
medium after stimulation. Supernatants tested derive from samples used for 
cytofluorimetric analysis.  
2.8.1 IL-
IL-1  ELISA kit was provided by Bender MedSystems. Briefly, the day before the assay 
a Nunc MaxiSorp flat-bottom 96 well plate was coated with 50 µl of Capture antibody 
(diluted 1:100 in PBS) for 16-18 h at 4°C. After coating, unbound antibody was removed 
by 4 washes  with 200 µl of Wash Buffer (PBS + 0.05% Tween), using a Biotrak II plate 
washer (Amersham Biosciences), and subsequently wells were blocked with 200 µl of 
PBS + 5% Bovine serum albumin (BSA) for 2 h at RT. Afterwards, wells were washed 
and 50 µl of supernatants or standards (consisting of IL-1  at known concentrations 
[1000-500-250-125-62.5-31.25-15-6-0 pg/ml] diluted in the same medium of samples) 
were added for 3 h, in the presence of 25 µl of biotinylated detection antibody (diluted 
1:50 in PBS + 1% BSA). After plate wash, 50 µl of HRP-Streptavidin (diluted 1:6666 in 
PBS +1% BSA + 0.1% Tween) were added for 30’ and, following wash, 100 µl of the 
substrate solution TMB (3,3’,5,5’-Tetramethylbenzidine, KPL) were added until blue 
colour development. Samples absorbance was read at 405 nm with Biotrak II Reader 
spectrophotometer.  
2.8.2 TNF-  and IL-6 
TNF-  and IL-6 ELISA kits were provided by Peprotech. The day before assay, Nunc 
MaxiSorp flat-bottom 96 well plates were coated with 50 µl of Capture antibody (diluted 
at a final concentration of 1 µg/ml in PBS) for 16-18 h at RT. After washes as described 
above, plates were blocked with 200 µl of PBS + 1% BSA for 2 h at RT. Then plates 
were washed and 50 µl of supernatants or standards (TNF-  and IL-6 at known 
concentrations [4000-2000-1000-500-250-125-0 pg/ml] diluted in the same medium of 
samples) were added for 2 h at RT. After washes, detection antibody (50 µl, diluted in 
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PBS + 0.1% BSA + 0.05% Tween at 0.25 µg/ml for IL-6 and 0.5 µg/ml for TNF- was 
incubated for 1 h, washed and finally 50 µl of HRP-Avidin (diluted 1:2000 in PBS + 
0.1% BSA + 0.05% Tween) were added for 30’. Plates were washed again, 100 µl of 
TMB were added and, after colour development, samples absorbance was read at 405 nm.  
2.9 Intracellular and extracellular ATP determination 
Monocytes and macrophages (2 x 10
6
 cells/well) seeded onto 24 wells plates were 
incubated for 4 or 18 h with Ludox TM40 NPs at increasing doses (diluted complete 
medium), in the presence or in the absence of lypopolisaccharide (LPS) 1 ng/ml as co-
stimulus. To reduce the activity of ecto-ATPases (membrane associated enzymes 
responsible of ATP degradation), ecto-ATPases inhibitor ARL 67156 (6-N,N-Diethyl-β-
γ-dibromomethylene-D-adenosine-5′-triphosphate, Sigma Aldrich) was added at a final 
concentration of 200 µM. At the end of incubation, cellular medium was collected and 
centrifuged at 1600 rpm for 7’ to eliminate residual cellular component, while cells were 
lysed as described in paragraph 2.11, with the addition of 1 mM sodium orthovanadate 
(Na3VO4), in order to inhibit ATP dephosphorylation by ATPases or phosphatases. ATP 
concentration in extracellular medium or cellular lysate was determined using an ATP 
Determination Kit (Invitrogen), based on the oxidation of luciferin, in the presence of 
ATP, to oxyluciferin with the concomitant production of photons (detectable, for 
example, by a luminometer). First, a working solution (kept at 4°C in the dark) was 
prepared just before measures. It contained dH2O, reaction buffer (consisting of 25 mM 
Tricine Buffer pH 7.8, 5 mM MgSO4, 100 µM EDTA and 100 µM NaN3), 0.5 mM D-
luciferin, 1 mM DTT and 1.25 µg/ml firefly luciferase. Standard solution was prepared by 
diluting ATP in dH2O at known concentrations (serial dilutions from 1 µM to 0.12 nM). 
At the moment of the measure, 90 µl of working solution were rapidly added to 10 µl of 
samples/standards in special plastic tubes (Sarstedt), and emitted light was detected by a 
TD-20/20 luminometer (Turner Designs) set on these parameters: 
- delay: 3 seconds 
- integrate time: 12 second 
- replicates: 1 
 
 
55 
 
2.10 Single proteins influence on SiO2-NPs toxicity/association 
Monocytes (2 x 10
6
 cells/well) seeded onto 24 wells plates were briefly washed with PBS 
to remove serum excess and subsequently incubated for 18 h at 37°C with Ludox TM40 
or fluorescent Stöber-NPs at different concentrations, in the presence of serum free 
RPMI-1640 supplemented with IgG 140 µg/ml (Sigma Aldrich), HRG 3 µg/ml (purified 
from human plasma as described in paragraph 2.19), HSA 1.2 mg/ml (Sigma Aldrich), 
ApoAI 24 µg/ml (Calbiochem) or HDL 50 µg/ml (Calbiochem). Proteins were used at a 
concentration correspondent to 2% human plasma. At the end of incubation, cellular 
viability (PI negative cells) and NPs cellular association were evaluated by 
cytofluorimetric analysis.  
2.11 Cellular lysis 
Monocytes and macrophages (2 x 10
6
 cells/well) seeded onto 24 wells plates were 
incubated at 37°C for 18 h with different doses of Ludox TM40 NPs with or without LPS 
1 ng/ml in complete medium, or for 4 h in RPMI-1640 supplemented with antibiotics and 
1% Nutridoma SP (Roche). At the end of incubation, supernatants were collected for 
ELISA assays or for precipitation procedure, while cells were washed with 1 ml ice cold 
PBS and immediately lysed for 30’ on ice in lysis buffer (50 mM Tris, pH 7.4, 150 mM 
NaCl, 2 mM EDTA, 2 mM EGTA,10% glycerol, 1% Triton X-100, 40 mM 
glycerophosphate, 50 mM sodium fluoride, 200 mM sodium vanadate and protease 
inhibitor mixture (Roche) [128]. Cells from 2 wells (4 x 10
6
) were lysed in 120 µl buffer. 
Afterwards, samples were centrifuged for 10’ at 13000 rpm at 4°C, soluble fraction 
(supernatant) was collected and stained with Loading Sample Buffer (LSB) (50 mM Tris 
HCl pH 6.8, 0.8% -mercaptoethanol, 2% SDS, 0.06% bromophenol blue and 6% 
glycerol) for electrophoresis and western blot analysis.  
2.12 Cellular supernatants precipitation 
Supernatants of cells stimulated in RPMI-1640 + 1% Nutridoma were precipitated with 
the following procedure. After supernatants brief centrifugation to eliminate any cellular 
residue, Trichloroacetic acid (TCA) was added at a final concentration of 10% (v/v) for 1 
h at RT. Then, samples were centrifuged at 13000 rpm for 15’ at 4°C, pellet of proteins 
was washed from TCA with 1 ml ice cold acetone and centrifuged as above. Precipitated 
proteins were solubilized in 42 µl of LSB, supplemented with protease inhibitors cocktail 
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(Roche). In case of yellow coloration development (indicative of TCA residues), 0.5 µl of 
Tris 2M were added to adjust pH.  
2.13 SDS-PAGE (Sodium Dodecyl Sulphate – Polyacrylamide Gel 
Electrophoresis) 
Samples solubilized in LSB were heated at 95°C for 5’, spun down and loaded (15 µl) 
into a Polyacrylamide gel. 5 µl of ColorBurst
™
 Electrophoresis Marker (Sigma Aldrich) 
were loaded in each gel as reference. Resolving gel, stacking gel and running buffer 
composition is indicated in Table 2.                                                               
  
Resolving gel Stacking gel Running Buffer 
Tris-HCl 0.39 M pH 8.8 Tris-HCl 0.125 M pH 6.8 Tris-HCl 25 mM pH 8.3 
Acrylamide solution 12% Acrylamide solution 4% Glycine 192 mM 
SDS 0.1% SDS 0.1% SDS 0.1% 
APS 0.1% APS 0.05% - 
TEMED 0.1% TEMED 0.35% - 
 
Table 2: Composition of buffers for electrophoresis 
Electrophoresis was run for 60’ – 90’ at 25 mA /gel and 100 V. At the end, gels were 
recovered, prepared for Western Blot or directly stained by Colloidal Coomassie or Silver 
Staining procedure, depending on the experiment.  
2.14 Western Blot 
 PVDF (polyvinylidene difluoride) membranes (Biorad) were activated for 30’’ in 
methanol, rinsed 3 times in water and equilibrated together with gels, sponges and paper 
towels (Whatman) in cold Transfer Buffer (Tris-HCl 25 mM pH 8.3, Glycine 192 mM, 
Methanol 10%). Then, proteins were transferred from gel to membrane at 4°C for 60’ - 
90’ at 200 mA – 80 V, under stirring. Once the transfer was completed, membranes were 
blocked for 1 h at RT with 5% non fat milk powder solubilized in TBS (Tris Buffered 
Saline) + 0.1% Tween, and subsequently incubated for 18 h at 4°C with primary antibody 
(diluted in 3% non fat milk solubilized in TBS 0.1% Tween). Then, membranes were 
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washed 3 times for 15’ with TBS 0.1% Tween, incubated for 1 h at RT with horseradish 
peroxidase (HRP) conjugated secondary antibody (diluted in 3% milk + TBS + 0.1% 
Tween), washed again 4 times and developed with enhanced chemo-luminescence 
reaction (ECL) as follows. Briefly, each membrane was incubated for 1’ in the dark with 
a solution containing Tris-HCl 100 mM pH 8.5, H202 0.05%, Luminol 1.25 mM and p-
Coumaric acid 0.2 mM, and exposed for 10’’ – 5’ to a photographic plate (Fujifilm Super 
RX). Plates were developed with Hyperprocessor developer (Amersham Biosciences). 
Signal quantification was performed using Image J.                                                           
In Table 3 a list of all primary and secondary antibodies used in this work is reported. 
 
Primary antibodies 
 Company Species Dilution factor 
anti human Albumin Calbiochem Rabbit 1 : 2000 
Anti human ApoAI Calbiochem Goat 1 : 2000 
Anti human ApoE Millipore Goat 1 : 2000 
Anti human Actin Sigma Aldrich Mouse 1 : 10000 
Anti human Caspase 1 Millipore Rabbit 1 : 500 
Anti human HRG Abnova Mouse 1 : 2000 
Anti human IL-1 Cell Signaling Rabbit 1 : 1000 
Anti human IgG2 Millipore Mouse 1 : 1000 
Secondary antibodies 
 Company Species Dilution factor 
Anti-goat Calbiochem Rabbit 1 : 2500 
Anti-mouse Calbiochem Goat 1 : 2500 
Anti-rabbit Bio-Rad Goat 1 : 3000 
 
Table 3: list of primary and secondary antibodies 
2.15 Silver Staining 
Silver staining procedure was carried out at RT. First, gels were fixed for 30’ in 50% 
methanol 10% acetic acid, incubated for 15’ in 5% methanol 1% acetic acid , washed 3 
times for 5’ with water and incubated for 90’’ in thiosulfate solution (200 µg/ml Na2S2O3 
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pentahydrate), in order to sensitize proteins to following treatment. Then, gels were 
washed 3 times for 30’’ with water and incubated in the dark for 30’ with 2 g/l silver 
nitrate (AgNO3), which binds aminoacid side chains. Gels were developed for 5-15’ with 
a solution containing 60 µg/ml sodium carbonate (Na2CO3), 4 µg/ml Na2S2O3 
pentahydrate and 0.0175% formaldehyde, through the reduction of Ag
+
 ions to metallic 
silver (Ag
0
) and the consequent formation of a brown precipitate in correspondence of 
proteic bands. Reaction was stopped with a 6% acetic acid solution. Bands quantification 
was performed using Image J.  
2.16 Colloidal Coomassie G-250 Staining 
Coomassie staining was carried out at RT. First, gels were fixed for 18 h in 50% methanol 
2% phosphoric acid (H3PO4), rinsed 3 times for 30’ minutes with water and incubated for 
1 h in a solution containing 34% methanol, 2% phosphoric acid and 17% ammonium 
sulfate (NH4)2SO4. Staining step was performed for 3 day in 34% methanol, 2% 
phosphoric acid, 17% ammonium sulfate and 0.066% Coomassie G-250, and it was 
followed by destaining in water for other 3 days. Coomassie stained proteins were excised 
from the gel and subsequently identified by mass spectrometry, in collaboration with Dr 
Patrizia Polverino De Laureto laboratory.  
2.17 In-Gel Digestion, MS/MS protein identification and database 
research 
After Coomassie staining, bands of interest were excised from the gel, crumbled in 1x1 
mm cubes into a low binding proteins tube (Eppendorf), washed with 150 µl of water for 
5’ and shrinked for 15’ at RT in 200 µl acetonitrile. Then gel particles were spun down, 
liquid was removed and gel pieces were dried in a vacuum centrifuge. To reduce 
disulphide bonds, gel bands were incubated at 56°C for 30’ with 200 µl of 10 mM 
dithiothreitol /0.1 M NH4HCO3, and subsequently spun down to better remove liquid, 
shrinked with acetonitrile as above and dried in a vacuum centrifuge. Reduced disulphide 
bonds were then alkylated for 20’ at RT in the dark with 150 µl of 55 mM 
iodoacetamide/0.1 M NH4HCO3. Then, iodoacetamide solution was removed, gel pieces 
were washed for 15’ with 200 µl of 0.1 M NH4HCO3 and, after liquid removing, they 
were shrunk with acetonitrile and dried. In order to completely destain gel pieces, they 
were incubated for 15’ with 0.1 M NH4HCO3 and, at the end, an equal volume of 
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acetonitrile was added for additional 20’ minutes (vortexing every 5’). At this point liquid 
was removed, gel pieces were shrinked and totally dried. This step was repeated until 
samples were completely destained. To digest proteins in smaller peptides, gel pieces 
were rehydrated by covering with the digestion buffer containing 50 mM NH4HCO3 and 
12.5 ng/µl of trypsin, incubated for 45’ at 4°C and subsequently kept over night at 37°C. 
At the end of incubation, gel particles were spun down and the supernatant was collected 
for an eventual MALDI analysis. Then, 15 µl of 25 mM NH4HCO3 were added to gel 
pieces at 37°C for 15’ with shaking, and additional 50 µl of acetonitrile were added for 
15’ at 37°C under stirring. After spinning, supernatant was collected, gel pieces were 
incubated with 50 µl of 5% formic acid for 15’ at 37°C with shaking, additional 50 µl of 
acetonitrile were added for others 15’ at 37°C with shaking and finally gel pieces were 
spun down and supernatant was collected and put together with the one collected just 
before.  At this point, supernatants were dried in a vacuum centrifuge and reconstituted in 
20 µl of 5% acetonitrile 0.1% formic acid. For electrospray MS analysis, the peptides 
were eluted in 50% acetonitrile containing 0.2% formic acid. Data were collected on a Q-
Tof AGILENT 6520 mass spectrometer (capillary voltage: 3,000–3,200 V; cone voltage: 
45 V; scan time: 1 s; interscan: 0.1 s). Spectra were analyzed using Micromass MassLynx 
V4.1 software. The MASCOT program (Matrix Science, www.matrix-science.com) was 
used to search for all MS/MS spectra against the Swiss-Prot and NCBI databases. The 
following parameters were used in the MASCOT search: trypsin specificity: maximum; 
number of missed cleavages: 1; fixed modification: carbamidomethyl (Cys); variable 
modifications: oxidation (Met); peptide mass tolerance: 61.0 Da; fragment mass 
tolerance: 60.5 Da; protein mass: unrestricted; mass values: monoisotopic.  
2.18 Nanoparticles incubation with human plasma or fetal calf serum 
Venous blood was taken from healthy volunteers and immediately treated with sodium 
citrate (at a final concentration of 0.38% v/v) as anticoagulant. Platelet poor plasma 
(typically 50% of blood volume) was obtained after a centrifugation for 10’ at 3000 rpm 
at RT without accelerator and brake. Fetal calf serum was the same used for cellular 
cultures. Human plasma (HP) or bovine serum (FCS) were diluted at different 
concentrations in PBS pH 7.4 + EDTA 1 mM, and incubated for different times (in most 
experiments, 15’) with various amounts of Ludox TM40 NPs at 37°C with shaking, in a 
final volume of 1 ml. dH2O was used instead of NPs as control. At the end of incubation, 
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the mixture was transferred in polycarbonate tubes (Beckman Coulter), which were 
completely filled with PBS 1 mM EDTA before ultracentrifugation. Nanoparticles were 
recovered by ultracentrifuging for 1 h at 100000 g at 4°C, using a XL-70 Ultracentrifuge 
(Beckman). Afterwards, supernatants were collected, NPs pellet was washed twice with 
PBS EDTA 1 mM filling the tubes (after each washing NPs were ultracentrifuged) and 
finally dissolved in 150 µl of non reducing loading sample buffer plus protease inhibitors 
cocktail. After heating at 95°C for 5’, equal volumes (4 µl – 19 µl) or equal amounts (3.3 
µg) of solubilized NPs were loaded into a 12% polyacrylamide gel (see paragraph 2.11).  
In pH dependence experiments, FCS was diluted at a final concentration of 10% v/v in 
PBS + sodium citrate 5 mM pH 5 or pH 7.2 (depending on the sample) and, after 
ultracentrifugation, NPs pellet was washed with the buffer at the same pH of the sample.  
2.19 Histidine rich glycoprotein purification  
HRG was purified from fresh or thawed human plasma (centrifuged at 12000 rpm for 20’ 
at 4°C to remove any aggregate), using a fast protein liquid chromatography (FPLC) 
system (Pharmacia), in collaboration with Prof. Luigi Bubacco laboratory. Briefly, 6 ml 
of water-swollen cation exchange resin Phosphocellulose (P-11, Whatman) were 
equilibrated at 4°C for 18-20 h with 10 volumes (1 volume = 6 ml) of Loading buffer (0.5 
M NaCl, 10 mM sodium phosphate, 1 mM EDTA, pH 6.8) supplemented with protease 
inhibitors. Plasma was diluted 1:2 with Loading Buffer + protease inhibitors, filtered 
through a 0.22 µM filter and loaded on the equilibrated column. Unbound proteins were 
removed by extensive washing (20-25 volumes) with Wash Buffer (0.8 M NaCl, 10 mM 
sodium phosphate, 1 mM EDTA, pH 6.8) plus protease inhibitors, and HRG was eluted 
by a progressive saline gradient (from 0.8 M to 2 M NaCl, 12 fractions of 1 ml were 
collected) followed by 4 volumes (12 fractions of 2 ml) of Elution buffer (2 M NaCl, 10 
mM sodium phosphate, 1 mM EDTA, pH 6.8), without protease inhibitors. The presence 
of HRG in collected fractions was evaluated by SDS-PAGE under reducing conditions, 
followed by silver staining and Western Blot analysis. HRG positive fractions were 
dialyzed for 20 h at 4°C against 1000 ml PBS, quantified by Bradford assay according to 
manufacturer’s instruction, frozen in liquid nitrogen and stored at -80°C.  
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2.20 IgG removal from HRG 
Immunoglobulins were removed from HRG fractions by the binding to Protein A 
Sepharose CL-4B resin (GE Healthcare). 100 µl of powdered resin were hydrated with 
500 µl of ice cold PBS at 4°C for 30’; then 1 ml of PBS was added and resuspended resin 
was divided in aliquots of 120 µl. After a wash with 1 ml of HRG Elution buffer, resin 
was incubated with 250 µl of HRG-containing fraction at 4°C for 8 h under shaking. At 
the end, resin was spun down, supernatant was collected and, after 2 washes with 1 ml of 
Elution buffer, pelleted resin was resuspended in 50 µl of reducing LSB 1X. 
Immunoglobulin removal was analyzed by SDS-PAGE and subsequent silver staining.  
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3. Results 
3.1 SiO2-NPs cytotoxicity 
Cytotoxicity of amorphous silica nanoparticles is largely documented in literature, both in 
in vitro [52] and in vivo models [58,61,62,64,66]. In some articles a better ability to 
induce cytocidal effects in phagocytic cells compared to non phagocytic ones is 
described, suggesting that nanoparticles endocytosis is important in determining adverse 
effects [60,68,69]. The majority of studies, however, are conducted on immortalized cells 
lines (murine or human), so the interaction, and its consequences, between nanoparticles 
introduced in the body and cellular types they come in contact with are not well 
represented. With the aim to document a “more physiological” condition, we decided to 
test amorphous silica nanoparticles toxicity on primary cells, directly purified from buffy 
coat. We chose two types of phagocytic cells (human monocytes and monocytes-derived 
human macrophages) and two types of non phagocytic cells (human lymphocytes and 
human epithelial cell line HeLa, used as control). We performed a systematic approach 
evaluating different parameters related to cytotoxicity, in order to understand something 
more about the mechanism. Experiments were conducted treating cells for 4 h or 20 h 
with increasing doses of Ludox TM40 or Stöber NPs, diluted in medium + 10% FCS 
(complete medium).  
3.1.1 Nanoparticles-induced membrane permeabilization 
To check if SiO2-NPs induce change in the permeability of the cell plasma membrane, we 
used propidium iodide (PI) and lactate dehydrogenase (LDH) assays. The first method is 
based on a dye, propidium iodide, unable to permeate cellular membrane. Damaged cells 
can be stained because they present membrane pores that allow PI (a small molecule, 
MW 670 Da) to enter, bind to DNA and increase its fluorescence (detectable, for 
example, at flow cytometer at 670 nm after excitation at 488 nm). The second method 
measures extracellular levels of LDH, a big homotetrameric enzyme (MW 145 kDa) 
normally present in the cytosol to catalyze the NADH dependent reduction of pyruvate to 
lactate (lactic fermentation). In case of cellular lysis, LDH is released in extracellular 
medium and can be detected with a colorimetric assay. 
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3.1.2 Nanoparticles-induced mitochondrial damage 
Mitochondria are organelles indispensable for vitality of cells, providing the first energy 
source (ATP) through a complex series of reactions (oxidative phosphorylation). To 
measure mitochondrial activity (indicative of cellular viability) we used MTS assay, 
based on the reduction of a tetrazolium salt to colored formazan by mitochondrial 
dehydrogenases, present in metabolically active cells. 
3.1.3 Nanoparticles-induced intracellular ATP decrease 
Intracellular ATP level is determined by the balance between its synthesis (through 
glicolysis and oxidative phosphorylation), its degradation to liberate energy and its 
release by passive (e.g., as consequence of cellular lysis) and active (e.g., in signaling 
processes) mechanisms. Even if this parameter is not used as a classic indicator of 
cytotoxicity, we investigated if it was affected by SiO2-NPs treatment in inflammatory 
cells (monocytes and macrophages), considering its importance in inflammasome 
activation mechanism. 
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Figure 13: SiO2-NPs cytotoxic effects on human monocytes, macrophages, lymphocytes and HeLa cells. 
(a) Time/dose-response analysis of Ludox TM40 NPs induced cellular lysis (% LDH release), membrane 
permeabilization (% PI
-
 cells) and mitochondrial damage (MTS), in the presence of complete medium. (b) 
Intracellular ATP content of monocytes and macrophages treated for 4 and 20 h with increasing doses of 
Ludox TM40 NPs, in the presence of complete medium. (c) Ludox TM40 cytotoxicity threshold and LD50 
after 4 and 20 h cellular treatment. Data are the mean of three independent experiments run in duplicate.  
As can be observed from LDH, PI and MTS mortality curves (Figure 13a), SiO2-NPs 
cytotoxicity is time dependent and occurs above a threshold concentration, higher for 
lymphocytes and HeLa in comparison to monocytes and macrophages in all the assays 
performed. Even LD50 values (representing nanoparticles doses that induce 50% of 
cellular mortality compared to untreated cells) are ~ 10 fold higher for non phagocytic 
cells than phagocytic cells (as represented in Figure 13c). These results suggest that 
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phagocytes are more sensitive than non phagocytes to SiO2 NPs effects, and are in 
agreement with data reported in the literature and obtained with cellular immortalized 
lines. An interesting observation is that cytotoxic NPs doses revealed by propidium iodide 
and MTS assays are quite similar and significatively lower than the ones revealed by 
LDH assay, especially after a short time treatment (4 h). This could be due to a first 
cellular damage involving mitochondrial failure and membrane semi-permeabilization, 
followed by the complete cellular lysis and the consequent  release of lactate 
dehydrogenase (an enzyme otherwise retained in intracellular environment for its big 
dimensions). At 20 h this effect is less evident because of the stronger toxicity of NPs, 
significantly compromising also membrane integrity.  
We also found that SiO2-NPs induce a decrease of intracellular ATP level (Figure 13b) in 
both monocytes and macrophages, in a time-dose dependent way. This is in accord with a 
result obtained by Yang et al. [129], where ATP depletion was documented in human 
mesothelial cells after treatment with asbestos (an other inflammasome activator). 
Surprisingly, threshold and EC50 determined for ATP release are 2-5 fold higher than for 
mitochondrial activity, suggesting that mitochondrial dysfunction could be compensated 
by glicolytic pathway and that the event determining intracellular ATP fall is cell 
disruption (hypothesis supported by the similar threshold and LD50 values between iATP 
assay and LDH assay). 
3.1.4 Necrosis or apoptosis? 
Membrane permeabilization and mitochondrial damage are events typical of necrotic 
death. Necrosis is a “passive” cell death resulting from environmental perturbations (e.g. 
heat shock and UV irradiation) accomplished with an uncontrolled release of 
inflammatory mediators [102]. On the other hand, necrosis can also be considered the 
sum of postmortem cellular changes that cells undergo following their death, regardless 
the real mechanism of death [130]. An other common type of cellular death is apoptosis, 
defined as a programmed cellular suicide with the aim to remove undesired individual 
components (for example affected by genetic mutations or chromosomic aberrations), 
preserving the safety of the entire cellular population or organism [102,131]. Apoptosis 
occurs under a strong genetic and environmental control, and is not associated to any 
inflammatory event [132]. 
67 
 
Nano-SiO2 induced apoptosis is reported in human hepatoma HepG2 cells [64], normal 
human hepatic cell line L-02 [67], human umbilical vein endothelial cells HUVEC [59] 
and in several studies performed on murine macrophages [133,134]. To assess if our 
cellular models undergo apoptotic death after silica nanoparticles treatment, we measured 
two peculiar markers of apoptosis: phosphatidylserine extracellular exposure and caspase-
3 activation. 
Phosphatidylserine is a membrane phospholipid normally present in the cytosolic face of 
the plasmalemma. In apoptotic cells, it is traslocated in the outer side of the membrane, 
here it contributes to the well controlled death process serving as eat-me signal for 
macrophages [135]. Surface exposed phosphatidylserine can be detected with fluorescent 
labeled Annexin V, a protein able to bind phosphatidylserine in the presence of calcium. 
[135,136]. Double staining with propidium iodide and Annexin V allowed to distinguish, 
at flow cytometer, necrotic cells (Annexin V + and PI + ) and apoptotic cells (Annexin V 
+ and PI -). 
Caspase 3 is cysteine protease belonging to the effector caspases of apoptosis and 
responsible of the cleavage of caspase-activated DNase inhibitor, resulting in typical 
nuclear fragmentation [102]. The activation of caspase-3 from its inactive pro-form can 
be assessed by a colorimetric assay. 
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Figure 14: Evaluation of SiO2-NPs induced apoptosis in human monocytes, macrophages, lymphocytes and 
HeLa cells. (a) cytofluorimetric analysis of phosphatidylserine exposure and plasma membrane 
permeabilization of cells treated with medium (negative control), ActD 1 g/ml (positive control for 
apoptosis) and Ludox TM40 NPs. Representative dot plots with percent of viable (bottom left quadrant), 
early apoptotic (bottom right quadrant), late apoptotic (top right quadrant) and necrotic (top left quadrant) 
cells are shown. (b) analysis of caspase 3 activation through a colorimetric assay. A.u. : Absorbance units. 
Data are from one of three representative experiments. 
After 18 h incubation with Actinomycin D (ActD) (a positive control for apoptosis), all 
cells show an apoptotic phenotype (PS exposure and caspase 3 activation) compared to 
the control. On the contrary, SiO2-NPs treatment induce apoptosis only in HeLa cells, as 
revealed by both assays, suggesting a different death mechanism between endothelial 
cells and leukocytes. 
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3.2 SiO2-NPs cellular association and localization 
Cellular response to nanoparticles derives, in the majority of cases, from their physical 
interaction. To characterize SiO2-NPs association with our cellular models, I performed 
experiments using cytofluorimetry and confocal microscopy, respectively, to quantify the 
amount of NPs interacting with cells and to determine their cellular localization, by 
incubating monocytes, macrophages, lymphocytes and HeLa with the fluorescein (FITC) 
conjugated Stöber NPs. It is possible to use Stöber NPs as a fluorescent (and so 
detectable) variant of Ludox TM40 NPs because they have very similar physic-chemical 
properties and they kill at the same manner our cellular models, with an higher toxicity 
for phagocytic cells. 
3.2.1 Cytofluorimetric analysis 
Cells incubated for 18 h with different doses of fluorescent Stöber NPs were analyzed for 
NPs-cellular association at flow cytometer, keeping the same FITC setting to compare 
different cellular types (that naturally have different autofluorescences) (Figure 15). 
 
Figure 15: Dose dependent Stöber NPs association to monocytes, macrophages, lymphocytes and HeLa 
cells after 18 h cellular treatment in complete medium. Data are from one of four representative 
experiments. MFI: mean fluorescence intensity 
Macrophages resulted to be the cells that interact more efficiently with SiO2-NPs, having 
the highest association rate and reaching values of medium fluorescence intensity (MFI, 
indicative of NPs-cells interaction) 10-20 times higher than other cells. Lymphocytes, 
small non-phagocytic cells, poorly associated to SiO2-NPs, while monocytes and HeLa 
cells appeared to be intermediate between macrophages and lymphocytes (HeLa present a 
higher MFI at higher NPs concentration tested). This result could reflect the innate ability 
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of macrophages (called “professional phagocytes”) to engulf undesired objects (cellular 
debris, viruses, particulates) compared to other cells.                                           
Phagocytic cells are known to internalize different types of particles into endosomes or 
phagosomes, that can be fused with acidic compartments (lysosomes) forming a 
phagolysosome, where for example antigens are processed by hydrolytic enzymes. We 
investigated if lysosomal internalization was conserved also for SiO2-NPs by incubating 
cells for 4 h and 18 h with the non fluorescent variant of SiO2-NPs (Ludox TM40) and 
monitoring at flow cytometer the signal associated to the fluorescent lysosomotropic 
probe Lysotracker Green, a flourophore linked to a weak base permeant to lysosomal 
membrane and retained into the acidic compartment after protonation (Figure 16).  
 
Figure 16: Induction of acidic intracellular compartments in monocytes, macrophages, lymphocytes and 
HeLa cells by Ludox TM40 NPs. After indicated times, cellular viability (a) and Lysotracker fluorescence 
intensity associated to alive cells (b) were quantified by cytofluorimetric analysis and expressed as a 
percentage of control samples (no NPs) and as mean fluorescence intensity (MFI), respectively. Data are 
the means from three experiments run in duplicate. 
After 4 h treatment, the fluorescence associated to Lysotracker clearly increased with the 
increment of SiO2-NPs doses in monocytes and macrophages, indicating a hypothetical 
accumulation of particles in new forming phagolysosomes. After a prolonged treatment 
(18 h), Lysotracker signal increased in the correspondence of non toxic SiO2-NPs doses 
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(as a possible consequence of lysosomal engulfment), while in cytotoxicity conditions 
(high NPs doses) it was subjected to a fall in both cells. This phenomenon could be 
attributed to Lysotracker fluorescence dissipation in the presence of cytotoxicity, and is 
probably consequent to lysosomal destabilization/loss of integrity induced by SiO2-NPs. 
Our hypothesis is supported by confocal microscopy experiments reported in recent 
papers [56,60,134], where a transition from a punctuate pattern of lysosomal loading 
agents (FITC dextran, acridine orange) to a diffuse cytoplasmic signal (indicative of 
lysosomal leakage) has been observed after silica treatment. In non phagocytic cells, 
Lysotracker associated signal remained unchanged (HeLa) or poorly increased 
(lymphocytes) at any time with the augment of SiO2-NPs doses, suggesting a negligible 
formation of new endo-lysosomes consequent to the low amount of phagocytized NPs.  
An indirect method to predict SiO2-NPs localization in our cellular models was to roughly 
estimate the pH around NPs in cells, assuming that pH values  4.5-5 were representative 
of acidic compartments. Our experimental approach consisted in the cytofluorimetric 
measure of the fluorescence associated to FITC-Stöber NPs in the absence or in the 
presence of NH4Cl 10 mM (added just before FACS acquisition) as acidic compartments 
neutralizing agent (for more details, see paragraph 3.3.6). Since FITC fluorescence 
increases with the increment of pH (as known from the literature [137] and confirmed by 
our spectrofluorimetric measures reported in Figure 17a), we speculated that the 
fluorescence of particles inside acidic vesicles would increase after NH4Cl neutralization, 
whereas fluorescent signal of particles located in a neutral environment (e.g., cytoplasm) 
would remain unchanged. The analysis of the ratio of MFI signals obtained from the same 
sample - or + NH4Cl allowed a pH value prediction (Figure 17b).  
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Figure 17: (a) Fluorescein labeled Stöber SiO2-NPs were incubated at 37°C in serum free medium (0% 
FCS) or medium plus 10% FCS at different pH values (4-7), and fluorescence maximal intensity was 
measured with a spectrofluorimeter and expressed as a percentage of the pH 7.0 value. (b) Indicated cells 
were incubated with the indicated doses of Stöber SiO2-NPs and the ratio of mean fluorescence intensity in 
the same alive cells samples before and after neutralization of intracellular acidic endosomal compartments 
by NH4Cl 10 mM was evaluated at flow cytometer. The mean pH around cell associated NPs was inferred 
from the titration curve exemplified in panel (a).  
At low doses (25 g/ml) SiO2-NPs were in acidic compartments (estimated pH  5.4) in 
monocytes, macrophages and HeLa, while in lymphocytes they were in a weakly 
acidic/nearly neutral environment. Upon increasing the NPs dose to 100 g/ml, the two 
phagocytic cells maintained the ability to localize NPs in acidic compartments (estimated 
pH  5.2) while HeLa started to behave similarly to lymphocytes (with a approximate pH 
 6 around NPs), indicating a less efficient phagocytosis in comparison to phagocytes. In 
the presence of SiO2-NPs cytotoxicity (150 g/ml) the pH surrounding NPs in monocytes 
and macrophages shifted to more neutral values (> 6), as a possible consequence of 
lysosomal rupture and dissipation of the H
+
 gradient normally maintained in these 
vesicles. This result is in agreement with the fall of Lysotracker signal under mortality 
conditions presented above.  
3.2.2 Confocal microscopy analysis 
To provide more information on SiO2-NPs uptake by the different cellular models, I 
assessed their cellular localization by confocal microscopy (lymphocytes were not 
considered because they did not interact significantly with NPs and, as cells in 
suspension, they are more difficult to prepare for this type of analysis). Monocytes, 
macrophages and HeLa were incubated for 18 h with fluorescent Stöber NPs, and 
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subjected to a lysosomal staining with the fluorescent lysosomotropic probe Lysotracker 
Red, in order to study the possible co-localization with nanoparticles accumulated in 
lysosomes (Figure 18). 
 
Figure 18: SiO2-NPs localization in monocytes, macrophages and HeLa. Indicated cells were incubated for 
18 h with medium (control) or two doses of Stöber SiO2-NPs (black: non toxic dose; red: toxic dose). 
Acidic compartments were stained with the lysosomal probe Lysotracker red. White arrows indicate 
Lysotracker positive acidic intracellular vesicles; yellow arrows indicate plasma membrane; red asterisks 
show cytoplasm vacuolization and membrane swelling; blue asterisk indicates small contracted cells.  
As expected, in professional phagocytes (macrophages) the signal associated to FITC 
labeled SiO2-NP (green) completely overlapped with the one of lysosomes (red), 
suggesting a very efficient phagocytosis. In monocytes this phenomenon was less evident 
but could be detected too, while in HeLa NPs associated signal was mostly located on the 
plasma membrane, indicating that epithelial cells poorly include NPs in intracellular 
endosomal compartments but, at the same time, are able to establish a superficial 
interaction (confirming significant MFI values obtained at flow cytometer). In addition, 
phase contrast pictures were indicative of the different type of cellular death induced by 
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toxic doses of SiO2-NPs (indicated in red), providing observations in agree with 
cytotoxicity data presented in the previous paragraph. Indeed, treated monocytes and 
macrophages presented big cytosolic vacuoles and membrane bleps (red asterisks), 
representative of necrosis, compared to untreated cells; HeLa after NPs exposure became 
smaller and contracted (blue asterisk), as characteristic of apoptotic cells. 
 
3.3 Inflammasome activation by SiO2-NPs 
Several studies document the pro-inflammatory potential of crystalline nanoparticles, 
responsible of the development of silicosis in many workers daily exposed to this 
material. Recently, also amorphous silica was found to promote inflammatory genes 
transcription and correspondent cytokines production (IL-1 , TNF- ) in mouse and rat 
models, even if in a less strong way than quartz [52,73]. However, most of these studies 
were conducted by priming cells with LPS (to induce IL-1  transcription) and 
subsequently adding silica as second stimulus for NALP3 activation, while the ability of 
SiO2 to induce an inflammatory response per se is poorly documented. To elucidate this 
aspect, we tested Ludox TM40 NPs on our two models of inflammatory cells (circulating 
monocytes and monocytes derived macrophages), focusing on different features of 
inflammasome activation. 
3.3.1 Nanoparticles-induced inflammatory response 
After treatment of monocytes and macrophages with Ludox TM40 NPs for 4 and 18 h, 
the levels of the three main inflammatory cytokines (IL-1 , TNF-  and IL-6) released in 
culture medium were measured (Figure 19). 
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Figure 19: Dose-time dependent inflammatory response induced by SiO2-NPs in monocytes and 
macrophages. Cells were incubated for 4 and 18 h with increasing doses of Ludox TM40 SiO2-NPs, and the 
levels of IL-1 , TNF-  and IL-6 released in the medium were measured by ELISA assays. Data are from 
one representative experiment out of five.  
A first evidence is that both monocytes and macrophages, if treated with SiO2-NPs, 
produce and release inflammatory mediators (IL-1 , TNF-  and IL-6) in a dose-time 
dependent way. Indeed, all the three cytokines show a “triphasic” trend, with a 
null/minimal production at low NPs concentration, a central peak (where NPs exert their 
inflammatory action) and a final fall at highest NPs doses, probably caused by the 
reduced number of cells still metabolically active because of the strong and very rapid 
toxicity. The time dependence of the phenomenon is evident because after 4 h treatment 
the first “NPs inflammatory dose” is 75 µg ml (IL1- ) and 50 µg/ml (TNF-  and IL-6) 
for monocytes and 50 µg/ml (IL-1  and TNF- , IL-6 is not detectable) for macrophages, 
while it results anticipated after 18 h treatment to 37.5 µg/ml for the three cytokines in 
both cells. Also the absolute quantity of cytokine released is influenced by the time of 
NPs exposure, with a general increasing tendency, indicating a progressive accumulation 
of cytokines in the medium. An interesting exception is represented by monocytes 
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produced TNF-  and IL-6, whose amount does not change between 4 and 18 h. A 
possible explanation could be that, differently from IL-1  that is produced by a three 
steps mechanism (gene transcription-protein translation-post traductional maturation) 
requiring a longer time, TNF-  and IL-6 are synthesized as already mature proteins (so 
they need less time to be produced) and after 4 h have reached the maximum 
concentration in the medium. This effect is not observable in macrophages, probably 
because as less efficient cells in producing inflammatory mediators (compared to 
monocytes) they synthesize all the three cytokines in a longer time. Comparing the 
amount of cytokines released by the two cellular types, it is evident that monocytes 
produce a higher quantity of cytokines (  10 folds for IL-1  and  2/5 folds for TNF-  
and IL-6). The minor reactivity of macrophages is not attributable to a higher resistance 
to NPs (in fact SiO2 toxicity in similar in the two cellular types), but to a reduced ability 
in producing inflammatory mediators. In both cellular models the main inflammatory 
cytokine induced by SiO2-NP is IL-1 followed by TNF- and lastly IL-6 (that in 
macrophages is just detectable because of its very low quantity), confirming that the main 
effect of silica is on the activation of inflammasome.  
3.3.2 SiO2 NPs – LPS synergism 
In the majority of studies reported in literature, cellular treatment with LPS (a TLR4 
agonist) is performed to “prime” cells before silica treatment [53,56,73,74]. In other 
words, LPS is used just as “first stimulus” for inflammasome activation to induce pro IL-
1  synthesis, while silica is added as “second stimulus” able to activate inflammasome 
and promote IL-1 maturation and release. Even if in this way the ability of silica to 
activate NLRP3 has been demonstrated, the real contribution of the two stimuli is not 
completely clear because they “work” together and, on the other hand, very little is 
known on the synergism between LPS and silica [138,139]. In 2011 our group 
demonstrated that Formyl-methionine-leucil phenylalanine (f-MLP, a model of 
formylated tripeptide) synergized with ORMOSIL NPs in IL-1 , TNF- IL-6 and IL-8 
production in monocytes and neutrophils [46]. I have studied the possible synergistic 
effect between LPS and amorphous SiO2-NPs by incubating monocytes and macrophages 
for 18 h in complete medium with Ludox TM40 NPs at different doses, with or without 
LPS at different concentrations.  
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Figure 20: Evaluation of the synergism between LPS and SiO2-NPs in the induction of inflammatory 
response. Indicated cells were incubated for 18 h with the indicated doses of LPS and Ludox TM40 SiO2-
NPs at different concentrations, and the levels of IL-1 , TNF-  and IL-6 released in the medium were 
measured by ELISA assays. Data are from one representative experiment out of four. N.D.: not determined. 
Synergism between two stimuli can be observed when the effect of their combination is 
major than the addition of their single effects. As expected, SiO2-NPs induced 
inflammatory cytokines above a threshold concentration in monocytes and, in lower 
amount, in macrophages, confirming our previous result that silica can promote 
inflammatory response per se (Figure 20). As seen before, IL-1  was the most 
represented cytokine, followed by TNF-  and, in a very small quantity, IL-6 (in 
macrophages almost null). After co-stimulation with LPS we obtained different results, 
depending on NPs and LPS concentration. In monocytes, LPS 1 ng/ml and 10 ng/ml 
enhanced IL-1  production after treatment with 100 μg/ml NPs respectively 4 and 2 
times; TNF-  was increased 2 times after treatment with LPS 1 ng/ml + NPs 100 μg/ml, 
while IL-6 was increased 4 times after stimulation with LPS 0.1 ng/ml + NPs 100 μg/ml. 
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It’s important to consider that high doses of LPS (100 ng/ml for IL-1 , 10/100 ng/ml for 
TNF-  and 1/10/100 ng/ml for IL-6 did not induce any synergism because LPS effect 
was maximum per se. In macrophages (less reactive to endotoxin), only a doubling in the 
production of IL-1  was visible after co-stimulation with LPS 1/10/100 ng/ml + NPs 100 
g/ml, while TNF- and IL-6 production were not synergized (the first because of the 
high effect of LPS “per-se”, the second because of the very weak cytokine production).                                                                                  
To be sure that eventual synergistic effects were not determined by an increased toxicity 
or cellular association of NPs in the presence of the co-stimulus, I performed control 
experiments monitoring cellular viability and NPs association with or without LPS. In 
Figure 21 is shown that LPS 1 ng/ml does not influence these two parameters in 
monocytes. Macrophages provided the same results, but data are not shown.                     
In conclusion, we demonstrated that endotoxin enhances SiO2-NPs induced inflammatory 
response, with the highest effect for IL-1  in monocytes. To better understand the 
mechanism of this synergism, we performed other experiments using LPS at a final 
concentration of 1 ng/ml (as dose providing the most effective effect). We concentrated 
our attention on IL-1 which is the main cytokine produced after inflammasome 
activation.  
 
Figure 21: Effect of LPS co-stimulation on SiO2-NPs cellular toxicity and association. Monocytes were 
incubated for 18 h with Stöber SiO2-NPs, in the presence or in the absence of LPS 1 ng/ml. Cellular 
viability and NPs cellular association were measured at flow cytometer. Data are the means of two 
experiments.  
3.3.3 Caspase 1 and IL-1  activation 
As described in paragraphs 1.4.3 and 1.4.4, mature IL-1 (17 kDa) derives from pro IL-
1  (31 kDa) after a processing operated by the active form of caspase 1 (the 
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heterotetramer p10 p20), which, in turn, derives from the autocleavage of pro-caspase 
(p45) to the mature form. We analyzed the dynamic of caspase 1 and IL-1  induction and 
activation in the presence of SiO2-NPs and LPS alone or together. This type of analysis is 
not easy because intracellular signal seen in western blot derives from a combination of 
multiple events (immature protein form is a balance between its production and 
processing; mature protein form between its formation and extracellular release). 
However, some macroscopic evidences can be observed.  
After 18 h cellular stimulation in complete medium, SiO2-NPs induced pro IL-1 (with a 
transcriptional and traductional steps) in monocytes and, at lower levels, in macrophages. 
Also LPS 1 ng/ml (as a classic inflammatory molecule) induced proIL-1 and, if 
combinated with NPs, the resulting level of pro-IL1 was the sum of the two stimuli 
alone (Figure 22a). At high NPs doses (100-300 μg/ml ± LPS for monocytes / 100-300 
μg/ml + LPS for macrophages) pro-IL1 decreased and IL1-  was correspondently 
released in the medium, as detected by ELISA assay. In monocytes, residues of the 
processed form of the cytokine were still visible inside cells in samples treated with 100-
300 μg/ml + LPS, while in the other cases cytokine amount was so low that was not 
detectable by western blot (but ELISA confirmed that it was produced and released in 
extracellular medium) (Figure 22 a-c). 
Caspase 1 resulted already present in its pro-form both in control samples of monocytes 
and macrophages, while a small amount of activated p20 was visible in macrophages. 
After treatment with NPs (with or without LPS), p45 appeared to be induced in 
monocytes, and at 300 μg/ml (a very toxic dose) a significant decrement was detectable 
(probably because of cellular lysis and consequent release of intracellular content). 
However, western blot did not provide any information on caspase 1 activation, because 
the mature form p20 was not visible (Figure 22b). On the contrary, macrophages showed 
some evidences of caspase 1 activation. In fact, p45 levels remained almost constant after 
NPs, LPS and NPs+LPS treatment, while p20 subunit increased (at NPs 25-50 μg/ml and 
NPs 25-50-100 μg/ml + LPS), suggesting (as one can expect) that both silica and 
endotoxin can activate caspase 1 processing. As for monocytes, high NPs doses (300 
μg/ml) determined a decrease of intracellular proteins (in this case p45 and p20) through 
cellular lysis (Figure 22b). 
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Figure 22: Western blot analysis of pro IL-1  and caspase 1 processing by LPS and SiO2 NPs treatment in 
monocytes and macrophages. (a, b) indicated cells (Mo: monocytes; Mf: macrophages) were treated for 18 
h in complete medium with increasing doses of Ludox TM40 NPs, with or without LPS 1 ng/ml. 
Intracellular pro IL-1  (p31), mature IL-1 p17) (panel a), pro caspase 1 (p45) and caspase 1 (p20) (panel 
b) were detected by Western blot analysis. Histograms on the right represent the blot signal quantification. 
(c) IL-1 levels (measured by ELISA assay) present in the extracellular medium of the same samples 
analyzed in (a, b)  
Furthermore, I have performed additional experiments to detect caspase 1 and IL-1  not 
only inside the cells but also in extracellular medium. It’s known that, after 
inflammasome activation, caspase 1 could be released extracellularly in a form of 
inflammasome inhibition [140]. Moreover, both proteins can be liberated as a 
consequence of cellular lysis. In these experiments, cells were incubated with SiO2-NPs 
and LPS in a serum free medium to avoid, after supernatants precipitation, a huge amount 
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of albumin and other abundant serum proteins that could interfere with electrophoretic 
separation. To compensate the lack of serum, a low concentrated mixture of proteins 
(Nutridoma) was added to medium. Cellular treatments were performed for a short time 
(4 h) and with low doses of SiO2-NPs, to avoid too high toxicity. As shown in Figure 23c, 
these conditions allowed us to obtain a synergism between NPs and LPS, reproducing the 
effect seen after treatments in complete medium for a longer time.  
 
  Figure 23: Western blot analysis of pro IL-1  and caspase 1 processing by LPS and SiO2 -NPs treatment 
in monocytes and macrophages. (a, b) indicated cells (Mo: monocytes; Mf: macrophages) were treated for 4 
h in serum free medium supplemented with Nutridoma with increasing doses of Ludox TM40 NPs, with or 
without LPS 1 ng/ml. Intracellular (intra) and extracellular (extra) pro IL-1  (p31), mature IL-1 p17) 
(panel a), pro caspase 1 (p45) and caspase 1 (p20) (panel b) were detected by Western blot analysis. 
Histograms on the right represent the blot signal quantification. (c) IL-1 levels (measured by ELISA 
assay) present in the extracellular medium of the same samples analyzed in (a, b). 
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In both monocytes and macrophages, intracellular pro-IL1  was induced by LPS, while a 
small increment after NPs treatment was visible only in macrophages. What appeared 
clear was that NPs (in the presence and absence of co-stimulus) determined the cleavage 
of IL- precursor (31 kDa) into its mature form (17 kDa) in both cells, and the majority 
of IL-1  was released in extracellular medium, through active mechanisms and also by 
cellular lysis (confirmed by extracellular presence of aspecific bands in silica treated 
samples) (Figure 23a). As in complete medium, monocytes produced higher amount of 
cytokine than macrophages (Figure 23c).  
Looking at caspase 1 blots (Figure 23b), the fact that p20 subunit was not present inside 
cells and appeared in extracellular medium in correspondence of SiO2-NPs treatment 
clearly indicated that it was activated by silica (confirming what is reported in literature). 
Our additional result was that LPS did not synergize with SiO2-NPs in caspase 1 
activation, suggesting that the enhanced IL-1  production after co-stimulation was not 
related to a caspase 1 “hyperactivation” but to other factors (e.g., LPS induced pro IL-1  
transcription).  
3.3.4 The role of ATP 
As described in paragraph 1.5.1., extracellular ATP strongly activates NLRP3 
inflammasome, by binding to its receptor P2X7, opening the ion gated channel and 
promoting K
+
 efflux and the consequent oligomerization of NLRP3. In monocytes, this 
mechanism is responsible for endotoxin induced IL-1  secretion, so that blockage of 
P2X7 with oATP (an inhibitor) abolishes IL-1 production [141]. As amorphous silica is 
able to activate NLRP3, I have investigated the role of ATP and P2X7 receptor in 
inflammasome assembly.                                                                                                 
Studying cytotoxicity mechanism of SiO2-NPs, we have found that they induce a decrease 
of intracellular ATP (Figure 13b). Following the hypothesis that ATP could be in part 
released outside the cell, I have measured (in the same experiment) intracellular and 
extracellular ATP after silica stimulation, focusing on the time dependence of the 
phenomenon (I have stimulated cells for 4 and 18 h) and on LPS possible influence.  
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Figure 24: Evaluation of intracellular and extracellular ATP concentration after monocytes and 
macrophages treatment with SiO2-NPs, in the presence or in the absence of LPS. Indicated cells were 
treated for 4 h and 18 h with increasing doses of Ludox TM40 SiO2-NPs with or without LPS 10 ng/ml. 
Intracellular and extracellular ATP levels were measured by a chemoluminescence assay in cellular lysate 
and in culture medium, respectively. Data are the mean of four experiments. 
After 4 h and 18 h treatment with SiO2-NPs, intracellular ATP decreased in monocytes 
and macrophages in a time dependent way (ATP fall was higher after a long time 
stimulation) (Figure 24, upper panels). LPS appeared to accelerate and increment ATP 
release in monocytes, while in macrophages the presence of endotoxin did not influence 
significantly the curve of ATP release. Macrophages presented a higher intracellular ATP 
concentration, because they are bigger than monocytes and contain an elevated number of 
organelles (in this case, mitochondria that are the main source of intracellular ATP).  
In general, SiO2-NPs treatment induced an increment of ATP concentration in 
extracellular medium in all the conditions, suggesting that, through cellular lysis or active 
mechanisms, the nucleotide is released outside the cells (Figure 24, lower panels). An 
important observation is that extracellular ATP concentration (following extrusion) 
remained in the order of nanomolar, not corresponding with the decrease registered inside 
the cells (which reached the order of millimolar). This can be due to extracellular 
degradation of the nucleotide by ecto-ATPases (despite the presence of ATPases inhibitor 
ARL), or to a decrease of intracellular ATP partially caused by a mitochondrial 
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dysfunction. In a more detailed analysis of data, ATP release in monocytes after 4 h 
treatment with SiO2-NPs clearly increased in a dose dependent way, and was not 
influenced by the presence of endotoxin. Also after 18 h treatment extracellular ATP 
augmented (the release was anticipated if compared to 4 h because of longer incubation), 
but in this case LPS per se induced a significant ATP extrusion (150 nM vs 10 nM of 
untreated cells) and, moreover, synergized with NPs in nucleotide release. At 300 µg/ml, 
plus or minus LPS, ATP level decreased because of the strong NPs cytotoxicity. LPS own 
effect is in accord with date present in literature [128,141], while the enhanced ATP 
release induced by silica and endotoxin co-stimulation could participate to the synergism 
in IL-1  production, acting as an enhanced second stimulus for inflammasome activation. 
Curiously, LPS role was visible only after 18 h stimulation, indicating that its action in 
promoting ATP externalization requires time. In macrophages, SiO2-NPs induced ATP 
release in a dose dependent way and, differently from monocytes, LPS did not induce any 
additional extrusion of the nucleotide. This latter result is in accord with literature [128], 
where it is reported that macrophages, contrary to monocytes, cannot release endogenous 
ATP. In addition, it can partially justify the low synergism in IL-1  production after co-
stimulation, in the sense that macrophages have a weaker second stimulus for 
inflammasome activation after NPs + LPS treatment. 
Once demonstrated that SiO2-NPs determine ATP release in extracellular medium in both 
monocytes and macrophages (probably through cellular lysis, but an active mechanism 
cannot be excluded), I have investigate if it could play a role in cytotoxicity and 
inflammatory response induced by SiO2-NPs. Usually, extracellular ATP binds to its 
membrane receptor P2X7 in an autocrine or paracrine way (respectively, when receptor is 
on the same cell that has released ATP or on a different cell), and triggers a series of 
pathways (first of all, NLRP3 assembly and activation to produce mature IL-1 ). A way 
to study if the binding between ATP and P2X7 is important in determining a particular 
cellular response to a certain stimulus is to block the receptor and check if any changes 
occur. This approach has been largely used in literature in studies concerning NLRP3 
activation, and through these experiments the importance of ATP binding to its receptor 
has been demonstrated for NLRP3 activation by several PAMPs or DAMPs, such as LPS, 
muramyl dipeptide (MDP), monosodium urate (MSU) [128,141]. The inhibitor mostly 
employed is 2’-3’ dialdehyde derivative of ATP [142], commonly known as oxidized 
ATP (oATP). As suggested by its name, it presents two aldehyde groups on ribose C2 and 
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C3, lacking the C2-C3 link present in ribose (Figure 25). As a structural analogue of ATP, 
it can bind P2X7 receptors, and because of its higher affinity than ATP to P2X7, it is used 
as irreversible inhibitor. 
 
Figure 25: Chemical structure of oATP and ATP 
Concerning ATP role in inducing cellular response to silica, Iyer et al. [185] reported that 
P2X7R-deficient murine macrophages do not present any difference in IL-1  production 
in comparison with wt macrophages, suggesting that this pathway is not involved. Since 
this is an isolated study, I have decided to perform a systematic study, comparing 
cytotoxicity (MTS, LDH, PI assays) and inflammatory response (IL- ) of SiO2-NPs in 
monocytes and macrophages in the presence or in the absence of oATP. Experiments 
were performed for 4 and 18 h, while LPS possible influence was considered only for 
monocytes.  
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Figure 26: Effect of ATP receptor blockage on SiO2-NPs induction of IL-1  in monocytes and 
macrophages. Indicated cells were incubated for 4 h or 18 h with increasing doses of Ludox TM40 NPs ± 
LPS, in the presence or in the absence of the ATP receptor inhibitor oATP 100 M. IL-1  levels released in 
the medium were measured by ELISA assay. Data are the means of four experiments. Significance of 
differences with respect to ctrl (no oATP) are indicated by * (p<0.05). N.D: not determined. 
 
As shown in Figure 26, in both monocytes and macrophages SiO2-NPs induced a release 
of IL-1  above a threshold concentration. Such threshold diminished over time, 
confirming our previous data of the time dependence of the phenomenon. In the presence 
of oATP 100 µM, IL-1  production was significantly inhibited after 4 h (at 100 µg/ml 
NPs,  85% inhibition in monocytes and  50% inhibition in macrophages) and after 20 h 
(at 50-75-100 µg/ml NPs,  50% inhibition in monocytes and  40% in macrophages). 
Also IL-1 levels resulting from NPs + LPS co-stimulation decreased of  90% after 4 h 
(at 100 µg/ml) and  50% after 20 h (at 50-75 µg/ml) in monocytes. This result strongly 
suggests that the binding of ATP to its receptor contributes to NLRP3 activation (and the 
consequent IL-1  maturation) induced by amorphous silica NPs, acting as a second signal 
similarly to other PAMPs and DAMPs. At high doses of SiO2-NPs (200-300 µg/ml) 
oATP was ineffective in IL-1  inhibition, probably because the strong NPs toxicity 
synergized with oATP intrinsic toxicity, masking the effect seen at lower doses of NPs.  
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Figure 27: Effect of ATP receptor blockage on SiO2-NPs cytotoxicity in monocytes and macrophages. 
Indicated cells were incubated for 4 h or 18 h with increasing doses of Ludox TM40 NPs ± LPS, in the 
presence or in the absence of the ATP receptor inhibitor oATP 100 M. NPs cytotoxicity was evaluated as 
mitochondrial damage (MTS), membrane permeabilization (PI) and cellular lysis (LDH). i: inhibition.  
In Figure 27 the effect of P2X7 blockage on SiO2-NPs cytotoxicity (evaluated by MTS, PI 
and LDH assays) is reported. After 4 h treatment, LD50 remained unchanged both in 
monocytes and macrophages in all the three assays. After 20 h treatment, in macrophages 
no changes were visible, while in monocytes SiO2 NPs LD50 showed a small increment 
of  20% with the three assays, in the presence either in the absence of LPS. This results 
suggest that, differently from IL-1  production, NPs induced cellular death does not 
depend (or minimally depends in the case of 20 h monocytes stimulation) on the pathway 
involving ATP binding to its receptor. In the next part of the thesis other possible 
mechanisms of cytotoxicity and inflammation will be considered. 
3.3.5 The role of caspase 1 
As reported in the literature for crystalline silica [53,56,71] and as confirmed by our 
experiments for amorphous silica (see paragraph 3.3.3), during NLRP3 activation the 
cysteine protease caspase-1 is subjected to autoprocessing, from its inactive precursor 
(p45) to the active form (p20 p10). Mature caspase 1 cleaves pro IL-1  in IL-1 . 
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Moreover, it has been reported by Reisetter et al. [109] that carbon black NPs induce in 
murine macrophages a cellular death requiring caspase-1 (the so called “pyroptosis”, 
already documented for macrophages infected by several types of pathogens). In order to 
investigate the role of caspase 1 in SiO2-NPs induced cellular death and inflammatory 
cytokines production, I have stimulated monocytes and macrophages for 4 and 18 h with 
SiO2-NPs, in the presence or in the absence of the caspase 1 inhibitor Ac-YVAD-CMK 
(N-Ac-Tyr-Val-Ala-Asp chlorometyl ketone) (Figure 28). YVAD is a synthetic tetra 
peptide whose aminoacidic sequence resembles the ones recognized by caspase 1 (YVHD 
in pro IL-1  and AVQD in pro caspase 1). Thanks to this similarity, the peptide can bind 
caspase 1 active site and inhibit irreversibly caspase 1 autoproteolysis (and consequently, 
catalytic activity). 
 
Figure 28: Chemical structure of caspase 1 inhibitor YVAD 
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Figure 29: Effect of caspase 1 inhibition on SiO2-NPs-induced inflammatory response in monocytes and 
macrophages. After pre-incubation for 1h with medium (ctrl) or caspase 1 inhibitor YVAD (100 or 200 
M), indicated cells were treated for 4 h or 20 h with increasing doses of Ludox TM40 NPs. IL-1 , TNF-  
and IL-6 levels released in the medium were measured by ELISA assay. Data are from one of three 
representative experiments. Significance of differences with respect to ctrl (no YVAD) are indicated by * 
(p<0.05). 
Figure 29 shows the effects of caspase 1 inhibition on cytokines (IL-1 , TNF-  and IL-6) 
induced by SiO2-NPs. In monocytes, after 4 h stimulation with SiO2-NPs, YVAD 
completely abolished IL-1 , TNF-  and IL-6 production at both concentrations used 
(100-200 µM), whereas after 18 h cytokines were less inhibited (even if their levels were 
still significantly reduced in comparison to controls) and 200 µM YVAD resulted more 
effective than 100 µM YVAD. This latter effect probably depends on the activation, over 
time, of major number of caspase 1 molecules, that to be successfully inhibited would 
need an higher concentration of YVAD. In a more detailed analysis, IL-1  decrease was 
70% (100 µM YVAD) and  90% (200 µM YVAD); TNF- decrease was 60% (100 
µM YVAD) and  85% (200 µM YVAD); IL-6 decrement was visible only at 200 µM 
YVAD (  95% at SIO2-NPs 37.5 µg/ml and  35% at SiO2-NPs 50 µg/ml).  
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In macrophages, after 4 h stimulation with SiO2-NPs, IL-1  was reduced of  50% at 
both YVAD concentrations, TNF-  decreased  80% (100 µM YVAD) and  50% (200 
µM YVAD) at 75 µg/ml SiO2-NPs (the only responsive dose) while, as seen in before, 
IL-6 was not produced and any YVAD effect could be detected. After 18 h stimulation, 
cytokines inhibition by YVAD appeared stronger (  80-90% for IL-1  and  80% for 
TNF- and, surprising, there was no difference between the two YVAD concentrations 
used. Summarizing, a first observation is that inflammatory cytokines production (after 
SiO2-NPs treatment) depends on caspase 1 activity in both cellular models, but in 
macrophages this phenomenon seems to be less important in such way, because at the two 
times cytokines decrease is minor than in monocytes and the increment of YVAD 
concentration does not increase its inhibitory effect (contrary to monocytes).                 
The second relevant observation concerns the type of cytokine that is inhibited. To check 
if YVAD interferes per se with the mechanism of IL-1 , TNF-  and IL-6 production or if 
inhibition was due to an other mechanism, we performed control experiments stimulating 
monocytes and macrophages with LPS 1 ng/ml for 20 h with or without caspase 1 
inhibitor. As expected, IL-1 levels decreased of 90% in both cells (according to YVAD 
action mechanism), while TNF- and IL-6 decrement was lower (TNF-  13% for 
monocytes and  35% for macrophages; IL-6: 5% for monocytes and macrophages), and 
in agreement with data present in literature [143,144]. Interestingly, TNF- and IL-6 
produced after silica treatment were significantly more inhibited by YVAD than after 
LPS stimulation, suggesting that YVAD intrinsic effect is not sufficient for this 
inhibition, and an additional mechanism is probably involved. On the contrary, SiO2-NPs 
induced IL-1  decrement is compatible with the one obtained after LPS treatment.  
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Figure 30: Effect of caspase 1 inhibition on SiO2-NPs cytotoxicity in monocytes and macrophages. After 
pre-incubation for 1h with medium (ctrl) or caspase 1 inhibitor YVAD (200 M), indicated cells were 
treated for 4h or 18h with increasing doses of Ludox TM40 NPs, and cytotoxicity was evaluated as 
mitochondrial damage (MTS), membrane permeabilization (PI) and cellular lysis (LDH). Histograms 
represent LD50 values. Data are the means of three experiments. Significance of differences with respect to 
ctrl (no YVAD) are indicated by * (p<0.05). i: inhibition. 
In order to evaluate if SiO2-NPs induce pyroptosis (a caspase 1 dependent cellular death), 
I have checked cellular viability (using MTS, PI and LDH assays) after silica treatment 
for 4 h and 18 h, in the presence or in the absence of YVAD. As reported in Figure 30, 
SiO2-NPs LD50 was not influenced by caspase 1 inhibition in 4 h treated monocytes and 
in 4-18 h treated macrophages in all the three assays performed. On the contrary, in 18 h 
treated monocytes LD50 increased in the presence of YVAD, respectively from 23 to 64 
µg/ml for MTS (64% inhibition of cytotoxicity), from 30 to 52 µg/ml for PI (42% 
inhibition of cytotoxicity) and from 25 to 55 µg/ml for LDH (62% inhibition of 
cytotoxicity), suggesting that, in such way, cellular death depends on caspase 1 activity. 
A possible explanation of the time – dependence of the process (viability increase is 
visible at 20 h but not at 4 h) could be the following. In macrophages, SiO2-NPs induced 
cellular death appears as a rapid process, indeed silica LD50 at 4 h (  40 µg/ml, with the 
exception of LDH assay) is very similar to LD50 at 20 h (  25 µg/ml with the three 
assays), indicating that SiO2-NPs exert in a short time their toxic effect. In monocytes the 
situation is different, because at 4 h LD50 is 71 µg/ml (MTS), 100 µg/ml (PI) and > 500 
µg/ml (LDH), while at 20 h it decreases at 23 µg/ml (MTS), 30 µg/ml (PI) and 25 µg/ml 
(LDH), indicating a slower death process, depending, for example, on a more complex 
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mechanism that requires time to occur. Our results indicate that this unknown mechanism 
of cell death could be pyroptosis, in fact, it is detectable only in cells dying over time 
(monocytes) and after a long incubation with SiO2-NPs (20 h). It is plausible that death 
occurring after short time treatment depends on a different, easier and more direct 
mechanism, similarly to macrophages (in fact, caspase 1 inhibition does not have any 
protective effect).  
3.3.6 The role of lysosomes acidification  
In paragraph 3.2.2 we have demonstrated that both monocytes and macrophages 
internalize SiO2-NPs into acidic endo-lysosomes (fluorescence associated to NPs 
overlapped with fluorescence associated to the lysosomotropic agent Lysotracker). A 
possible mechanism of silica toxicity proposed in literature involves silica induced 
lysosomal destabilization and subsequent rupture (“lysosomal leakage”), with the 
consequent intracellular release of proteases and hydrolases normally contained in these 
organelles [56]. Once in the cytosol, such enzymes contribute to inflammasome activation 
(acting as “danger signal”) and to cellular destruction. Recently, it has been shown that 
acidic lysosomal pH neutralization significantly reduces IL-1  production and, in few 
cases, cellular death consequent to amorphous/crystalline silica [56,73,74,134] and 
carbon nanotubes treatment [145]. To investigate if acidic pH may play a role in 
determining SiO2-NPs adverse effects, we incubated monocytes and macrophages with 
SiO2-NPs for 4 h and 18 h, with or without 1 h pre-treatment with 10 mM ammonium 
chloride (NH4Cl) and 12.5 nM Bafilomycin AI (BafAI), and we checked if any 
modulation of cytotoxic and inflammatory activities occurred.  
NH4Cl is a salt whose dissociation in solution produces HCl and NH3, a weak base that, 
thanks to its neutral charge, rapidly diffuses across plasma and lysosomal membranes. In 
lysosomes, NH3 is protonated by H
+
 to NH4
+
, subtracting protons to the acidic 
environment. Moreover, the membrane is much less permeable to the protonated species, 
leading NH4
+
 intralysosomal accumulation, osmotic water influx and lysosomal swelling, 
providing room for more NH3 in an auto-powering process [146]. As a consequence, 
intralysosomal pH increase from 4.5 to 6.2 after NH4Cl 10 mM perfusion [146,147]. 
Bafilomycin AI is a macrolide antibiotic produced by the bacteria Streptomyces Griseus, 
consisting of 16-membered lactone ring (Figure 31a) and able to inhibit Vacuolar-type 
H+-ATPase (V-ATPase) at nanomolar concentrations [148]. V-ATPases are proton 
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pumps situated on the membrane of several intracellular compartments (vacuoles, 
lysosomes, endosomes) responsible of the maintenance of acidic pH through the 
introduction of H
+
 from the cytoplasm into the organelles lumen, using the energy 
released by ATP hydrolysis. They consist of a cytoplasmic portion V1 (ATP-hydrolytic 
domain) and a membrane sector Vo (proton-translocation domain) (Figure 31b). V1 
contains three alternating copies of subunits A and B assembled in a ring, which 
participate to ATP binding and hydrolysis, a central stalk composed of single copies of 
subunits D and E and a peripheral stalk made of subunits C, E, G and H. Central and 
peripheral stalk connect V1 to V0 domain, that is composed of a ring of six proteolipid 
subunits (c
I
, c
II
, c
III
, present in double copy), a subunit a (containing two H
+
 hemi-
channels) and other subunits (d, e) [149][150]. V-ATPases pump protons into the lumen 
through a rotary mechanism, with a stechiometry of 2H
+
/1ATP [149]. Briefly, protons are 
first engaged at the cytoplasmic side of the hemi-channel in subunit a and protonate 
specific Glu residues on each c subunit of the c-ring. ATP bound at the interface of A and 
B subunits in V1 is hydrolyzed, and this drives the rotation of the c-ring, followed by 
protons displacement from the proteolipid subunits into the luminal hemi-channel of 
subunit a and the subsequent release into the lumen of the compartment. During this 
process, helical swiveling (rotation of the helices relative to one other) in c-ring and 
subunit a is important. Bafilomycin AI inhibition of V-ATPases occurs through the 
binding to the subunit c of V0, by preventing helical swiveling [150]. 
 
Figure 31: (a) chemical structure of Bafilomycin AI. (b) V-ATPase structural model (modified from [151]).  
The eventual interference of NH4Cl and BafAI with SiO2-NPs cellular association was 
evaluated in preliminary experiments, by incubating monocytes and macrophages for 4 
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and 18 h with fluorescent Stöber NPs, with or without the two neutralizing agents. As 
represented in Figure 32, any significant change was detected at 50-100 µg/ml NPs after 4 
h and at 25 µg/ml NPs after 20 h (the doses considered in cytotoxicity experiments).  
 
Figure 32: effect NH4Cl, BafAI and YVAD on SiO2-NPs cellular association. Indicated cells were pre-
incubated for 1 h with medium alone or supplemented with NH4Cl 10 mM, BafAI 12.5 nM or YVAD 100 
µM, and then treated for 4 h and 18 h with Stöber SiO2-NPs at increasing concentrations. NPs cellular 
association was measured at flow cytometer.  
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Figure 33: Effect of acidic compartments neutralization SiO2-NPs cytotoxicity in monocytes and 
macrophages. After pre-incubation for 1h with medium (ctrl), NH4Cl 10 mM or BafAI 12.5 nM, indicated 
cells were treated for 4h or 18h with increasing doses of Ludox TM40 NPs, and cytotoxicity was evaluated 
as mitochondrial damage (MTS), membrane permeabilization (PI) and cellular lysis (LDH). i: inhibition. 
Data are the means of three experiments. Significance of differences with respect to ctrl (no NH4Cl and 
BafAI) are indicated by * (p<0.05). i: inhibition. 
After 4 h treatment, SiO2-NPs cytotoxicity was inhibited  10% (MTS) and 30% (PI) in 
monocytes after lysosomal pH neutralization, whereas in macrophages  this phenomenon 
appeared less evident (  16% with PI assay) (Figure 33). After 20 h treatment, in 
monocytes NH4Cl induced a SiO2-NPs LD50 augment from 26 g/ml to 43 g/ml (38% 
inhibition of cytotoxicity, considering the three assays), and BafAI incremented SiO2-NPs 
LD50 from 26 g/ml to 64 g/ml (  60% inhibition of cytotoxicity), while in 
macrophages a medium inhibition of only 16% was detectable in samples treated with 
both neutralizing agents. Our result suggests that in monocytes SiO2-NPs toxicity is 
influenced by lysosomal pH (alkaline pH protects from cellular death), and this effect is 
more pronounced after 18 h treatment. BafAI appeared more effective because it directly 
blocks the H
+
-ATPase pump (the source of protons accumulated in lysosomes), while 
NH4Cl acts with an indirect mechanism. On the contrary, SiO2-NPs toxicity was less 
influenced by acidic pH in macrophages at both 4 h and 18 h, indicating that a different 
death mechanism is involved.  
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Figure 34: Effect of acidic compartments neutralization on SiO2-NPs induction of inflammatory response 
in monocytes and macrophages. After pre-incubation for 1h with medium (ctrl), NH4Cl 10 mM or BafAI 
12.5 nM, indicated cells were treated for 4h or 18h with increasing doses of Ludox TM40 NPs, and IL-1 , 
TNF-  and IL-6 levels were measured in cellular medium by ELISA assay. Data are from one 
representative experiment out of four. Significance of differences with respect to ctrl (no NH4Cl and BafAI) 
are indicated by * (p<0.05).  
To check if acidic compartments neutralization interfered per se with inflammatory 
cytokines production, control experiments were carried out by stimulating cells with LPS 
1 ng/ml as control. IL-1 levels were decreased of  20% by NH4Cl and 10% by BafAI in 
monocytes, while  30% decrement was observed in macrophages for both agents. TNF-
and IL-6 were similarly reduced (  13% by NH4Cl and 10% by BafAI in monocytes, 
and  13% by NH4Cl and 22% by BafAI in macrophages). Our result is in accord with the 
weak IL-1 TNF-  and IL-6 inhibition after NH4Cl treatment (< 40%) documented by 
Jang et al. [152]. 
In monocytes incubated for 4 h with SiO2-NPs, IL-1  and TNF-  were strongly inhibited 
by NH4Cl and BafAI (  90%) (for IL-6 any effect was detectable due to its negligible 
levels) (Figure 34). After 18 h, IL-1 and TNF- inhibition by NH4Cl was strong at low 
SiO2-NP doses (at 37.5 and 50 µg/ml, > 80%) and weaker at higher doses (  30-40% at 
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100 µg/ml), whereas BafAI at all NPs doses reduced of  90% cytokines level. Also IL-6 
was decreased of 90% at 50 µg/ml NPs and  of 40% at 75 µg/ml NPs.                                                                                                       
SiO2-NPs induced cytokines were less affected by acidic compartments neutralization in 
macrophages, indeed their levels were considerably less decreased than in monocytes (20-
50% inhibition at 4 and 18 h).  
In the two cellular types, inflammatory response reduction by NH4Cl and BafAI was 
consistent with the correspondent decrease of sensitivity to SiO2-NPs, in accord to the 
hypothesis that inflammatory event occurs as a consequence of a cytotoxic event. In fact  
monocytes (more protected against SiO2-NPs by the presence of acidic compartments 
neutralization) presented a stronger inhibition of  IL-1 , TNF-  and IL-6 production than 
macrophages, where neutralization did not lead to a significant cellular viability recovery. 
However, the fact that in both cells inflammatory response appeared to be more 
influenced than cellular mortality by NH4Cl and BafAI, and this trend cannot be justified 
only by an interference on cytokines production mechanism, suggests that an unknown 
additional mechanism could be involved. 
 
3.4 The effect of serum on SiO2-NPs activity 
Nanoparticles injected into the bloodstream (the most common way to reach a tissue for 
drug delivery, gene therapy or imaging) are rapidly coated by a series of plasma proteins, 
that influence and modulate NPs interaction with cells at different levels (toxicity, 
phagocytosis, induction of inflammation/coagulation). Since plasma (for in vivo models) 
or serum (for in vitro models) play a determinant role in NPs activity, I have investigated 
if and how serum amount modulates SiO2-NPs effects described in paragraphs 3.1, 3.2 
and 3.3.  
3.4.1 DLS measurements 
DLS measurements provided information about SiO2-NPs aggregation state in the 
presence of different amounts of serum, useful for a better understanding and 
interpretation of results obtained from biological assays. To this aim, all DLS protocols 
were carried out at 37°C. Figure 35a shows that SiO2-NPs diameter increased from ~ 35 
nm of monodispersed form (0% FCS) to large aggregates (d =100-200 nm) in the 
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presence of low amounts of FCS (0.5-2%), decreasing to smaller nanoparticulated 
structures (40 < d < 80 nm) at 10-40% FCS. Measurements performed keeping serum 
concentration constant (10%) and varying NPs doses (0-500 g/ml) confirmed the 
formation of large NPs-serum proteins agglomerates (d = 400-600 nm) at NPs 
concentrations > 200 g/ml (Figure 35b). Both serum and NPs dependence experiments 
suggested that in conditions of serum deficiency (serum/NPs ratios (%(v/v) : mg/ml) 
below 100) nanostructures resulting from NPs interaction with serum proteins have size 
significatively larger than in the presence of serum excess, as schematized in Figure 35c.  
 
Figure 35: Dynamic light scattering measurements of SiO2-NPs in the presence of fetal calf serum. (a) 
Stöber NPs were incubated for 10’ at 37°C with increasing doses of FCS (0-40% v/v) in the presence of 
PBS, and volume-weighted distribution analyses were performed. Top right panel: 0-40% FCS range. Main 
panel: zoom on 0-10% FCS range, in gray large aggregates. (b) Stöber NPs at increasing concentrations (0-
0.5 mg/ml) were incubated for 10’ at 37°C with 10% FCS in the presence of PBS, and volume weighted 
distribution analyses were performed. * A second, minor, population of 80 ± 30 nm size is detected; ** A 
second population with 7 ± 2 nm size, owing to serum proteins is detected. (c) a schematic example of 
possible SiO2 NPs-serum proteins aggregates in FCS deficiency and FCS excess condition.  
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3.4.2 Cytotoxicity 
Figure 36 represents the LD50s obtained after 18 h incubation of monocytes, 
macrophages, lymphocytes and HeLa with SiO2-NPs, diluted in media containing 
increasing serum concentrations (0-40% v/v). The macroscopic general trend in all cell 
types is an increase of LD50 with the increment of serum amount, indicating a protective 
serum effect against cellular death, in agreement with previous evidences [61]. More in 
detail, in the absence of serum monocytes, macrophages and lymphocytes were very and 
similarly susceptible to SiO2-NPs (LD50 3, 5, and 4 µg/ml respectively), while HeLa 
cells were significantly more resistant (LD50 83 µg/ml). This trend was maintained at 
low serum concentrations (0.5-2-5), while at 10% FCS (a dose typically used in cellular 
cultures) and at higher doses (20%, 40%) lymphocytes became much less sensitive to 
SiO2-NPs (LD50 reached values comparable to Hela). On the contrary, FCS protective 
effect resulted sensibly less marked in the two phagocytic cells, in particular for 
macrophages (at 40% FCS, SiO2-NPs LD50 was 32 g/ml, 3 times lower than for 
monocytes (93 g/ml)).  
 
Figure 36: Effect of fetal calf serum on SiO2-NPs induced cell death. Monocytes, macrophages, 
lymphocytes and HeLa were incubated for 18 h with increasing doses of Ludox TM40 NPs, in the presence 
of different amounts of FCS (0-40% v/v). Cellular mortality was determined as membrane permeabilization 
at flow cytometer (PI), and LD50 values were obtained from dose-response mortality curves. Data are the 
mean of four experiments run in triplicate. * Extrapolated values > 500 µg/ml.  
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3.4.3 Inflammatory response 
As SiO2-NPs cytotoxicity is shifted to higher NPs doses by serum increasing, I have 
investigated if also inflammatory response (that we have demonstrated being correlated to 
toxicity) was influenced by FCS %. Graphs reported in Figure 37 show that IL-1 , IL-6 
and TNF-  production occurred above cytotoxicity threshold and, in parallel with 
toxicity, was shifted to higher NPs doses with the increment of serum. This almost perfect 
coincidence of the beginning of cellular death with the detection of inflammatory 
mediators at any serum percentage robustly confirms that SiO2-NPs cytotoxicity and 
induction of inflammation are strictly correlated. Another interesting observation is that, 
for the same mortality, at higher serum doses the levels of cytokines are major, probably 
because in the presence of more nutrients and grow factors cellular metabolism is more 
efficient. As previously reported, at any serum percentage monocytes produced more 
cytokines than macrophages, and IL-1 resulted to be the most abundant.  
 
Figure 37: Effect of fetal calf serum on SiO2-NPs induced death and inflammatory response in monocytes 
and macrophages. Indicated cells were incubated for 18 h with increasing doses of Ludox TM40 SiO2-NPs, 
in the presence of different amounts of FCS (0-40% v/v). Cellular viability (determined at flow cytometer) 
and IL-1 , IL-6 and TNF- production are represented in the same graph. Data are the mean from triplicate 
samples.  
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3.4.4 Cellular association 
To evaluate the effect of serum on NPs cellular association, monocytes, macrophages, 
lymphocytes and HeLa were treated for 1 and 5 h with fluorescent Stöber NPs at low 
doses (≤ 50 µg/ml) to minimize cytotoxicity, in the presence of increasing FCS amounts 
(Figure 38). Preliminary spectrofluorimetric measures excluded any influence of serum 
on NPs fluorescence (Figure 17a). Confirming data obtained in paragraph 3.2.1, SiO2-
NPs mostly associated to macrophages, followed by HeLa, monocytes and lymphocytes. 
In non phagocytic cells, the presence of serum clearly decreased 10-20 times NPs cellular 
association at any time and NPs dose, depending on FCS % (10 < 2 < 0). In addition, at 
the three FCS concentrations, NPs association reached the maximal value already after 1 
h, suggesting that NPs-cell interaction is mediated by an easy rapid process (it’s no 
accident that in lymphocytes, less phagocytic than HeLa, this non-time dependent trend 
was more pronounced). On the contrary, monocytes and macrophages presented (at any 
FCS % and NPs dose) an evident time-dependence of NPs association, compatible with a 
slower and more sophisticated interaction mechanism (possibly phagocytosis). In 
phagocytic cells (in particular macrophages), NPs cellular association was less inhibited 
by the presence of serum, decreasing only 2-4 times at 10% FCS compared to 0% FCS. 
This well correlates with the protective effect of serum in the two cellular categories 
(strong in non-phagocytes and moderate in phagocytes), suggesting that, in such way, 
cellular death might depend on NPs cellular association.  
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Figure 38: Effect of fetal calf serum on SiO2-NPs association to monocytes, macrophages, lymphocytes 
and HeLa cells. Indicated cells were incubated for 1h and 5h with Stöber SiO2-NPs at increasing 
concentrations in the presence of 0-2-10% FCS, and NPs cellular association was evaluated at flow 
cytometer. Data are the mean from three experiments run in duplicate.  
To better understand the link between NPs cellular association and cellular viability we 
compared in parallel and in the same cell population the amount of alive cell-associated 
SiO2-NPs with the degree of cell cytotoxic effect, in dose/time dependent experiments at 
different FCS concentrations (Figure 39).  
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Figure 39: Correlation of SiO2-NPs-induced cell death with cell association in different doses, incubation 
times and serum concentrations. HeLa, macrophages, lymphocytes and monocytes were treated with 
increasing doses of Stöber SiO2-NPs for 1h, 5h and 18h in the presence of 0-2-10% FCS, and NPs 
cytotoxicity/cellular association were evaluated by cytofluorimetric analysis. Where the number of alive 
cells was < 100 fluorescence data concerning NPs-associated mean fluorescence intensity were considered 
not reliable ant not reported. Data are from one representative experiment out of two.  
As shown above, SiO2-NPs cytotoxicity was dose-time dependent in all considered cells, 
and was shifted to higher NPs concentrations at increasing serum (more evidently in non 
phagocytes compared to phagocytes). At the same time, signal of SiO2-NPs associated to 
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alive cells was strongly decreased in lymphocytes and HeLa in the presence of serum, 
while in monocytes and macrophages it resulted less affected and, interestingly, in some 
cases (e.g. after 18 h SiO2-NPs treatment in 0-2% FCS) it reached a plateau and 
eventually decreased above a certain NPs concentration, suggesting that there may be a 
maximal amount of NPs associated with cells compatible with physiological balance. We 
investigated this aspect concentrating on HeLa and macrophages, first because they 
similarly interacted with NPs and, second, after cellular death they were still detectable in 
the cellular system (monocytes and lymphocytes got disaggregated and disappeared), 
allowing a comparison between MFI of total, alive (PI negative) and death (PI positive) 
cells by cytofluorimetric analysis (Figure 40). We found in both cell types that, either in 
the absence or in the presence of serum, NPs associated to alive cells in a dose dependent 
way until reaching a maximal cell load (horizontal arrows), coincident with cytotoxicity 
threshold (vertical arrows). Conversely, NPs signal associated to permeabilized cells was 
found to linearly increase also above such threshold. Our result suggested that cells can 
interact with a maximal amount of NPs without compromising viability but, once reached 
this maximum load, they undergo death. Consequently, NPs increased signal became 
attributed to permeabilized cells (keeping in mind that fluorescence may be augmented 
also by the dissipation of lysosomal pH after leakage and by some non-specific 
interactions of particles to intracellular structures after membrane rupture), while the one 
of alive cells remains constant at the maximal loading value. In particular, in HeLa at 0% 
FCS the cytotoxicity threshold was ~ 100 g/ml and maximal cellular load was ~ 130,000 
MFI, while at 10% FCS threshold was shifted to ~ 300 g/ml and, surprising, cellular 
load was lower (~ 35,000 MFI), indicating that the small amount of NPs associated in 
these conditions were more toxic. In macrophages, either cytotoxicity thresholds (10 
g/ml at 0% FCS, 25 g/ml at 10% FCS) and maximal NPs cellular loads (~ 20,000 MFI 
at 0% FCS, ~ 40,000 MFI at 10% FCS) were lower than in HeLa cells in the same 
circumstances, consistently with macrophages major sensitivity to SiO2-NPs.  
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Figure 40: Relationship between SiO2-NPs cytotoxicity threshold and NPs cell load in macrophages and 
HeLa. Indicated cells were incubated for 5h in serum free medium or for 18h in medium plus 10% FCS 
with increasing doses of Stöber SiO2-NPs. Percentage cell death (lower panels) and mean fluorescence 
intensity due to NPs associated to total, alive and dead cells (upper panels) were quantified at flow 
cytometer. Vertical arrows are drawn to emphasize the correspondence between cytotoxicity threshold and 
the maximal cellular NPs amounts in alive cells, in turn marked by horizontal arrows in upper panels. Data 
are from a representative experiment out of four.  
3.4.5 Cellular localization  
To get morphological information also on the SiO2-NPs cellular distribution in different 
serum conditions I analyzed unfixed cells incubated for 2.5 h with Stöber SiO2-NPs in the 
presence of increasing serum amounts at confocal microscopy.  
In HeLa cells (Figure 41a) at 0% FCS SiO2-NPs accumulated on well defined clusters on 
plasma membrane at low doses (50 µg/ml), distributing on the entire membrane surface at 
high doses (at 500 µg/ml fluorescence signal was interrupted in correspondence of big 
membrane bleps, visible from contrast phase picture and indicative of strong toxicity). At 
intermediate FCS percentages (0.5-2%), SiO2-NPs were still mostly localized on plasma 
membrane, forming large aggregates with serum proteins at 300-500 µg/ml (aggregates 
are present not only in correspondence of cells but also in the surrounding medium, and 
are consequent to serum defect, as explained in paragraph 3.4.1). At 10% FCS, NPs 
associated signal was reduced compared to null-low serum % (according to 
cytofluorimetric data) and, again, mainly localized on plasma membrane, even if fine 
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dispersed intracellular vesicles within the cytoplasm were visible. Large NPs-serum 
proteins aggregates were absent because, at 10% concentration, serum is not defective 
compared to NPs. Phase contrast pictures showed that serum deprivation per se 
influenced HeLa morphology, with a transition from the classic stretched form in 10% 
FCS to a round apoptotic-like aspect at 0% FCS. However, SiO2-NPs toxicity appeared to 
be stronger in the absence of serum (cellular plasma membrane degenerated in big bleps 
and cytoplasm became non homogeneous) than in complete medium (treated cells 
maintained the same aspect of control cells), confirming serum protective effect presented 
in paragraph 3.4.2.  
In monocytes (Figure 41b), in no or few serum (0-2%), SiO2-NPs distributed on the 
plasma membrane, often forming a cap on one pole of cell surface, but also in 
intracellular compartments. As for HeLa, serum-NPs aggregates were visible, associated 
to cells or dispersed in the medium. At 10% FCS, SiO2-NPs signal clearly localized in 
intracellular vesicles sparse in the cell cytoplasm with poor membrane staining, indicating 
that serum presence is necessary for NPs phagocytosis in monocytes. Phase contrast 
pictures highlighted a strong SiO2-NPs toxicity at 0, 0.5 and 2% FCS (monocytes 
appeared completely disrupted or with large cytosolic vacuoles), while at 10% FCS 
cellular morphology was not affected by SiO2-NPs, indicating a minor sensitivity.  
In macrophages (Figure 41c), in serum free medium SiO2-NPs were irregularly dispersed 
into the cytoplasm, denoting the ability to internalize uncoated SiO2-NPs (contrary to 
HeLa and monocytes). However, in the presence of serum intracellular SiO2-NPs signal 
appeared more homogeneous and accumulated in compartments resembling typical 
phagosomes/phagolysosomes, suggesting as for monocytes that serum promotes NPs 
internalization. Phase contrast pictures showed completely death cells at 0% FCS, highly 
vacuolizated cells at 0.5-2% FCS and normal cells at 10% FCS after SiO2-NPs treatment. 
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Figure 41: Effect of fetal calf serum on SiO2-NPs cellular localization in HeLa cells (a), monocytes (b) and 
macrophages (c). Fluorescence and corresponding phase-contrast fields of one representative experiment 
from five are shown. Arrowheads indicate plasma membrane, arrows point to intracellular vesicles and 
asterisks show membrane swelling in HeLa cells and large cytoplasmic vacuoles in monocytes and 
macrophages.  
Quantitative information on the actual efficacy of different cell types to internalize bound 
SiO2-NPs as a function of serum were obtained by exploiting the ability of the membrane 
impermeant bio-compatible dye Trypan Blue (TB) to quench the fluorescence of the 
FITC-labeled Stöber SiO2-NPs in flow cytofluorimetric assays. Trypan blue adsorbs light 
in the range from 475-675 nm [153] which covers the wavelength of fluorescein 
fluorescence emission (519 nm), so that FITC fluorescence is efficiently quenched by the 
dye. In preliminary experiments, we estimated the quenching efficacy of 3 mg/ml TB of 
fully membrane bound or fully internalized Stöber SiO2-NPs, respectively incubating 
monocytes with SiO2-NPs at 4°C and binding SiO2-NPs to monocytes membrane as 
before, extensively washing and performing a chase for 24 h at 37°C. Extracellular signal 
quenching resulted to be ~ 60% , probably because the dye was not able to reach all 
fluorophore molecules within NPs matrix, whereas intracellular signal was quenched of ~ 
16%, due to a filtering effect of TB solution layer around the cell. Similar observations on 
TB fluorescence quenching potential have been obtained by Nuutila et al. [154]. 
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Considering such parameters, the relative amount of internalized SiO2-NPs as % of total 
cell associated was estimated, as described in paragraph 2.5.  
 
Figure 42: Extimation of cellular distribution of SiO2-NPs in monocytes, macrophages, lymphocytes and 
HeLa cells. Indicated cells were incubated for 1.5 h with increasing doses of Stöber SiO2-NPs, in the 
presence of 0-10% FCS. Then, samples were analyzed at flow cytometer with or without Trypan Blue 3 
mg/ml to estimate the amount of internalized NPs. 
In the absence of serum, ~ 20-30% of SiO2-NPs associated to cells were internalized at 
relative low doses (25-50 µg/ml); at higher doses (100-300 µg/ml) signal associated to 
intracellular NPs decreased in monocytes, lymphocytes and HeLa (respectively, to 20, 0 
and 0%) while it remained almost unchanged in macrophages (Figure 42). In the presence 
of 10% FCS, the percentage of SiO2-NPs internalized by cells did not change compared 
to 0% FCS in the two non-phagocytic models (lymphocytes and HeLa), while it was 
significantly enhanced in phagocytes. Indeed, in monocytes intracellular signal increased 
at higher SiO2-NPs doses reaching 80% of total cell load at 300 µg/ml, whereas in 
macrophages it was maximal already at 25 µg/ml (~ 100% endocytosis). Summarizing, 
TB experiments confirmed and provided a more quantitative view of confocal 
microscopy analysis, underlining the relevance of serum for SiO2-NPs uptake by 
phagocytic cells and, in opposition, the poor phagocytic ability of lymphocytes and HeLa 
in the absence either in the presence of FCS.  
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3.4.6 Hemolytic activity  
To get more information on SiO2-NPs cytotoxicity mechanism and the possible influence 
of FCS and pH, we checked NPs ability to induce red blood cells lysis (hemolysis) in the 
absence or in the presence of FCS 10% and at acidic (5) and neutral (7.2) pH (Figure 43). 
Hemolysis was time dependent at both 0% and 10% FCS and, as for cytotoxicity, was 
reduced by the presence of serum (Figure 43). Interestingly, at 0% FCS acidic pH 
strongly increased hemolytic activity of NPs at both times, in fact after 1h treatment 
EC50 (NPs dose producing 50% of the hemolytic effect) was 32.9 µg/ml at pH 5 and 65.7 
µg/ml at pH 7.2, and after 4h it was 26.9 µg/ml at pH 5 and 55.8 µg/ml at pH 7.2. This 
result is in accord with the reduction of hemolysis at alkaline pH documented by Shi et al. 
[155], and can be explained by the increased ionization (negative charge) of silanol 
groups at basic pH and the consequent stronger repulsion between net negatively charged 
red blood cells and SiO2-NPs. On the contrary, in the presence of 10% FCS the effect of 
pH was significantly lower and, at the times tested, pH 5 and pH 7.2 curves showed 
minimal differences (only after 4h treatment EC50 at pH 5 (347 µg/ml) was slightly 
lower than at pH 7.2 (357 µg/ml)).  
 
Figure 43: Dose-time dependent hemolytic activity of SiO2-NPs, in different serum (0% and 10%) and pH 
(5, 7.2) conditions. PBS-washed red blood cells were incubated for indicated times with increasing doses of 
Ludox TM40 NPs, in 0 or 10% FCS and at pH 5 or 7.2. After brief centrifugation, the release of 
hemoglobin in the supernatant was evaluated spectrophotometrically at 450 nm. Data are the means of three 
experiments.  
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3.4.7 The effect of caspase 1 inhibition and acidic compartments neutralization in no 
serum media 
To investigate if SiO2-NPs induced cellular toxicity and inflammatory response in the 
absence of serum were influenced by caspase-1 inhibition and lysosomes neutralization 
similarly to standard conditions (10% FCS), I have performed experiments stimulating 
monocytes and macrophages for 4 and 18 h in serum free medium supplemented with 
Nutridoma (Figure 44). 
 
Figure 44: Effect of acidic compartments neutralization and caspase 1 inhibition on SiO2-NPs induced 
cellular death in monocytes and macrophages in serum free condition. After pre-incubation for 1h with 
medium (ctrl), YVAD 100 M, NH4Cl 10 mM or BafAI 12.5 nM, indicated cells were treated for 4h or 18h 
with increasing doses of Ludox TM40 NPs. Cellular mortality was evaluated as mitochondrial damage 
(MTS), membrane permeabilization (PI) and cellular lysis (LDH). Data are the means of three experiments.  
In monocytes, SiO2-NPs LD50 (measured by MTS, PI and LDH assays) was  10 times 
lower than in the presence of 10% FCS (5-7.5 µg/ml versus 50-100 µg/ml at 4 h; 3-4 
µg/ml versus 25 µg/ml at 20 h), while in macrophages the difference between the two 
serum conditions was less marked (at 4 h, LD50 was  30 µg/ml (0% FCS) vs  40 µg/ml 
(10% FCS); at 20 h, LD50 was  20 µg/ml (0% FCS) vs 30 µg/ml (10% FCS)). This 
result confirmed our preliminary observation that SiO2-NPs effects are less influenced by 
serum in macrophages compared to monocytes. In the presence of 10% FCS, we have 
found that SiO2-NPs toxicity was significantly reduced after caspase 1 inhibition and 
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lysosomes neutralization in monocytes, while in macrophages it was poorly affected (see 
paragraphs 3.3.5 and 3.3.6). Surprising, in the absence of serum neither YVAD, NH4Cl 
and BafAI were able to diminish SiO2-NPs toxicity in both cellular types at 4 h and 20 h 
(as revealed by the three cytotoxicity assays performed). The loss of protective effect 
provided by caspase 1 inhibition and lysosomal neutralization in monocytes suggests that, 
in the absence of serum, SiO2-NPs may kill cells by a mechanism different from the one 
observed at 10% FCS, more similar to macrophages (that even in 10% FCS were less 
dependent on caspase 1 activity and lysosomes acidic pH). Inflammatory cytokines 
measured in parallel (IL-1  and TNF- resulted inhibited in the presence of YVAD, 
NH4Cl and BafAI (Figure 45), although cellular death was not affected by these agonists.  
 
Figure 45: Effect of acidic compartments neutralization and caspase 1 inhibition on SiO2-NPs induced 
inflammatory response in monocytes and macrophages, in serum free conditions. After pre-incubation for 
1h with medium (ctrl), YVAD 100 M, NH4Cl 10 mM or BafAI 12.5 nM, indicated cells were treated for 
4h or 18h with increasing doses of Ludox TM40 NPs. IL-1 , TNF-  and IL-6 levels were measured in 
cellular medium by ELISA assay. Data are from one representative experiment out of two. Significance of 
differences with respect to ctrl (no  YVAD, NH4Cl and BafAI) are indicated by * (p<0.05). 
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3.5 SiO2-NPs protein corona 
Once demonstrated that serum (an ubiquitous component of cellular media for the 
maintenance/stimulation of most cellular models for in vitro assays) largely influences 
several aspects of cellular response to NPs, I have concentrated on the characterization of 
serum proteins binding to SiO2-NPs surface (the so called “NPs corona”). First, I have 
determined the protein pattern bound to Ludox TM40 NPs in the standard conditions of 
biological assays (in the presence of 10% FCS at 37°C), using SiO2-NPs at 300 µg/ml as 
representative dose. NPs adsorbed proteins were visualized by Coomassie or silver 
staining and identified by mass spectrometry analysis. As represented in Figure 46, the 
two coloration methods revealed a very similar protein pattern. We found that the main 
FCS proteins adsorbed to NPs surface were plasminogen, albumin, apolipoprotein AI 
(ApoAI), hemoglobin and apolipoprotein AII (ApoAII). Plasminogen is the inactive 
precursor of plasmin, a serine protease responsible of fibrinolysis process through the 
regulated cleavage of fibrin (the protein forming blood clots) [156,157]. Albumin (the 
most abundant serum protein), presents several functions, such as maintaining the colloid 
osmotic pressure, transporting low water-soluble substances to site of action, metabolism 
or excretion, and providing a pool of amino acids for protein synthesis [158]. 
Hemoglobin, responsible of oxygen transport, is not a circulating protein because it’s 
normally present inside red blood cells. Since FCS is obtained after blood coagulation, we 
think that this process may have induced hemolysis, releasing hemoglobin in serum and 
so allowing the binding to NPs (in fact, this protein is not present in the pattern obtained 
after incubation of NPs with human plasma, directly taken from a volunteer (see 
paragraph 3.5.3). Apolipoproteins AI and AII constitute respectively 70% and 20% of 
high density lipoproteins (HDL) protein mass [159,160]. HDL are small lipoproteins 
responsible of cholesterol transport from peripheral cells to the liver (where it will be 
catabolized), preventing its deposition within arteries and lowering the risk of 
cardiovascular diseases [161]. Briefly, after HDL secretion from the liver and intestine in 
a “lipid-free” form, they acquire phospholipids and free cholesterol from peripheral cells 
through ABCA1 transporter (ATP-binding cassette transporter AI). Subsequently, free 
cholesterol is esterified by LCAT (lecithin: cholesterol acyltransferase), through the 
transfer of a fatty acid from lecithin to the free hydroxyl residue of cholesterol. Finally, 
SR-BI (scavenger receptor BI) mediates HDL-CE (HDL-cholesteryl ester) accumulation 
in the liver, where they undergo to catabolism [160,162-165]. In this context, ApoAI and 
114 
 
ApoAII are HDL-associated proteins enriched in amphipathic helices (that probably 
mediate the interaction with the lipid component) [159,166], and their principal functions 
are LCAT activator (ApoAI) and HDL structural component (ApoAII) [164,166]. 
 
 
Figure 46: Fetal calf serum proteins pattern bound to SiO2-NPs. 300 g of Ludox TM40 NPs were 
incubated at 37°C for 15’ with 10% FCS and, after NPs recovery by ultracentrifugation, washing and 
solubilization in sample buffer, samples were loaded onto a 12% non reducing polyacrilamide gel and 
stained by Colloidal Coomassie G250 (a) or silver nitrate (b). Indicated bands from gel (a) were excised and 
identified by mass spectrometry. (c) Table summarizing molecular weight (MW) and isoelectric point (pI) 
of identified proteins. Values refer to the mature (secreted) proteins and were determined using ProtParam 
program. 
After this preliminary identification of the components of NPs corona, we investigated 
proteins distribution on increasing amounts of NPs, incubating Ludox TM40 at different 
doses (0-1000 µg/ml) with 10% FCS at 37°C (miming the conditions of biological 
assays). For a better comprehension of the result, SDS-PAGE were performed by loading 
equal volumes of resuspended NPs (different quantities) (Figure 47a) and equal quantities 
of resuspended NPs (different volumes, Figure 47b).  
 
 
Protein 
 
MW 
(kDa) 
 
pI 
1- plasminogen 88.4 7.39 
2- albumin 66.4 5.71 
3- apolipoprotein AI 27.5 5.36 
4- hemoglobin fetal subunit  15.8 6.51 
5- apolipoprotein AII 8.7 5.34 
c 
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Figure 47: Influence of SiO2-NPs dose on fetal calf serum proteins pattern bound to NPs surface. 
Increasing concentrations of Ludox TM40 SiO2-NPs were incubated for 15’ at 37°C with 10% FCS. After 
NPs recovery by ultracentrifugation, washing and solubilization in sample buffer, equal volumes (20 l) (a) 
or equal amounts (3.3 g) (b) of solubilized NPs were loaded onto a non reducing 12% polyacrylamide gel 
and stained with silver nitrate. Graphs on the right represent signal quantification of bands. 1: plasminogen, 
2: albumin, 3: ApoAI, 4: hemoglobin, 5: ApoAII. Data are from one representative experiment out of three.  
Figure 47a shows that SiO2-NPs-attached plasminogen, apolipoproteins (AI and AII) and 
hemoglobin amount increased with the increment of NPs doses until ~ 100 µg/ml 
(plasminogen, apolipoproteins) or ~ 300 µg/ml (hemoglobin), while at higher 
concentrations their level remained constant, indicating that no more proteins were 
available for the binding to NPs because they have been completely exhausted from 
serum. On the contrary, albumin (the most abundant serum protein) poorly binds to SiO2-
NPs at concentrations < 100 µg/ml (suggesting a possible lower affinity for the surface 
then other proteins). However, in the correspondence of plasminogen, apolipoproteins 
and hemoglobin depletion, albumin started to adsorb in good amounts, proportionally to 
NPs dose. By loading an equal quantity of NPs (3.3 µg) in the gel it is possible to better 
appreciate the visible reduction of apolipoproteins and hemoglobin per SiO2-NPs mass 
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unit at concentrations > 100 µg/ml, whereas albumin (as present in excess) remains 
constant at all NPs doses (Figure 47b).  
3.5.1 The influence of FCS concentration 
Serum proteins adsorption on NPs surface depends not only on their abundance but also 
on their affinity for a particular nanostructure (determined by factors as charge, 
hydrophobicity, dimensions and shape). Recently, the terms “soft corona” and “hard 
corona” have been introduced to distinguish respectively low affinity proteins that loosely 
bind to NPs and high affinity proteins that tightly bind to NPs. To investigate which 
proteins have the highest affinity for SiO2-NPs surface, 0 (as control) or 300 µg/ml Ludox 
TM40 were incubated at 37°C with increasing serum concentrations (2-10-40%) (Figure 
48). In the absence of NPs, a trace of albumin was found to precipitate into the tube after 
ultracentrifugation (probably because of its huge amount), but it didn’t compromise our 
result because it was considered as “blank” and subtracted to other samples. Interestingly, 
we found a different pattern of proteins bound to NPs in diverse serum conditions. At 2% 
FCS, albumin was the main polypeptide associated, and it was also present as dimer 
(band correspondent to 100 kDa). At upper FCS concentrations, albumin amount clearly 
decreased (visible from either the monomeric and dimeric form), while plasminogen, 
apolipoproteins and hemoglobin (undetectable at 2% FCS) appeared in the pattern, 
proportionally to serum concentration. This serum dependent trend suggested us a 
possible explanation of what occurred at NPs / serum interface. In the presence of few 
FCS (2%) albumin, as the most abundant serum protein, reaches still relevant 
concentration values (0.5-1 mg/ml) and is favored in SiO2-NPs binding over other 
proteins (that, as less abundant, at 2% FCS are almost negligible). The fact that increasing 
serum results in albumin displacement to the detriment of other proteins suggests that the 
latter (e.g. at 10-40% FCS) reach a concentration sufficient to compete with albumin for 
NPs binding and, thanks to their probable higher affinity, they occupy the majority of 
places on NPs surface (increment) leaving to albumin few or no places (decrease).  
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Figure 48: Influence FCS concentration on proteins pattern bound to SiO2-NPs surface. 0 g (- SiO2 NPs) 
or 300 g (+ SiO2 NPs) of SiO2 NPs were incubated for 15’ at 37°C with 2-10-40 % FCS and, after NPs 
recovery by ultracentrifugation, washing and solubilization in sample buffer, samples were loaded onto a 
12% non reducing polyacrilamide gel and stained with silver nitrate. Histograms on the right represent 
signal quantification of bands. 1: plasminogen, 2: albumin, 3: ApoAI, 4: hemoglobin, 5: ApoAII. Data are 
from one representative experiment out of three.   
3.5.2 The influence of pH 
In paragraph 3.3.6 we have demonstrated that lysosomal pH is important in determining 
SiO2-NPs cellular toxicity and inflammatory response. Since NPs coated of serum 
proteins are internalized in phagolysosomes in monocytes and macrophages (see 
paragraph 3.3.2), we investigated if NPs “corona” might change from extracellular 
medium/cytosolic environment (pH 7.2-7.4) to cellular acidic compartments (pH 5). To 
this, Ludox TM40 NPs (0-50-100-300 µg) were incubated at 37°C with 10% FCS pH 5 or 
pH 7.2, and then standard experimental procedure was followed. In the absence of NPs, a 
non-specific protein signal was visible with 10% FCS pH 5, probably because at low pH 
(non physiological condition) serum proteins are more prone to precipitate. However, 
samples without NPs were considered as blank and subtracted to the others for band 
quantification. According to previous paragraph, at both pH NPs-bound plasminogen and 
albumin amount increased at higher SiO2-NPs doses while apolipoproteins and 
hemoglobin levels remained almost constant (in particular between 100 and 300 µg/ml 
NPs). Furthermore, we found that plasminogen and albumin significantly decreased at pH 
7.2 compared to pH 5 (respectively of 85% at the three NPs doses and of 66% at 300 
µg/ml NPs), whereas hemoglobin and apolipoproteins were not subjected to relevant 
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changes (Figure 49). This result shows that SiO2-NPs bound proteins do not undergo 
substantial modifications upon NPs uptake in lysosomes (only albumin and plasminogen 
present in the NPs bio-interface but not yet bound to the surface tend to absorb more), 
suggesting that toxicity mechanisms occurring in these compartments are not related to a 
simple pH-dependent rearrangement of the corona. This result is in accord also with the 
almost unchanged hemolytic activity of SiO2-NPs in the presence of serum at acidic (pH 
5) or neutral pH (pH 7.2) (paragraph 3.4.6). 
 
Figure 49: Influence of pH on proteins pattern bound to SiO2-NPs surface. 0, 50, 100 and 300 g/ml of 
Ludox TM40 NPs were incubated for 15’ at 37°C with 10% FCS at two different pH (5 and 7.2). After NPs 
recovery by ultracentrifugation, washing and solubilization in sample buffer, samples were loaded onto a 
12% non reducing polyacrilamide gel and stained with silver nitrate. Histograms on the right represent 
signal quantification of bands and are the means of three experiments. 1: plasminogen, 2: albumin, 3: 
ApoAI, 4: hemoglobin, 5: ApoAII. Significance of differences with respect to samples at pH 5 are indicated 
by * (p<0.05). 
3.5.3 Fetal calf serum vs human plasma 
Once characterized at different levels the interaction of fetal calf serum proteins with 
SiO2-NPs (FCS was used as model system of in vitro condition), we wanted to identify 
the principal proteins of human plasma (HP) binding SiO2-NPs surface, simulating a 
possible in vivo condition. Indeed, NPs used as drug carriers/imaging agents are mostly 
injected into the bloodstream, where they are coated by a series of plasma proteins that 
mediate cellular response to the foreign material. The experiment (performed with 2 mg 
SiO2-NPs incubated with 10% HP at 37°C) was carried out in parallel with 10% FCS 
incubation, to compare proteins adsorbed to NPs in the two situations.  
119 
 
 
 
  
 
 
 
 
 
Figure 50: Comparison between  SiO2-NPs bound proteins derived from human plasma (HP) or fetal calf 
serum (FCS). 0 (-) or 2 mg (+) of Ludox TM40 NPs were incubated for 15’ at 37°C with 10% HP or FCS 
(a), or with increasing HP or FCS percentages (0, 10, 40, 80) (b). After NPs recovery by ultracentrifugation, 
washing and solubilization in sample buffer, samples were loaded onto a 12% non reducing polyacrilamide 
gel and stained with silver nitrate. (c) Detection of IgG, HRG, HSA and ApoAI by Western Blot on HP 
samples of (b). Data are from one representative experiment out of four. (d) Table summarizing molecular 
weight (MW), isoelectric point (pI) and plasma concentration of identified proteins. Values refer to the 
mature (secreted) proteins and were determined using ProtParam program. 
Interestingly, we found a different protein pattern in the presence of human plasma or 
bovine serum (Figure 50a). In fact, at 10% FCS the main proteins adsorbed were 
 
Protein 
 
MW 
(kDa) 
 
pI 
 
Plasma 
concentration 
(mg/ml) 
1- Immunoglobulin G 150 - 5-10 
2- Histidine rich glycoprotein 57,6 7 0.15 
3- Albumin 66,4 5,67 50-60 
4- Apolipoprotein AI 28,0 5,27 1-1.5 
5- Apolipoprotein AII 8,7 5,05 0.3-0.5 
6- Apolipoprotein CIII 8,8 4,72 0.12-0.14 d 
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plasminogen (7), albumin (8), ApoAI (9), hemoglobin (10) and ApoAII (11), confirming 
our previous data. In 10% HP, we identified by mass spectrometry Immunoglobulin G 
(IgG), Histidine rich glycoprotein (HRG), albumin (HSA), Apolipoprotein AI (ApoAI), 
Apolipoprotein AII (ApoAII) and Apolipoprotein CIII (ApoCIII). Further, some of them 
were recognized by specific antibodies in Western Blot analysis (Figure 50c). Histidine 
rich glycoprotein is a multidomain protein able to interact with several ligands and 
involved in the regulation of numerous biologic processes. In particular, Poon et al. found 
that HRG copurifies with immunoglobulins, which are necessary for HRG-mediated 
clearance of necrotic cells by phagocytes [167]. Consistently, Gorgani et al. demonstrated 
than HRG promotes macrophages Fc RI-dependent ingestion of apoptotic cells by 
binding naked DNA exposed on membrane bleps [168]. In addition, HRG is also a 
regulator of angiogenesis, coagulation, cellular adhesion and proliferation [169-171]. 
ApoCIII belongs to VLDL (very low density lipoprotein) complexes (  50% of the 
protein fraction) and, contrary to ApoAI and ApoAII, is poorly present in HDL (  2% of 
the protein fraction). ApoCIII has inhibitory functions in the catabolism of triglyceride 
rich lipoproteins (VLDL), indeed it inhibits lipoprotein lipase and hepatic lipase 
(responsible of the hydrolysis of triglycerides into free fatty acids) and blocks also the 
clearance of lipoproteins by hepatic receptors [166]. For this reasons, ApoCIII 
overproduction is often associated to hypertrigliceridemia.  
Curiously, in the same conditions (e.g. 10% FCS) albumin and apolipoproteins were 
present in both patterns but in different quantities (HSA predominated in bovine serum 
while ApoAI, ApoAII and ApoCIII were more abundant in plasma), consistent with the 
fact that lipoproteins concentration is higher in plasma than in FCS [172]. Similarly to 
bovine serum, also HP protein pattern was modified at increasing plasma concentrations 
(Figure 50b), with a loss of NPs bound albumin and the concomitant increase of IgG, 
HRG, ApoAI, ApoAII and ApoCIII, suggesting that also human albumin, although it is 
the most abundant plasma protein, at high plasma concentrations is displaced by 
polypeptides less represented but with an higher affinity for SiO2-NPs.  
We subsequently performed functional assays to evaluate if SiO2-NPs may induce 
different cytotoxic/inflammatory effects in the presence of bovine serum either human 
plasma (as they bind different proteins). After 20 h macrophages incubation with SiO2-
NPs, we found that cytotoxicity and induction of inflammatory cytokines (IL-1  and 
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TNF- ) occurring in the presence of FCS were significantly inhibited/abolished in the 
presence of HP (Figure 51), indicating that, in such way, plasma is a more protective 
environment against SiO2-NPs cytotoxicity. Since the one of the main differences 
between proteins adsorbed on SiO2-NPs surface after incubation with HP or FCS was the 
much higher amount of apolipoproteins present in the first case, we investigated if they 
could play a role in protecting cells against SiO2-NPs adverse effects by treating 
macrophages with SiO2-NPs in the presence of normal FCS or “lipoproteins-depleted” 
FCS. Serum delipidation was obtained incubating FCS with increasing concentrations of 
SiO2-NPs that, as represented in Figure 47, at doses > 300 µg/ml exhaust almost all the 
lipoproteins (while more abundant proteins, such as albumin, still remain in the system).  
 
Figure 51: Comparison between SiO2-NPs cytotoxicity/inflammatory response in the presence of FCS or 
HP in macrophages. Cells were incubated for 18 h with Ludox TM40 SiO2-NPs (with or without LPS), in 
the presence of FCS or HP. Cellular mortality was evaluated by cytofluorimetric analysis (PI), while IL-1  
and TNF-  levels released in extracellular medium were quantified by ELISA assay. Significance of 
differences with respect to FCS is indicated by * (p<0.05). Data are from one representative experiment out 
of three.  
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Figure 52: Comparison between SiO2-NPs cytotoxicity/inflammatory response in the presence of normal or 
delipidated FCS. (a) Medium + 10% FCS was incubated at 37°C for 20’ with increasing doses of Ludox 
TM40 NPs (0-75-300-1000 g/ml). After ultracentrifugation to precipitate NPs, supernatant was collected, 
loaded onto a 12% non reducing polyacrilamide gel and stained by silver nitrate. (b, c): Macrophages were 
incubated for 18 h with Ludox TM40 NPs, in the presence of normal or delipidated 10% FCS obtained as 
described in (a). Cellular mortality was evaluated by cytofluorimetric analysis (PI), while IL-1 levels 
released in extracellular medium were quantified by ELISA assay. Significance of differences with respect 
to normal 10% FCS is indicated by * (p<0.05).  
Figure 52a shows that SiO2-NPs at a concentration of 1 mg/ml deplete serum from the 
majority of ApoAI and ApoAII, without exhausting plasminogen, albumin and 
hemoglobin. Macrophages incubated with apolipoproteins-deficient serum clearly 
resulted more sensitive to SiO2-NPs treatment than in the presence of normal FCS (Figure 
52b). Indeed, at 25 µg/ml NPs cellular viability was decreased from 100% (normal FCS) 
to 45% (depleted FCS) and, in the latter condition, a significant production of IL-1 was 
observed (Figure 52c). Our result might support the hypothesis of a possible protective 
effect of apolipoproteins, documented also by Barrett et al. [173]. 
3.5.4 Functional assays with isolated plasma proteins 
In the last part of my thesis, I will present preliminary data concerning the influence of 
isolated plasma proteins on cellular response to SiO2-NPs. This is an important point 
because the knowledge of the role of single proteins adsorbed to NPs would allow the 
design of nanoconstructs that, for example, bind to proteins protective against cellular 
toxicity.  
a b c 
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First, histidine rich glycoprotein was successfully purified from human plasma by the 
cation exchange resin phosphocellulose (Figure 53a, b). As reported in literature, 
immunoglobulins (IgG2) co-purified with HRG, as they participate to HRG-dependent 
clearance of necrotic cells by phagocytes [167]. Incubation with Staphylococcus Aureus 
Protein A allowed the removal of IgG from HRG preparation (Figure 53c); however, both 
protein purification from plasma and IgG precipitation need to be improved for future 
work.  
 
Figure 53: Histidine rich glycoprotein purification from human plasma. After purification procedure of 
HRG by the cation exchange phosphocellulose resin P11, 20 µl of human plasma 1:100 (HP), 20 µl of flow 
through 1:100 (FT), 20 µl of wash 1:2 (W) and 20 µl elution fractions were loaded onto a reducing 12% 
polyacrilamyde gel and stained with silver nitrate (a) or with anti-HRG antibody by Western Blot (b). (c) 
IgG were removed from HRG positive fractions by incubation with sepharose beads conjugated to 
Staphylococcus Aureus Protein A. Whole fraction (HRG + IgG), IgG depleted fraction (HRG – IgG) and 
detached IgG (IgG) were loaded onto a 12% reducing polyacrylamide gel and stained by silver nitrate.  
Then, monocytes were incubated with Stöber NPs for 18 h in serum free medium, in the 
presence of some single proteins added at a concentration corresponding to 2% HP (IgG: 
140 g/ml, ApoAI: 24 g/ml, HSA: 1.2 mg/ml, HDL: 50 g/ml, HRG: 3 g/ml), and 
cellular viability/alive cells fluorescence were evaluated at flow cytometer (Figure 54). 
IgG and HRG (co-purified with immunoglobulins) did not protect significantly cells from 
SiO2-NPs cytotoxicity (LD50 no proteins: 4.85 ± 0.2 g/ml; LD50 IgG: 9.85 ± 4.3 
g/ml), while NPs cellular association was enhanced by IgG, consistently with the 
hypothesis that in phagocytic cells NPs uptake can be mediated by the binding of 
adsorbed immunoglobulins to Fc receptors [174]. ApoAI showed a little protective effect 
(LD50 ApoAI: 15.65 ± 4,3 g/ml), and NPs cellular association didn’t undergo 
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significant changes. Interestingly, both HSA and HDL clearly enhanced cellular viability 
in the presence of SiO2-NPs, with a stronger effect of HDL (LD50 HSA: 44.2 g/ml, 
LD50 HDL: > 80 g/ml) and, in parallel, alive cells MFI values were similarly decreased 
in comparison to cells treated in the absence of proteins (Figure 54).  
 
Figure 54: Effect of single plasma proteins on SiO2-NPs cytotoxicity and cellular association in monocytes. 
Cells were incubated with Ludox TM40 NPs for 18h in serum free medium (no proteins) or medium 
supplemented with indicated proteins. Cellular viability and NPs cellular association were evaluated at flow 
cytometer. Data are the mean of two experiments. 
Concentrating on the two protective proteins (HDL and HSA), we further investigated if 
they similarly influenced SiO2-NPs membrane toxicity by hemolysis experiments 
performed in serum free medium or in the presence of HDL or HSA (Figure 55). After 
short time incubation (1h), NPs were strongly hemolytic at relatively low doses (< 50 
g/ml) in the absence of serum, no hemolytic in the presence of albumin and 50% 
hemolytic at 300 g/ml in the presence of HDL. The lower protective activity of HDL at 
high NPs doses could be attributed to their unability to cover the entire NPs surface (as 
they have been completely depleted from serum as shown in figure 47), leaving part of 
NPs uncoated and highly interacting with membrane. On the contrary, the more plentiful 
protein albumin can saturate all the NPs superficies and apparently protect cells from 
lysis. Interestingly, at longer incubation times (4h and, more evidentely, at 18h), HDL 
were still protective against hemolysis until 100 g/ml NPs, while in the presence of 
albumin NPs showed a hemolytic activity linearly dependent on NPs dose and incubation 
time, resulting, in some cases, more dangerous than in the presence of HDL. Such result 
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suggests a less efficiency of albumin in preventing membrane damage in comparison to 
HDL, and can partially justify the lower HSA protective effect reported in Figure 54.  
 
Figure 55: Effect of single plasma proteins on SiO2-NPs hemolytic activity. PBS-washed red blood cells 
were incubated for indicated times with increasing doses of Ludox TM40 NPs, in the absence of serum (0% 
FCS) and in the presence of HDL 35 g/ml or HSA 5 mg/ml. After brief centrifugation, the release of 
hemoglobin in the supernatant was evaluated spectrophotometrically at 450 nm. Data are from one 
representative experiment out of three.  
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4. Discussion and conclusions 
In this PhD thesis several aspects concerning environmental or anthropogenic NPs 
interaction with human cells have been investigated, using as nanomaterial model 
synthetic amorphous silica nanoparticles and as cellular models two categories of 
populations (phagocytic and non phagocytic cells) exemplificative of the ones mostly 
interacting with nanoparticles. In particular, SiO2-NPs cytotoxic and pro-inflammatory 
mechanisms have been largely characterized, focusing the attention on how they could be 
influenced by the presence of serum and, in a more detailed and functional analysis, by 
specific serum/plasma proteins. In this last section, a critical summary of the main results 
obtained and a possible integrated view of them will be presented and discussed.                                                       
The first relevant finding is that in the presence of serum (a condition closer to the 
physiological context of NPs in contact with blood) phagocytic cells (monocytes and 
macrophages) are ~ 10 fold more sensitive to SiO2-NPs than non phagocytic cells 
(lymphocytes and HeLa). In addition, in the correspondence of cytotoxicity they undergo 
a strong pro inflammatory cytokines secretion (TNF- , IL-6 and, over all, IL-1 ), in 
agreement with another our result indicating that SiO2-NPs induce necrosis/oncosis (an 
inflammatory death) but not apoptosis in monocytes and macrophages. This points the 
attention on the fact that, upon NPs introduction into the organism, the most affected 
cellular populations may be the circulating (monocytes) or resident (macrophages) cells 
of RES/MPS system. These cells may be subjected to a catastrophic death with the 
activation of intracellular pathways like the NLRP3 inflammasome and the release of 
inflammatory mediators that may cause additional adverse effects in the surrounding 
environment. These already critical effects might be worsened if blood contains traces of 
endotoxin (~ 1 ng/ml), scarcely pro-inflammatory per se but able to synergize with SiO2-
NPs in the production of pro inflammatory mediators. We purpose, as a possible 
explanation of this higher sensitivity of phagocytes compared to non phagocytes, their 
better ability to internalize NPs-serum protein complexes, because of their peculiar 
endocytic mechanism (phagocytosis, mostly mediated by a plethora of receptors such as 
Fc receptors, Complement receptors and Scavenger receptors) [42] allowing a rapid and 
very efficient uptake of particles of large size (> 0.5 M) (as can be viruses, bacteria and 
cellular debris). On the contrary, non phagocytic cells (in our case lymphocytes and 
HeLa) in the majority of cases internalize external objects through pinocytosis, engulfing 
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extracellular fluid containing small molecules or solutes in vesicles with a maximal cut-
off of 90-120 nm. Such dimensional limit of the objects that can be uptaken by 
phagocytes or non phagocytes is important in our experimental context, as we have found 
that SiO2-NPs (whose monodispersed size is 25-32 nm) upon contact with serum form 
larger structures (big aggregates of 200-500 nm diameter when serum is defective and 
small aggregates of 40-80 nm diameter when serum in excess), so that they are still easily 
engulfed by monocytes and macrophages (localizing into acidic endo-phagosomes) but 
minimally captured by lymphocytes and HeLa cells (accumulating on the plasma 
membrane). In the case of a serum free condition, the difference between phagocytic and 
non phagocytic cells appears less pronounced, as NPs are present only in their small 
monodispersed form. However, our data suggest that phagocytes (in particular 
macrophages) internalize SiO2-NPs better then HeLa cells, and are therefore more 
sensitive to their effects. In conclusion we found that serum influence on SiO2-NPs 
biological effects is much more relevant (that is protective) for non phagocytic cells than 
for phagocytes, as the latter can still internalize large nanoparticles-serum protein 
complexes via phagocytosis and may possibly still interact with a silicon surface through 
serum proteins-independent mechanisms (for example, by the scavenger receptor 
MARCO as reported in [175,176] ) that allow NPs storage into intracellular 
compartments. We also found that alive cells can accumulate into acidic endo-lysosomes 
a maximal amount of NPs (defined “critical intracellular load”), above which cytotoxicity 
and pro-inflammatory events initiate leading to a catastrophic cellular death. Phagocytes 
may reach this “critical load” at lower NPs doses (as they have a better ability to uptake 
particles) than non phagocytes, and so result more sensitive to NPs treatment (Figure 56). 
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Figure 56: Model of differential interaction/cytotoxicity of SiO2-NPs/serum proteins complexes in non 
phagocytes (lymphocytes and HeLa) and phagocytes (monocytes and macrophages). 
To understand the link between NPs accumulation in endo-lysosomal vesicles and the 
cytotoxicity/pro-inflammatory responses occurring in phagocytes we started from the 
literature. It is in fact reported that, for example, silica crystals accumulation in acidic 
compartments can induce their destabilization and rupture, leading to the release into the 
cytosol of several lytic enzymes -proteases, hydrolases, lipases- able to dismantle the cell 
and to activate inflammatory pathway (e.g., NLRP3 inflammasome) [56]. We tried to 
better characterize this process using our two phagocytic models and found unexpected 
and interesting differences. We initially discovered that, in the correspondence of SiO2-
NPs cytotoxicity threshold, endo-lysosomal compartments containing NPs undergo 
disruption (confirming data already present in literature). An additional result was that, in 
the presence of serum, endo-lysosomal acidic pH is important in determining NPs 
cytotoxic potential in monocytes, in fact in the presence of neutralizing agents (NH4Cl 
and BafAI) SiO2 -NPs LD50s were shifted to higher values, indicating a protective effect. 
This could be due to a possible rearrangement of the protein corona of NPs at pH values 
(4-5) lower than in normal condition (7). Alternatively, an enhanced activation and 
activity of lytic enzymes at acidic pH may determine not only a more efficient disruption 
of cellular structures but also a rapid degradation of NPs corona with the consequent 
exposure of the nude silicon surface, able to exert adverse effects simply “by contact”. 
130 
 
Our data, indicating that nor protein pattern bound to SiO2-NPs nor that the rough activity 
of NPs on cells (intended as plasma membrane activity and evaluated by hemolysis 
assays in the presence of 10% FCS) change significantly between acidic (5) and neutral 
(7.2) pH, highlight the major importance of proteases activation by acidic pH for NPs 
cytotoxicity. Interestingly, the dependence of SiO2-NPs cytotoxicity on acidic pH is much 
less pronounced in macrophages. This could be due to several still unidentified aspects, 
such as additional SiO2-NPs cytotoxicity mechanisms not dependent on pH or to a 
different binding and internalization route on NPs-protein complexes in comparison to 
monocytes, attributed to the different expression levels of some membrane receptors (e.g., 
the scavenger receptor B1, implicated in HDL uptake) recognizing proteins present in 
SiO2 NPs corona. Another interesting result was that in both cellular types the SiO2 NPs – 
induction of pro inflammatory cytokines was partially inhibited by acidic compartments 
neutralization, despite this poorly interferes with monocytes/macrophages activation by 
the classical agonist LPS. Focusing on IL-1  (as the main pro-inflammatory mediator 
induced by particulate structures upon NLRP3 inflammasome activation), it has to be 
reminded that its production requires a “priming step” (throughout pro-IL1  mRNA is 
synthesized by a transcriptional step and pro-IL1 is produced by a translational step), 
and an “activation step” (in which NLRP3 inflammasome is assembled and activated 
through a mechanism either dependent on ROS generation, ATP binding to its receptor or 
lysosomal proteases activity), resulting in caspase 1 mediated processing of pro IL-  
into IL- that is released extracellularly. Our previous results (not presented in this 
thesis) demonstrated by Real Time PCR analysis that SiO2-NPs induce IL-1  mRNA 
transcription. Here we firstly show by Western Blot analysis that IL-1  mRNA is 
translated into IL-1  immature form and subsequently cleaved into mature IL-1 by 
caspase 1 (in fact, the blockage of caspase 1 through the inhibitor YVAD strongly 
reduces this process). Since caspase 1 activation is, according to the literature, the last 
event before IL-1  production, we investigated possible steps occurring “upstream”, 
important for the NLRP3 activation. The fact that acidic compartments neutralization 
partially reduces IL-1 levels clearly indicates that the lysosomal proteases most likely 
released upon lysosomal rupture could process a hypothetical substrate able to activate 
NLRP3. However, as the IL-1 inhibition was not complete, we studied other possible 
mechanisms involved in inflammasome activation, in particular the binding of ATP to its 
membrane receptor P2X7. We found that also by preventing the binding of ATP to P2X7 
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through a competitor (oATP) IL-1 levels were partially diminished, indicating that also 
this pathway contributes to SiO2-NPs NALP3 activation. In future experiments, it would 
be interesting to evaluate how acidic compartments neutralization and P2X7 blockage 
could influence caspase 1 activation, since it is supposed that they act upstream.  
With the aim to link the cytotoxic and pro inflammatory events, we investigated if 
caspase 1 and P2X7 inhibition could affect also cellular death, thinking about a possible 
pyroptotic mortality mechanism or about a paracrine-endocrine danger signal constituted 
by extracellular ATP. Curiously, as for acidic compartments neutralization, SiO2-NPs 
LD50 was lowered by the presence of YVAD (strong reduction) or oATP (poor 
reduction) in monocytes after treatment for a long time (20 h), while in macrophages any 
important effect was observed at any time. This result reinforced the hypothesis that SiO2-
NPs treatment induces different death modalities in monocytes and macrophages. In 
particular, in monocytes a more complex mechanism similar to pyroptosis (blocked by 
caspase 1 inhibition) and depending on endo-lysosomal acidic pH is initiated, while in 
macrophages cellular death appears to be due to a simpler oncotic mechanism. Such 
dissimilarity between the two cellular models is less evident looking at pro-inflammatory 
cytokines production (resulting always reduced after treatment with YVAD, oATP or 
acidic compartments neutralizers), probably because in such way these agonists interfere 
with inflammasome activation by SiO2-NPs.                                                                                                    
In addition to the NPs endocytosis-dependent cellular death described up to here, SiO2-
NPs can kill cells also by simply interacting with plasma membrane, for example, in a 
serum free condition or when target cells are completely unable to internalize external 
entities (such as erythrocytes). Amorphous silica is known to effectively bind biological 
membranes, as its silanol groups (SiOH) exposed on the surface can form H bonds with 
the oxygens of PO4
-
 groups of phospholipids and, alternatively, deprotonated negatively 
charged silanols (SiO
-
) can establish an electrostatic interaction with the positively 
charged quaternary ammonium moiety of phospholipids (like phosphatidylcholine) [177]. 
Such direct binding causes a rapid and strong cellular disruption, as demonstrated by all 
our experiments carried out in the absence of serum. For a better comprehension of this 
cytotoxicity mechanism, we firstly choose the model of red blood cells lysis to investigate 
if silanols protonation state could modify SiO2-NPs membranolytic effect. We found that 
at neutral pH (7.2) cellular lysis occurred at higher NPs doses than at acidic pH (5), 
consistently with the idea of a reduced interaction between silica surface and biological 
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membrane components by increasing pH values. We also found that, in the absence of 
serum, both monocytes and macrophages were not protected by lysosomal compartments 
neutralization and caspase 1 inhibition. A plausible explanation of this result could be 
that, since in a serum free condition SiO2-NPs are mainly located on the plasma 
membrane without being internalized into the cells, the cytotoxicity mechanism is no 
more dependent on events occurring intracellularly (as caspase 1 or lysosomal proteases 
activation) registered in particular in monocytes in the presence of 10% FCS. On the 
other hand, contrary to hemolysis carried out at pH 5.2 or 7, treatment with NH4Cl or 
Bafilomycin AI does not show any protective effect as this two neutralizer agents act at 
intracellular vesicles level, without affecting silanol groups protonation state when NPs 
remain in the medium. However, also in serum free condition SiO2-NPs – induced pro 
inflammatory cytokines were partially inhibited in the presence of YVAD, NH4Cl and 
BafAI, indicating that before the complete cellular lysis some dangerous signals such as 
ATP secretion (able to bind its membrane receptor) or ROS production (possibly leading 
to lysosomal destabilization through membrane lipids peroxidation) may be activated, 
with the consequent recruitment and switching on of NLRP3. So, in general we can 
conclude that SiO2-NPs cytotoxic event is always associated to the secretion of pro 
inflammatory mediators, but they don’t necessary strictly and “linearly” depend on the 
same pathway (in fact in the presence of various inhibitors they behave differently).  
After defining the main differences between SiO2-NPs cytotoxicity mechanism in our two 
myeloid phagocytic cellular models in the presence or in the absence of serum, we 
concentrated on the first condition as it is more representative of a possible in vivo 
situation (referring to NPs injected into the blood stream as drug carriers or imaging 
agents). It is universally accepted that NPs exert their biological effects on cellular 
populations they come in contact with not as entities per se but dressed with 
macromolecules (over all proteins) present in the surrounding environment. Hence, we 
identified the main serum/plasma proteins absorbed to SiO2-NPs surface and we 
correlated them with NPs biological activity. The first main finding emerging was that 
SiO2-NPs bind to proteins with different affinities, with an higher propensity for 
Apolipoproteins (AI and AII, components of HDL complexes) and a low preference for 
albumin, despite this is the most plentiful serum/plasma protein. This result (evident from 
experiments carried out with both FCS and HP) is in agreement with the literature 
[31,32,178] and probably due to a general specific lipoproteins-NPs interaction driven by 
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their similar size/curvature. In addition, other proteins forming SiO2-NPs corona have 
been identified (IgG, HRG and ApoCIII for HP, plasminogen and hemoglobin for FCS). 
Concentrating on HDL and albumin, we found multiple evidences suggesting that they 
differentially contribute to NPs biological activity, with a higher protection against 
cytotoxicity of HDL. First, in a condition of HDL excess (HP vs FCS and FCS vs 
delipidated FCS) SiO2-NPs adverse effects were strongly reduced. Second, in the 
presence of certain FCS concentration (e.g.10%), SiO2-NPs cytotoxicity was null/minimal 
at concentrations in which the protein corona was mainly constituted by HDL with low 
albumin (below 50-75 g/ml), while at increasing doses NPs exerted their toxic potential 
despite their surface was still completely coated (this time, by high albumin and low 
HDL, because high affinity lipoproteins have been depleted from serum and the 
additional places on NPs surface could be occupied by the more plentiful albumin). 
Moreover, we also noted that SiO2-NPs cytotoxicity (in monocytes) resembles the one of 
endo-lysosomal/pyroptotic pathway (partially prevented by lysosomal neutralization and 
caspase 1 blockage) when nanoparticles were administered at doses in which protein 
corona was still composed by high HDL/low BSA (50-75 g/ml), while at higher doses 
(in which albumin is the predominant absorbed protein) cytotoxicity occurred through a 
membrane-dependent mechanism (not prevented by agonists). These hypotheses were 
confirmed by some experiments. First, in monocytes SiO2-NPs LD50 was higher in the 
presence of medium + HDL than of medium + albumin (however, NPs toxicity was 
strongly reduced by both proteins if compared to a serum free condition). The fact that 
NPs similarly associated to cells if incubated with either HDL or BSA excluded that this 
different sensitivity could be simply due to a differential NPs intracellular load, 
suggesting a more complex mechanism differently dependent on the two specific 
proteins. In the matter of this, additional hemolysis experiments (representative of a 
membrane toxicity) clearly indicated that HDL coated NPs lack membranolytic activity 
(occurring only when HLD are defective leaving nude spaces on NPs surface), while 
albumin coated NPs can damage plasma membrane, supporting our initial hypothesis of 
an endocytic pathway for HDL-NPs, and a membrane action for albumin-NPs. Since NPs 
coated with albumin showed a hemolytic activity similar, although occurring with a 
slower kinetics, to nude ones we supposed that its binding to NPs surface could be less 
stable due to its low affinity, possibly leaving unprotected sites (nude surface) able to 
exert a membranolytic activity. This latter hypothesis is congruent with our DLS 
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measurements in 10% FCS, clearly evidencing a drastic increment of the dimension of 
SiO2-NPs-serum proteins aggregates in the correspondence of the switch from a NPs 
corona mostly formed by HDL to a corona in which albumin is predominant (at NPs 
concentrations > 100 g/ml), suggesting that low affinity proteins (even if present at 
doses still able to saturate total NPs surface) interact disorderly with NPs, forming less 
compact and more dispersed aggregates of large size and leaving unoccupied places onto 
the surface. A schematic summary of the hypothetical different modality of SiO2-NPs 
cytotoxic/pro inflammatory mechanism is illustrated in Figure 57. To get more 
information and to validate this model, however, additional experiments must be done, 
for example by investigating NPs cellular localization and testing acidic compartments 
neutralizer and caspase 1 inhibitor protective effects in the presence of HDL and albumin. 
It would be interesting to perform this type of analysis on both our phagocytic cellular 
models (monocytes and macrophages), in order to better understand also their different 
response to SiO2-NPs.  
In addition to HDL and albumin, we also started a preliminary characterization of the 
influence on cellular SiO2-NPs effects by other proteins absorbed on silica surface, 
preferring the ones from HP to better mimic a putative in vivo situation. In particular, we 
found that IgG and HRG did not protect cells from NPs cytotoxicity (contrary to HDL 
and albumin) and that, on the contrary, IgG incremented NPs cellular association. So, it 
would be interesting to analyze the mechanism of NPs cellular interaction driven by these 
“bad” proteins, paying particular attention on the possible role of receptors, like Fc 
receptors, normally involved in the phagocytosis of opsonized particles during immune 
response. Moreover it is interesting to investigate if HRG acts per se or by the mediation 
of IgG (naturally bound to its N terminal). The final aim of this functional analysis of 
single plasma proteins absorbed on NPs surface would be to design more biocompatible 
nanoparticles (characterized by low cytotoxic/pro inflammatory potential and stealth 
properties), by favoring the binding of “protective” proteins and limiting the one of “bad” 
proteins after their injection into the bloodstream or in other biological fluids. In 
principle, this might be obtained by synthesizing NPs exposing on their surface different 
chemical groups able to bind different proteins that can differently modulate NPs 
biological activity. Encouraging results recently obtained in our laboratory indicate that 
ORMOSIL-NPs are less toxic/pro-inflammatory than amorphous SiO2-NPs and, in line 
with our hypothesis of a differential influence of surface-bound proteins, their protein 
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corona is mainly composed by apolipoproteins (putative “good” proteins) with a minimal 
trace of IgG and HRG (putative “bad” proteins adsorbed in a good amount on amorphous 
SiO2 NPs surface). In conclusion, despite amorphous SiO2-NPs (thanks to their cheapness 
and large availability) are useful for a preliminary characterization of the role of single 
absorbed proteins in modulating cellular response to nanomaterials, futures studies for the 
design of a nanoparticle model suitable for nanotheranostic should be performed using 
ORMOSIL-NPs. First, because they are more biocompatible than SiO2-NPs (with less 
cytotoxic/pro-inflammatory and procoagulant effects) [179] and, second, because, due to 
their synthesis procedure and chemical nature (in particular the presence organic groups), 
they can be easily modified with different superficial groups, hopefully conferring a 
higher biocompatibility.  
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Figure 57: Proposed models of cytotoxic and pro-inflammatory mechanism of SiO2-NPs in the presence of 
different NPs-serum proteins complexes in monocytes. (a) different types of nanoagglomerates formed at 
increasing NPs doses in the same serum concentration (e.g., in 10% FCS). Low NPs concentrations: NPs 
corona is mainly constituted by HDL; NPs-serum proteins complexes are monodispersed or poorly 
aggregated and very compact. From the point “HDL defective” (high NPs concentrations): NPs corona is 
composed by HDL and serum albumin (SA); NPs serum proteins complexes are more dispersed and bigger. 
The evolution of the NPs corona composition around single particles, as a function of NPs concentration, is 
highlighted by the dotted line circles. (b) Serum free condition: uncoated NPs directly interact with plasma 
membrane, causing its damage, the release of danger signals such as ATP, the activation of pro 
inflammatory pathways and finally an oncotic death. The few NPs endocytosed can destroy endo-
lysosomes, with the consequent release of proteases contributing to inflammasome activation. (c) 
Monodispersed-HDL coated unit condition: NPs-HDL complexes (lacking membrane activity) are 
endocytosed into endo-lysosomes, where we postulate that the protein corona is processed by acidic 
proteases/hydrolases with the consequent exposure of nude NPs surface, lysosomal rupture and release of 
the proteases that activate cell death and inflammatory pathways. (d) Aggregated HDL/SA coated unit 
condition: large NPs-HDL-SA complexes display some direct membrane activity and are also phagocytized 
into endo-lysosomes in which they continue to induce an acidic independent membrane damage and the 
release of proteases activating inflammatory pathways and inducing cellular death. In b, c and d the 
pathways of NALP3 inflammasome activation are indicated by dotted lines.  
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